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[1] Reproduced with the permission from: A. Gini, T. Brandhofer, O. García Mancheño, Org. Biomol. Chem., 2017, 15, 
1294. Copyright 2017 The Royal Chemistry Society; schemes, figures and text may differ from the published version. 
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1.1 Csp3-H bond oxidative functionalization: An introduction 
Csp3-H bonds are omnipresent in synthetic and natural compounds.1 From small 
neurotransmitters to big bio-polymers, all the organic compounds are essentially chains or rings 
of consecutive carbon atoms covered each with one or more hydrogen atoms, occasionally followed 
by heteroatoms (such as oxygen, nitrogen or halogen). Although such heteroatoms are essential 
for common organic synthetic strategies, nature has engineered various approaches to introduce 
high value fragment in molecules by simple activation of Csp3-H bond in a regioselective manner,2 
for example what is observed in the biosynthesis of several alkaloyds.2a,2f,2e Indeed, one of the 
biggest challenges, easily tackled by nature, is the similar high energy of the different present 
Csp3-H bonds,3 which hinders achieving a complete regioselectivity without abusing of synthetic 
steps. As it follows, the scientific community is far to carry out similar and almost perfect 
strategies, and the most general methodology on the functionalization of Csp3-H bond still relief 
in standards cross-coupling approaches involving a pre-insertion of a good leaving group (LG), 
which drives the next reaction, typically a nucleophilic substitution or a transition metal (TM) 
catalysed coupling (Scheme 1).4 It is important to notice that, even though the C-H bond in sp2 
and sp carbons have higher dissociation energy compared to Csp3-H, the intrinsic proprieties of 
unsaturated carbon chains lead to easier and extremely regio-selective direct functionalization of 
Csp2-H or Csp-H bond, such as standard Heck and Sonogashira cross-coupling reactions.5,6 
 
Scheme 1. Direct oxidative C-H functionalization vs. cross coupling. 
Another important issue is the incompatibility of the enrolled reagents with the functional 
groups in the molecule, especially when strong organometallic nucleophiles are involved.4 Thus, 
to avoid this controversy other unwanted protection/deprotection steps are required. Therefore, 
Csp3-H functionalization reactions inspired by nature’s high efficiency and chemoselectivity are 
highly desirable and an ongoing endeavour in synthetic chemistry. In this regard, one of the most 
promising approach is the dehydrogenative or (mono-) oxidative functionalization of Csp3-H bonds. 
Among this approach, several other similar C-H bond direct functionalization strategies were 
successfully developed. For example, other interesting methodologies involve the C-H bond 
activation by a transition metal or by metal-carbene formation,7,8 the activation by hydrogen 
radical abstraction through an in situ generated N-centered radical,9 radical halogenations,10 the 
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more classical Friedel-Crafts-type reactions or the simple deprotonation-substitutions (via acid-
base) not involving a C-H oxidation of the reaction partner.11 The dehydrogenative or (mono-) 
oxidative functionalization of Csp3-H strategy was just a dream at the beginning of the last 
century, but in the last 20 years chemists explored massively this approach, resulting to a 
relentless flow of outstanding applications that try to elude the poor regioselectivity among similar 
Csp3-H bonds. In general, such approaches rely on the symmetry of the desire target, or on steric 
hindrance, to exclude specific site. However, the intrinsic nature of Csp3-H bonds, i.e. different 
influences from adjacent functional groups, lead to slightly but exploitable changes of dissociation 
energy between diverse C-H bonds (Scheme 2).12 As consequence, the choice of the right oxidative 
system has a major role in scheduling a strategy with the outlook of a complete regioselective C-
H bond functionalization on a substrate with several possible active sites. In this fashion, it would 
be noteworthy to analyse the current evolution in Csp3-H functionalization based on an oxidant 
perspective, while discussing the advantage and disadvantage of each class of oxidant. 
 
Scheme 2. BDEs of C-H bonds of standard substrates. 
  
 
 
 
 
 
 
 4 
 
1.2 Peroxides as Oxidants 
The most representative examples of dehydrogenative and (mono-)oxidative Csp3-H bond 
functionalization involved strong radical hydroxyperoxide oxidants such as tert-butyl 
hydroxylperoxide (TBHP). Besides the general low selectivity of this reactant, several reported 
procedures employ it as terminal or as primary oxidant, generally paired with copper or iron based 
catalysts.13 Metal catalysis results in many cases essential to achieve not only in the C-X bond 
formation, but to enhance the selectivity and to help the activation of the hydroxyperoxide at lower 
temperatures. However, when such strong peroxides are employed, it is essential to avoid sensitive 
functional groups and to target substrates with a highly distinct oxidizable site.  
 
Between 2004 and 2006, C. S. Li and co-workers published plenty of outstanding examples 
on copper catalysed Csp3-H bond activation involving TBHP as oxidant.14 Among these 
publications, it resulted doubtless that tetrahydroisoquinoline is a special target when such 
strategies are applied (Scheme 3). From the pioneering work reported in 2004, in which alkynes 
were the chosen reaction partners, several different nucleophiles have been successfully employed. 
However, the methods are limited to nucleophiles that are stable in such oxidative environment. 
In addition, Li’s group showed that it was possible to extend, this methodology to different Csp3-
H bonds in α to a nitrogen atom, such as in dimethyl anilines or cyclic amines.14a,14d Noteworthy, 
it was possible to perform the addition of an alkyne in asymmetric manner by adding a chiral 
ligand (Scheme 3).14b 
 
Scheme 3. Various TBHP mediated C-H functionalization of THIQ. 
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In addition, the C.-J Li’s group achieved the THBP-mediated functionalization of allylic C-
H bond of cyclic alkenes using copper and cobalt as dual catalytic system (Scheme 4).14f   
 
 
Scheme 4. Cobalt/Copper dual catalysis for the functionalization of allylic C-H bond. 
In 2010, T. Xie and co-workers published an interesting Ugi-type three-component reaction 
involving THBP/copper-mediated Csp3-H direct functionalization of N,N-dimethyl anilines.15 The 
proposed strategy appears a valid option for the synthesis of α-amino imides, but it has some 
limitations regarding the scope. This methodology is not applicable to electron-rich anilines, 
highly electron-poor anilines and ortho unsubstituted aryl isocyanides. In addition, the reaction is 
limited to aryl carboxylic acids. The yields are reasonable, but a poor reactivity is observed when 
the target is not a N,N-dimethyl aniline (Scheme 5). 
 
Scheme 5. THBP-mediated C-H bond functionalization/Ugi-type reaction.  
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TBHP is not only able to mediate the activation of Csp3-H bonds close to a nitrogen. For 
example, in 2013 the group of J.-H. Li proposed an interesting strategy for the formation of oxo-
indolines by addition of ether-radicals, formed via TBHP-mediated HAT process, to electron-poor 
alkenes (Scheme 6).16 
 
Scheme 6. Synthesis of oxo-indolines by C-H functionalization/cascade reaction.  
In this case, the reaction is performed under iron catalysis, which promotes both the 
activation of the TBHP and the SET process to restore the aromaticity to form the desire product. 
Although the reaction works relatively well with linear and cyclic ethers, diethers, cyclic 
thioethers and methyl piperidines, the strategy is restricted to symmetric substrates. 
Furthermore, the employed high temperature (120 °C) and the requested large amount of ethers 
(20 equiv.) limits the procedure to small scale reaction with cheap and temperature-stable ethers. 
It is interesting to noticed that in 2015 H. Ge and co-workers published a similar Csp3-H bond 
activation for the addition of ethers on comumarin and flavon derivatives.17  
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Even though TBHP can perform efficient C-H bond functionalization on several targets and 
the copper/TBHP system could be considered a benchmark in the C-H bond activation, the high 
reactivity of TBHP limits the scope, especially considering a late stage functionalization of 
sensitive substrate. Thus, the attention was shifted to more tolerating oxidants such as dialkyl or 
diacyl peroxides,18 from which the formation of the active radical species is considerable slower. 
The dialkyl and diacyl peroxides, such as di-tert-butyl peroxide (DTBP), dicumyl peroxide (DCP) 
and dibenzoyl peroxide (BPO), were then explored in many Csp3-H bond functionalization 
reactions, including rather inert substrates. In fact, in recent years, the mediated Csp3-H bond 
activation of cyclic symmetric alkanes resulted a potent methodology for the alkylation of several 
radical acceptors.19 The most notably examples are involving simple alkenes,19a chromones,19b 
dithiols19c or aldehydes19d (Scheme 7).  
 
Scheme 7. Di-tert-butyl peroxide mediated C-H functionalization of alkenes. 
The generated alkyl radical intermediate can also be involved in cascade reactions.20 For 
example, C. Zhu and co-workers reported in 2015 the synthesis of novel quaternary carbon centres 
by a DCP promoted free radical cascade process concerning a radical addition/SO2 
elimination/arene migration (Scheme 8).20a Several N-aryl-N-(arenylsulfonyl)methaacrylamides 
were used efficiently apart from substrate bearing strongly electron-poor or bulky ortho 
substituents.  
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Scheme 8. Alkyl radical addition to electron-poor alkane. 
More recently, J.-T. Yu and his collaborators proposed another interesting cascade 
reaction, implicating a benzoyl peroxide mediated Csp3-H bond activation/carboannuliation of 
ynones with alkanes (Scheme 9).20b The activation of alkanes presents some important limitations 
due to the required typical high temperature to achieve both the activation of the peroxide and 
the HAT on the alkane. Furthermore, there is a poor regioselectivity for the functionalization on 
linear and not symmetric substrate. Other notable target molecules suitable for the Csp3-H bond 
activation by diacyl or dialkyl peroxides are benzylic, moieties21a, 21c amides21b or ethers21d.  
 
 
Scheme 9. Benzoyl peroxide mediated Csp3-H bond activation/carboannuliation of ynones. 
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1.3 Benzoquinones and Oxygen as Oxidant 
Benzoquinones are another class of oxidants that have been employed in various oxidative 
Csp3-H functionalization applications, such as direct cross dehydrogenative coupling (CDC) 
reactions mediated by 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) reported by C.-J. Li and 
co-workers.22 Nevertheless, the main concern about these oxidative agents is their high intrinsic 
toxicity.23 Therefore, oxygen has attracted a great attention in the past few years as one of the 
greenest and cheapest oxidants.24 Unfortunately, its reactivity as oxidant is poor. As a result, there 
are only few examples where oxygen was used without any additive, such as metal catalysts or 
terminal oxidants. In such cases, oxygen is involved in an auto-oxidative process with those 
substrates that may form a peroxide intermediate at the targeted Csp3-atom, which acts as the 
real catalytic oxidant.25 Thus, currently oxygen itself cannot be evaluated as an efficient active 
oxidation agent in this chemistry, except when used as secondary oxidant. 
 
1.4 Stable N-Oxyl radicals as Oxidants 
Since the first synthesis of the persistent 2,2,6,6-tetramethylpiperidinyloxyl radical 
(TEMPO, E0ox = 0.76V/ E0red = 1.48V) by Lebedev and Kazarnovskii in 1959,26 the interest around 
stable radical nitroxides have relentlessly increased. Among stable N-oxyl radicals, TEMPO is 
well known as highly versatile oxidant and it has recently been used in C-H coupling reactions, 
including oxidative Csp3-H bond functionalization. The first TEMPO/O2 induced example of such 
transformation was reported by N. Jiao and co-workers in 2012.27 Thus, the simple reaction 
between acridanes and carbonyl based nucleophiles in the presence of a catalytic amount of 
TEMPO, under oxygen atmosphere at 60 °C, led to the corresponding C-9 substituted coupling 
product in moderate to excellent yields. Although the mechanism of this transformation is still 
unknown, the author proposed that oxygen is involved in both the oxidation of the substrate and 
the reactivation of the generated TEMPO-OH to TEMPO radical (Scheme 10). 
 
Scheme 10. TEMPO-mediated C-C coupling of acridanes. 
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In 2014 D. Xue and Y. Long have presented an efficient TEMPO/air mediated 
intramolecular Csp3-H amination of N-substituted 1,2-phenyldiamines(Scheme 11).28 In this case, 
a stoichiometric amount of TEMPO was employed at 110 °C to afford multisubstituted 
benzimididazoles in poor (N-alkyl) to excellent (N-aryl) yields.  Notably the reaction could also be 
carried out with catalytic amount of TEMPO, but then an oxygen atmosphere was required to 
achieve a similar efficiency. The proposed mechanism involves a first TEMPO-mediated single 
electron transfer (SET) process to form a radical cation I, followed by a hydrogen abstraction. The 
generated iminium intermediate II can easily evolve to the bicyclic aromatic product by 
nucleophilic addition (III) and final aerobic oxidation via the intermediate IV.  
 
Scheme 11. TEMPO/O2 oxidation system in Csp3-H bond amination/intramolecular cyclization 
reactions. 
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Recently, B. Han and co-workers described an elegant and novel TEMPO-mediated 
intermolecular aza-Diels-Alder reaction by oxidative C-H functionalization of ketohydrazones 
(Scheme 12).29 The authors proposed that two equivalents of TEMPO are necessary to achieve 
such transformation: i) the first molecule extracts the hydrogen radical from the hydrazone moiety 
V and ii) the second stabilizes the radical intermediate VI, which undergo a Cope-like TEMPOH 
elimination leading to the active hetero-diene VII. Moderate to good yields on the Diels-Alder 
adduct could be obtained, though only stabilized dienophiles and aromatic hydrazines were well 
tolerated in this reaction. 
 
 Scheme 12. TEMPO-mediated oxidative aza-Diels-Alder reaction 
The applications of other stable persistent N-oxyl radicals in Csp3-H functionalization are 
few and, in general, the radical oxidant has a marginal role in the oxidation system.30 
Nevertheless, in-situ generated N-oxyl radicals from N-hydroxyphtalamide-like molecules are 
reported as efficient catalytic mediators in Csp3-H bond functionalization such as nitrations and 
fluorinations (Scheme 13).31  
  
Scheme 12. N-Hydroxyphtalamides as N-oxyl-like oxidant precursors. 
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1.5 Cationic organic oxidants  
1.5.1 Hydride Abstractors  
This section will cover ionic oxidants, which do not involve a radical intermediate but 
proceed by a direct hydride abstraction from the substrate. In this regard, N-oxammonium and 
carbenium salts have recently been stablished as the standard classes of oxidants of this type.  
Oxoammonium salts 
The first example of oxidative Csp3-H bond functionalization employing a TEMPO 
oxoammonium salt was reported in 2010 by García Mancheño and co-workers (Scheme 13, i).32  
 
Scheme 13. TEMPO+BF4- mediated CDC reaction with carbonyl. 
In this pioneering work, different activated carbon pronucleophiles, such as malonates or 
keto ester compounds, were involved in the reaction with various benzyl ethers and amines under 
iron catalysis. In the absence of the metal catalyst, the main products of the reaction resulted both 
the oxygenated dimer and the oxidation product of the starting material. Therefore, it was 
postulated that the catalyst served only as a Lewis acid in the C-C coupling, facilitating the slow 
re-opening of this dimer intermediate to the active oxonium or iminium species. In 2011, the same 
group extended the procedure to less reactive C-H-based nucleophiles such as alkyl and α,β-
unsaturated aldehydes (Scheme 13, ii). Slightly changes of the condition were necessary to enrol 
such nucleophiles: a different lewis acid catalyst (copper(II) instead of iron(II)) and a catalytic 
amount of acetic anhydride or acetic acid.33 Later on, the first example of Csp3-H 
functionalization/intermolecular cyclization tandem reaction of N-carbamoyl 
tetrahydroisoquinolines and benzyl carbamates mediated by the 4-acetoamido TEMPO salt (4-
AcNH-TEMPO+BF4-) was reported by García Mancheño and co-workers (Scheme 14).34 This 
fascinating way to obtain the oxazinone ring involves the reaction of olefins with benzylic 
carbamates bearing a leaving group. The initially employed Boc-protecting group led to a mixture 
of the desired product along with the one derived from the reaction with 2-methylpropene formed 
in situ by elimination of Boc group under the employed conditions. The next choice of adamantyl 
carbamate as uncommon protecting group was inspired by the Bredt’s rule, which negate the 
formation of a double bond on tertiary “bridge” carbon of policyclic systems. This solution 
dramatically changed the efficiency of the reaction, since the leaving adamantyl carbocation 
cannot produce a competitive alkene by further elimination. 
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Scheme 14. 4-AcNH-TEMPO+BF4- in Csp3-H functionalization /intermolecular cyclization 
tandem reaction to oxazinones. 
In 2013 D. Toste and co-workers designed a prominent example of intramolecular 
enantioselective annulation (Scheme 15).35 Following the good results obtained in the 
intermolecular cyclization reported by García Mancheño, Toste’s group developed an attractive 4-
AcNH-TEMPO+BF4- promoted asymmetric Csp3-H amination of N-(2-benzamide)-
tetrahydroisoquinolines catalyzed by chiral 3,3’-triazolyl BINOL-derived phosphates. Various 
bulky protecting groups were tolerated on the amide moiety and good to excellent 
enantioselectivities were achieved. 
 
Scheme 15. Chiral phosphate-catalyzed oxidative asymmetric Csp3-H 
functionalization/intramolecular cyclization. 
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In 2015 L. Liu described a further enantioselective Csp3-H functionalization reaction of N-
carbamoyl tetrahydroisoquinolines using a TEMPO salt as oxidant (Scheme 16).36  
 
Scheme 16. TEMPO salt-mediated asymmetric alkynylations. 
Thus, the coupling of terminal alkynes catalyzed by chiral copper complexes was reported. 
However, in this manner the generated catalytic Cu-nucleophile could not effectively react with 
the highly unstable acyliminium species. The authors proposed an intelligent way to improve the 
efficiency of the reaction by trapping the iminium intermediate VIII with ethanolates. It was then 
possible to activate the generated alkoxy species IX to slowly regenerate the ionic active 
intermediate VIII’ by enrolling a metal Lewis acid catalyst. Despite the moderate yields, the 
enantiomeric excesses proved to be in most the cases around 90%. An extension of possible 
nucleophiles able to participate in the Csp3-H functionalization of tetrahydroisoquinolines 
(THIQs) has been proposed by Q. Wang and co-workers. Between 2014 and 2015 the group 
published two different applications of Csp3-H functionalization mediated by the TEMPO+BF4+ 
salt involving TMS-based nucleophiles (Scheme 17).37,38 The first example was a metal-free α-
cyanation with trimethylsilyl cyanide performed in acetonitrile at room temperature.37 In this 
case, the addition of acetic acid was necessary to inhibit the decomposition of the oxidant. 
Moreover, this procedure could also be extended to isochromanes.  
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Scheme 17. Csp3-H bond functionalization with TMS-based nucleophiles. 
In the second example, a direct C-H allylation with allyltetramethylsilane of N-
acyl/sulfonyl tetrahydroisoquinolines was developed.38 It is worth to notice that various less 
reactive analogues of tetrahydroisoquinoline could also be applied, leading to moderate to good 
yields on the corresponding allyl derivatives. Another interesting nucleophile has been recently 
employed by Xie and co-workers in the Csp3-H functionalization of THQs mediated by 
oxoammonium salts (Scheme 18).39 2-Methylquinoline is in equilibrium with its enamine form X, 
which could act as a nucleophile. Thus, various substituted 2-methylquinolines were involved in 
this functionalization, providing good to excellent yields. It is relevant to mention that water 
resulted the best solvent, giving attractiveness to this greener procedure. However, the scope is 
quite limited from the substrate side: only aromatic N-protecting groups could be employed. 
 
 
Scheme 18. 2-Methylquinolines as nucleophiles. 
In the past few years, glycine and peptide-like derivatives have proved as an interesting 
target in Csp3-H functionalization. However, the literature lacks of robust methodologies where 
milder oxidants are employed. Indeed, just few relevant steps have been done to extend the 
application of mild oxidants to such substrates, in particular TEMPO salts. The García’s group 
reported two different pioneer works between 2011 and 2013 enrolling TEMPO salt as oxidant 
(Scheme 19, eq. i and ii). Various N-aryl glycine esters were then involved in Csp3-H 
functionalization/cyclization reactions using olefins to give multi-substituted quinolines. 
Moreover, the homo-coupling of the glycine substrates to dihydroquinazolines under iron catalysis 
was also developed.40,41 Olefins were initially chosen as nucleophile because, after the first 
addition, they lead to a carbocation intermediate that resulted essential for the cyclization through 
an aromatic electrophilic substitution step.  
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Furthermore, the presence of a Lewis acid catalyst was crucial for the success of such methodology, 
since it facilitated both the nucleophilic addition and the cyclization. Indeed, the absence of a 
Lewis acid led to lower yields when olefins are involved or no reaction in the case of the annulation 
between two glycine ester moieties. The oxidation to a more stable aromatic system (when it was 
possible) was achieved by the oxidant in excess. However, it was also possible to isolate the 
tetrahydroquinoline intermediate performing the reaction at room temperature. It is interesting 
to notice that this procedure could be performed in a multicomponent approach, adding aniline 
and α-ester aldehyde to form in situ the desire target.  
 
Scheme 19. TEMPO+BF4- mediated derivatization of glycine esters.  
Recentyl, S. D. Yang and co-workers have reported another example of C-H 
functionalization on glycine ester (Scheme 19, eq. iii).42 This paper described a way to achieve 
chiral α-amino esters by asymmetric addition of aryl boronic acids under palladium catalysis. A 
TEMPO salt was used as oxidant to achieve the reactive iminium species, which takes part as 
electrophile in the coupling reaction mediated by the in situ formed chiral catalyst. Different chiral 
ligands were tested, resulting (4R,4'S)-4,4'-diisopropyl-4,4',5,5'-tetrahydro-2,2'-bioxazole the best 
in terms of both yield and enantio-selectivity. Although the yields are strongly influenced by 
substituents, the enantiomeric excesses are high in almost of the cases (around 80-90% ee). 
Trityl salts. 
In the last 5 years, L. Liu and co-workers have obtained important results using trityl salts 
as oxidants with tetrahydroisoquinolines as substrates. In 2014, they proposed the first example 
of Csp3-H functionalization of tetrahydroisoquinolines using trityl perchlorate salt as hydrogen 
abstractor (Scheme 20, eq. i).43 Several different benzyl, alkynyl, allyl and vinyl trifluoroborate 
salts were applied as nucleophiles, leading to the desired coupling products with good to excellent 
yields under metal-free conditions. In addition, other benzyl amines-like molecules could be 
effectively engaged. Noteworthy, in the same year such procedure was extended to benzopyranes44 
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(Scheme 20, eq. i) and unactivated ethers (Scheme 20, eq. ii).45 Despite the excellent results 
achieved with both classes of substrates, unactivated ethers required a stoichiometric amount of 
gallium chloride as Lewis acid and trityl chloride as oxidant to efficiently promote the reaction.45 
 
Scheme 20. Trityl salt-mediated Csp3-H functionalization. 
Tropylium  salts. 
Tropylium ion represents another type of interesting mild ionic oxidant. Though less 
reactive than the corresponding trityl salt, it is capable of oxidizing the alpha C-H bond of various 
amines. Taking this into account, in 2011 T. H. Lambert reported the use of such mild oxidant for 
the α-cyanation of a variety of diffently substituted amines to generate α-aminonitriles (Scheme 
21).46 Besides the simplicity of this transformation, the by-products produced are only water-
soluble potassium tetrafluoroborate and volatile cycloheptatriene, which can easily be removed 
from the desired product. 
 
Scheme 21. α-Cyanation of amines with tropylium ion as oxidant. 
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1.5.2 Radical-Cations as Oxidants  
In this section, the applications of a different type of oxidants such as radical cations will 
be discussed. The dual nature of these species provides the potential of tuning the generation of a 
radical or an ionic intermediate in C-H functionalization reactions.47 In this regard, triaryl 
aminium salts, such as the commercially available tris(4-bromophenyl)aminium 
hexachloroantimonate (TBPA+•, E0 = 1.15V), have recently been identified as mild oxidants for 
such transformations. Consequently, the group of X. Jia has intensively been working towards the 
application of aminium salts in Csp3-H bond functionalization. Thus, their succesful 
implementation in several Povarov-type reactions with various glycine ester derivatives and N-
benzyl substituted anilines has recently been proven (Scheme 22, eq. i and ii).48 In these cases, 
catalytic amounts of TBPA+• (10 mol %) were employed under oxygen atmosphere (1 atm) in the 
presence or absence of InCl3 as catalyst to produce the corresponding quinolines. Alternatively, 
the same In-catalyzed Povarov reactions of glycine derivatives could be performed by generating 
in situ the active radical cation from the amine precursor TBPA (20 mol %) by treatment with 
ceric ammonium nitrate (CAN) (20 mol %).48 Moreover, in 2014 X. Jia and co-workers further 
extended the use of TBPA+• for the formation of dihydropyridines from glycine ester derivatives 
and α-ketoesters in the presence of catalytic amounts of TMSCl (Scheme 22, iii).49 
 
Scheme 22. Aminium salts as radical-cation oxidants. 
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Recently, Murphy and co-workers have developed another interesting two-step approach 
that permits the high selective functionalization of a N-CH3 group in the presence of a more 
thermodynamically favored N-CH2-R moiety (Scheme 23).50 To achieve such high chemoselectivity 
with N-methyl N-dialkyl amines, a DABCO/TBPA-PF6 oxidative-system was proposed. The 
effective bulky oxidant ammonium radical cation DABCO+• (XI), which acts as both hydrogen 
abstractor and radical trap, was fast oxidized by the more common reagent TBPA-PF6. The 
successive addition of phenyl magnesium bromide led to the substituted products in moderate to 
high yields. 
 
Scheme 23. Selective functionalization of methyl dialkyl amines. 
 
1.6 Iodine-based Oxidants 
Since the discovery of hypervalent iodine reagents by D. B. Dess and J. C. Martin, this 
chemistry has received an increased attention due to the diverse chemical transformations 
successfully mediated by such type of oxidants.51 Among others, hypervalent iodine reagents have 
shown interesting and wide applications in amine oxidations.52 In 2007, T. Ngouansavanh and J. 
Zhu reported the first example of C-H functionalization/Ugi-type multicomponent reaction of 
tetrahydroisoquinolines mediated by 2-iodoxybenzoic acid (IBX) (Scheme 24).53  
 
Scheme 24. IBX-mediated Ugi-type reaction. 
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Different carboxylic acids and isocyanides were tested at 60 °C in DMSO/THF mixture. 
Additionally, 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indoles and di-benzyl amines could also react 
under those conditions. In 2009, Y. M. Liang and co-workers reported the first example of Csp3-H 
functionalization of aliphatic amines with (diacetoxyiodo)benzene (PIDA) (Scheme 25).54  
 
Scheme 25. PIDA as oxidant and nucleophile source. 
In this work, various N-aryl piperidines were successfully oxidized to the corresponding 
enamine, moiety not stable in the reaction condition. Hence, a following functionalization to a 
diesther took place. The authors proposed that the PIDA activates the double bond of the in-situ 
generated enamine XII, making it susceptible to the addition of a first molecule of acetate through 
an intermediate of type XIII. Then, a SN2 occurs on the hypervalent iodine unit XIV, giving the 
final diesther along with iodobenzene as by-product. It is important to observe that substituted 
piperidines were not tested and the reaction is moisture sensitive. Moreover, 
tetrahydroisoquinolines could also be enrolled under these conditions, but using considerably less 
amount of oxidant (1.2 vs. 4 equivalents) and strong carbonyl nucleophiles (Scheme 26). 
 
Scheme 26. PIDA-mediated Csp3-H functionalization of THIQs. 
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On the other hand, in 2015 R. V. A. Orru and co-worker reported a novel example of IBX-
mediated formation of enamine from unactivated aliphatic amines, which were subsequently 
involved in an Ugi-type multicomponent reaction (Scheme 27).55 Several bicyclic and tricyclic 
pyrrolidines were tested at 60 °C with various carboxylic acids and isocynides. The obtained yields 
after prolonged reaction times (2 days) were good considering the difficult substrate-type 
employed. Moreover, it is interesting to notice that this methodology can be applied on oxidative 
aza-Friedel-Crafts reaction with the same aliphatic amine in moderated yields. 
 
 
Scheme 27. Csp3-H functionalization of unactivated polycyclic aminoalkanes. 
As illustrated in the previous sections, tetrahydroisoquinoline is a sort of privileged 
substrate, and in the area of iodine-based oxidations several applications have also been reported 
with this type of compounds. Therefore, it is important to notice that THIQs can be considered 
benchmark test substrates for the development of novel strategies in oxidative Csp3-H bond 
functionalization. In fact, in 2013 a metal-free iodine catalyzed Csp3-H activation of 
tetrahydroisoquinolined under oxygen atmosphere was reported by Prabhu and co-workers 
(Scheme 28).56  
 
Scheme 28. I2-catalyzed cross-dehydrogenative coupling of THIQs  
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A broad spectrum of nucleophiles was extensivelly tested at room temperature: cumarines, 
nitroalkanes, phosphites, trymethylsilylcyanides, imides, amides, as well as electron rich aromatic 
rings. Even though the procedure is limited to N-aryl substituted THIQs, moderate to high yields 
were obtained. It is worth to notice that during the screening of the optimal reaction conditions, 
different catalytic systems were tested and both potassium iodide and N-iodosuccinimide resulted 
high efficient under oxygen atmosphere. Returning back to more standard hypervalent iodine 
oxidants, in 2014 C. J. Li and co-workers proved the robustness of [bis(trifluoro-
acetoxy)iodo]benzene (PIFA) in the Csp3-H functionalization of THIQs in the presence of Grignard 
reagents (Scheme 29).57 
 
Scheme 29. PIFA in the Csp3-H functionalization of THIQs with Grignard reagents. 
The biggest issue of this reaction was the incompatibility between the strong Grignard 
nucleophile and the electrophilic iodine reagent. Therefore, a sequential addition procedure was 
employed. The oxidation step was carried out for 10 minutes at r.t. prior the addition of the 
Grignard reagent at 0 °C. Nevertheless, owing to the strong class of nucleophilic reagents involved 
in the reaction, both the alkylation and the arylation proceeded in excellent yields. Alternatively, 
Z. Du and co-workers developed a simple and potent procedure to obtain 3-hydroxy-2-oxindoles 
and spirooxindoles from the corresponding anilides, using phenyliodine(III) bis(trifluoroacetate) 
(PIFA) as oxidant in trifluoroethanol as solvent (Scheme 30).58  
 
Scheme 30. PIFA-mediated Csp3-H functionalization/internal cyclization of anilides. 
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Firstly, the iodine-based oxidant induced the ring-closing reaction to XV. Thus, a further 
oxidation (XVI) and consecutive addition of a trifluoroacetate moiety led to an unstable diester 
XVII. This intermediate could then undergo an alcoholysis (path A) to the corresponding alcohol 
or, in the case of diphenylmalonamides, another cyclization to the spiro-structures (path B). In 
2014, Z. Du also reported an intramolecular C-H bond functionalization of N-alkyl-N-aryl 
anthranilic acids mediated by the in situ formed (azidoacetoxyiodo)benzene, giving the 
corresponding benzoxazine in good yield (Scheme 31, i).59 The in situ azide/acetate ligand exchange 
on the hypervalent iodine is fundamental to reach the corresponding stronger intermediate 
oxidant I(III)-N3, which resulted an efficient reagent with less reactive substrates, without 
important changes on regioselectivity. In the 2016, the same group showed the potential of this 
special oxidative system in the intramolecular anullation of tetrahydroisoquinolines to form high-
value quinazolinone derivatives (Scheme 31, eq. ii).60 This methodology worked efficiently with 
amides, carboxylic acids and, in moderated yields, also with ketones.  
 
 
Scheme 31. PIDA/NaN3 promoted C-N and C-O bond formation. 
It should be noticed that this azide dependent oxidative system was for the first time 
employed in Csp3-H bond functionalization reactions by P. Antonchick and co-workers (Scheme 
26).61,62  
 
Scheme 32. Alkyl insertion into heteroarenes using PIFA/NaN3 and proposed mechanism. 
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The functionalization of unactivated alkanes with various nitrogen-containing 
heteroarenes61 and (thio)chromones62 was efficiently achieved using PIFA, sodium azide as 
additive and a large excess of alkane at room temperature in 4 hours.  The formed azide radical 
XVIII (E0 ≈ 1.33V)11b from the hypervalent iodine-N3 species activates the alkane by radical 
abstraction of a hydrogen generating a radical alkane and XIX (Scheme 26). Moreover, the 
resulting acid by-product from the oxidant XX may facilitate the insertion step via protonation of 
the basic heteroarene nitrogen. Lastly, it has to be mentioned that the group of P. Antonchick has 
efficiently further exploited this azide-hypervalent iodine approach for additional applications in 
C-H bond functionalization.63 
  
1.7 Conclusion and Outlooks 
Despite some current limitations, especially on the class of substrate that is enrolled, the 
most significant recent advances in the area of oxidative Csp3-H bond functionalization rely on 
the introduction of specific, selective and, in last instance, more benign oxidative systems. This 
has already been translated not only in an improvement of previous methodologies, but it has also 
already led to the discovery of new transformations. Furthermore, the right choice of a mild 
oxidant-system will permit to circumvent incompatibility issues and allow the broadening of the 
list of suitable substrate classes and reagents. Thus, it can be easily envisioned the original design 
and development of more practical, highly inspiring and unconventional transformations 
embracing this technology based on mild oxidative Csp3-H bond functionalization.  
Following this perspective, it is clear the potential of envisioning new methodologies by 
following such oxidative based approach, looking for unexplored reactivities or targets. In this 
context, this dissertation focuses on my results on the Csp3-H bond activation concerning the 
synthesis and the functionalization of (poli)heterocyclic moieties. Several strategies and unusual 
targets have been explored, aiming at obtaining the most easy, safe and selective system.  
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2 
 
C-H functionalization leading to unstable 
intermediates: Trapping by dipolar 
cycloaddition 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2.1 
[1] Reproduced with the permission from: A. Gini, M. Segler, D. Kellner, O. García Mancheño, Chem. Eur. J. 2015, 21, 
12053. Copyright 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim; schemes, figures and text may differ from 
the published version. 
[2] Contents of table 1 and the chapter 2.1.5 “Reactivity and Mechanistic Studies” were performed by M. Segler 
Chapter 2.2 
[1] Contents of the table 2, entries 4d, 4e, 4g and 4h, and table 3, entries 4k and 4l were performed by T. Brandhofer.  
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2.1 Trapping unstable nitrones to form Isoxazolines 
2.1.1 Introduction 
4-Isoxazolines are valuable 5-membered heterocycles1 with interesting biological activities, 
including anti-inflammatory or miotic kinesin inhibition properties among others.2 In addition, 
they are also used as versatile building blocks for the preparation of numerous biological active 
compounds such as 1,3-amino-alcohols and -carbonyls,3 β-lactams,4  a variety of N-heterocycles5  or 
natural products such as alkaloids (Figure 1).6 
 
Figure 1. Versatility of isoxazolines as building blocks and biactive units. 
Several methods for the preparation of isoxazolines and isoxazolidines have been described, 
including both metal-catalyzed and metal-free approaches.7 These procedure, are mainly based on 
the 1,3-dipolar cycloaddition reaction (1,3-DC) between isolated stable nitrones8 with alkynes and 
olefins as dipolarophiles. Despite the various powerful available methods, they are basically 
restricted to the use of N-alkyl and N-aryl substituted nitrones. This leads to isoxazolines with 
groups at the nitrogen that are difficult to cleave or even unremovable, which significantly limits 
the scope of this methodology for further synthetic applications.9 Therefore, the use of nitrones 
bearing removable electron-withdrawing groups such as acyl or carbamoyl units is highly 
desirable. These dipole species are however difficult to isolate and manipulate due to their 
intrinsic instability. Thus, only few examples have been reported in the literature,10,11 in which 
such nitrones have been generated in situ from N-acyl protected precursors. A prominent example 
is the base-mediated elimination of the sulfonyl group of N-carbamoyl N-hydroxy-β-amido sulfones 
(Scheme 1).10 
 
Scheme 1. Previously reported approaches for the in situ generation and trapping of N-carbamoyl 
protected nitrones. 
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2.1.2 Objectives 
The employment of unstable N-acyl and carbamoyl nitrones in dipolar cycloaddition is still 
an ongoing challenge, since there are several limitations regarding the nature of the substrate. 
Indeed, the presence of necessary sacrificial functional groups on the target hydroxylamines is 
highly unwanted, especially considering the several synthetic steps needed for the insertion of 
such moieties.12 Thus, the development of novel strategies in which the nitrones are formed by 
activation of simple N-acyl and N-carbamoyl hydroxylamines is still demanding. In this context, 
we aimed at a more direct and metal free approach which involves the oxidative activation of the 
target hydroxylamine through a formal dehydrogenative process. However, the instability of the 
involved intermediates may lead to undesired decomposition products under standard oxidative 
condition, and the choice of the reagents is crucial for a successful formation and trapping of the 
unstable nitrone. Indeed, the oxidant and its side-products may have a major role in the 
decomposition of the active intermediates, and the cycloaddition needs to be faster than the other 
possible degradation routes. Thus, based on our experiences in oxidative coupling reactions of 
Csp3-H bonds using mild oxidants,13 several oxidative systems would be tested for the development 
of a more general and metal-free synthesis of N-carbamoyl and N-Acyl isoxazolines by dipolar 
cycloaddition involving in situ formed nitrones (Scheme 2). 
 
Scheme 2. Our proposal for the in situ formation/trapping of unstable nitrones. 
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2.1.3 Results and Discussion 
Initially, N-Boc protected benzylhydroxylamine (1a) was chosen as model substrate for the 
one-pot in situ oxidative nitrone formation and cycloaddition trapping reaction with dimethyl 
acetylenedicarboxylate (2a, DMAD) (Table 1).  
Table 1. Optimization of the model reaction[a] 
 
Entry oxidant (equiv.) solvent Temp. (°C) yield (%)[b] 
1 tBuOOH (2) neat rt -- 
2 DDQ (2) DCM rt <5 
3 TEMPO+BF4- DCM rt <5 
4 TEMPO (2) DCM rt 25 
5 TEMPO (2) DCM 50 75 
6 4-NHAc-TEMPO (2) DCM 50 64 
7 4-OH-TEMPO (2) DCM 50 60 
8 TEMPO (2) DCM 70 87 
9 TEMPO (2) BTFc 70 63 
10 TEMPO (2.5) DCM 70 80 
11 -- DCM 70 -- 
12 TEMPO (0.1)/O2[c] DCM 50 25 
13 TEMPO (2) DCE 70 80 
[a] 1a (0.25 mmol, 1 equiv.), 2a (4 equiv.) and oxidant in DCM (0.125 M) at the corresponding 
temperature for 24 h. [b] Isolated yields. [c] 1 atm of O2 was used. BTF = Benzotrifluoride (or 
trifluorotoluene). 
Various oxidants were tested under neat conditions or in dichloromethane as solvent at 
room temperature to minimize the possible decomposition of the generated N-carbamoyl nitrone. 
Whereas the typical reagents for dehydrogenative cross-coupling (CDC) reactions or Csp3-H bond 
functionalization14 such as organic peroxides, DDQ or TEMPO oxoammonium salts did not lead to 
the desired product (Table 1, entries 1-3), the use of TEMPO radical15,16 provided isoxazoline 3aa 
in a promising 25% yield (Table 1, entry 4). A complete conversion of the hydroxylamine 1a was 
observed with all the oxidants explored. However, except for the reaction with TEMPO, a complex 
reaction mixture was obtained in which only traces of the desired product were present. This 
indicates that the in situ formed N-carbamoyl nitrone and/or the product decompose readily in the 
presence of a strong oxidant. Conversely, when using TEMPO radical the low conversion into 3aa 
and observation of certain decomposition by-products at room temperature could be attributed to 
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a not effective next cycloaddition step. The increase of the temperature to 50 °C favored the overall 
transformation, most probably by increasing the efficiency of the second 1,3-cycloaddition trapping 
reaction. Thus, 3aa was obtained in a good 75% yield (Table 1, entry 5). Other TEMPO radical 
derivatives were also suitable oxidants (Table 1, entries 6-7), leading to slightly lower yields (60-
64%). Taking TEMPO as the oxidant of choice, the temperature, solvent and amount of oxidant 
was finally optimized. Consequently, the use of 2 equivalents of TEMPO at 70 °C in DCM in a 
pressure schlenk tube led to an improved yield of 87% (Table 1, entry 8). 1,2 dichloroethane (DCE) 
was also tested as solvent at the optimized condition due to its higher boiling point (70 °C vs 40 
°C), but with slightly lower performance (Table 1, entry 13). With these excellent results in hand, 
the scope of the reaction was explored. Various N-acyl and N-carbamoyl protected 
benzylhydroxylamines were evaluated in the reaction with 2a (Table 2). The carbamoyl group Boc 
proved to be superior to its corresponding acyl group pivaloyl (Piv) (87% vs. 17%). Other carbamate 
substitution (R = EtO and BnO) was well tolerated, leading to isoxazolines 3 in moderate to good 
yields. However, a low yield (21%) and a significant decomposition of the starting material 1 were 
observed when using sterically hindered protecting groups such as Troc, or in the case of Fmoc 
(3fa), no product was detected. In addition, it was observed that in the reaction a by-product 4aa, 
derived from the addition of TEMPO to the dipolarophile 2a, was also formed in high yields. This 
explains the need of employing an excess of 2a to achieve high conversions into 3.  
Table 2. Scope of the reaction: N-Carbamoyl/Acyl group variation[a][b] 
 
[a] 1 (0.25 mmol, 1 equiv.), 2 (4 equiv.) and TEMPO (2 equiv.) in DCM (0.125 M) at 70 °C for 24 h. [b] Isolated yields.  
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The reaction of hydroxylamine 1a with different dipolarophiles 2 was then investigated 
(Table 3). The diethylester derivative 2b reacted in a similar way to 2a (84% vs. 87%). 
Furthermore, the bulkier tert-butyl acetylenedicarboxylate (2c) provided 3g in a good 52% yield, 
whereas the use of the mono-ethylester 2d led to no desired reaction. In these last cases a 
substantial decomposition of the in situ formed nitrone was observed. Unexpectedly, other typical 
cyclic dipolarophiles such as N-methyl (2e) and N-phenyl maleimide (2f) showed a low reactivity, 
providing the corresponding isoxazolidines 3ae and 3af in only 22% and 5% yield. Finally, 
unactivated dipolarophiles such as styrene and butyl vinyl ether did not participate in the reaction 
under our standard conditions.  
Table 3. Scope of the reaction: Dipolarophile variation[a][b] 
 
[a] 1 (0.25 mmol, 1 equiv.), 2 (4 equiv.) and TEMPO (2 equiv.) in DCM (0.125 M) at 70 °C for 24 h. [b] Isolated yields. [c] 
n.d. = Not detected. [d] 96 h reaction. 
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In order to enroll more effectively the less reactive dipolarophiles such as maleimides in 
the cycloaddition step, the reaction was carried out in the presence of 2a as a cheap sacrificial 
reagent (Scheme 3). Considering the higher performance of DMAD as dipolarophile and the 
formation of 4a, we envisioned that 2a might be involved in an important mechanistic step of the 
process and therefore it may facilitate the reaction of other dipolarophiles (see below for further 
discussion). Satisfactorily, the desired products 3ae and 3af were then obtained in 50% and 44% 
yields after 96 h, and only traces of the product derived from 2a were formed (3a, <5%). 
 
 
Scheme 3. DMAD as cheap sacrificial reagent: Enrollment of less reactive dipolarophiles. 
Next, a variety of different N-substituted N-Boc hydroxylamines was studied (Table 4). In 
first instance, it is worthy to mention that the reaction could be scaled up to 5 mmol without 
detriment on the reactivity (3aa, 82% yield, 24 h). Moreover, electron-donating groups such as p-
tBu, p-OMe and m-OMe at the aromatic unit led to similar good results (51, 84 and 71% yield, 
respectively). However, the introduction of substituents at the ortho position, such as an o-MeO 
group, was not well tolerated and translated to a significant drop on the yield to 43%. In addition, 
only decomposition products were detected when high steric hindered target such as 1n were 
enrolled in the reaction. Halogen-containing (p-Br and p-ClC6H4-) and electron-deficient (p-
CF3C6H4-) substrates 1m-o also reacted satisfactorily, providing 3 in good yields (63-80%). This 
methodology showed a remarkable broad structural scope since not only benzylic but also the more 
demanding allylic (1s) and alkylic (1p-r) substituted N-Boc hydroxylamines could be successfully 
enrolled in this transformation. Consequently, allyl isoxazoline 3sa was obtained in a good 50% 
yield and alkyl derivatives 3pa-ra in moderate to excellent yields (up to 74%), although propargyl 
derivative (1t) did not participate in the desire reaction under the proposed condition, leading to 
full conversion of decomposition products. 
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Table 4. Scope of the reaction: Substitution of the N-Boc hydroxylamine 1[a][b] 
 
[a] 1 (0.25 mmol, 1 equiv.), 2a (4 equiv.) and TEMPO (2 equiv.) in DCM (0.125 M) at 70 °C for 24 h. [b] Isolated yields.  
 
2.1.4 Attempts for the functionalization and deprotection of 3a 
Several attempts to further functionalize the obtained isooxazoline 3 were tested. In first 
instance, various experiments were carried to achieve the deprotection of the Boc group, but in all 
the cases the desired product was not observed (Scheme 4, eq. i and ii). Tetrabutyl ammonium 
floride (TBAF) resulted an inefficient reagent for the the deprotection of 3aa, recovering almost 
all the unreacted starting material. Furthermore, strong basic conditions are not suitable with 
such electron-poor isooxazoline as 3aa, leading to a complex mixture of by-product (Scheme 3, eq. 
ii). Noteworthy, from NMR analysis the signal of the Boc group, as well as the signal of the benzylic 
hydrogen, were missing. Thus, we supposed that in first instance a deprotection/aromatization 
reaction occurs. Then, other uncontrolled rearrangement reactions lead to a multitude of 
decomposition products. The re-aromatization of electron-poor N-H free isoxazolines was also 
observed by A. Tomelli and co-workers.17 Two different procedure for the site-selective reduction 
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were carry out, but with poor results (Scheme 3, eq. iii and iv). Although the low electron-density 
of the double bond moiety in 3a, sodium boron hydride (NaBH4) revealed itself as an ineffective 
reagent for the reduction of 3a to form 7a. Furthermore, all the attempts to break the N-O bond 
were unsuccessful, and only an undefined mixture of products was observed.18 
 
 
Scheme 4. A summary of tested functionalization/deprotection procedures 
 
2.1.5 Reactivity and Mechanistic Studies 
In order to better understand the formation of 4aa, DMAD (2a) was reacted with 
stoichiometric amounts of the oxidant TEMPO (Scheme 5, i). While no reaction was observed in 
the absence of 1a, the by-product 4aa was obtained quantitatively in the presence of the substrate 
hydroxylamine. These results indicate, as we initially anticipated, a certain interaction or prior 
reaction with the substrate, which might suggest an active participation of the dipolarophile in 
the in situ generation of the required nitrone species. Moreover, the formation of 4a by a radical 
addition of TEMPO to 2a to form a more reactive carbon-centered radical can be envisioned. In 
this regard, a similar reaction between TEMPO and electron-poor endiynes has been postulated 
by B. König and P. R. Schreiner as intermediate step (radical A) for a radical 5-exo-dig cyclization 
(Scheme 5, ii).19 The course of the model reaction between 1a and DMAD (2a) was next followed 
by GC-FID in the first 7 hours (Scheme 5, iii). We could observe that the hydroxylamine was 
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rapidly consumed (<10% left after 60 min). At the same time almost two equivalents of DMAD 
have reacted and the formation of the TEMPO addition by-product 4aa was observed. However, 
the final cycloaddition product 3aa was built up comparably slowly. 
 
 
 
Scheme 5. Reactivity insights. 
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Furthermore, the dipolar cycloaddition reaction with the electron-deficient N-carbamoyl 
nitrones is generally less favored than the classical with N-aryl or alkyl derivatives (Scheme 5).20 
The reaction with N-benzyl hydroxylamine 9, which leads to a stable and isolable nitrone 12,21 
proceeded more readily than the one with the N-Boc derivative 1a. Thus, milder conditions (r.t. 
vs. 70°C) were required. Additionally, the unstable N-carbamoyl nitrone may ready decompose 
under the employed temperature and long reaction times.  
 
Scheme 6. Reactivity comparison between in situ formed unstable N-Boc and stable N-Bn 
nitrones.  
Therefore, the nitrone might not be present in high concentrations, suggesting the 
participation of a different intermediate. With all this information, a plausible mechanism is 
depicted in Scheme 6. First, a hydrogen atom abstraction from the hydroxylamine 1 occurs. This 
hydrogen can be abstracted directly by TEMPO15 or by the carbon-centered radical 13 obtained 
upon reversible radical addition of TEMPO to 2a (Path a). The nitroxide 14 is then formed together 
with 4 or TEMPOH, which can also react with 2a in a conjugate addition way to form the same 
by-product (Path b). Next, two molecules of nitroxide 14 disproportionate via a SET process 
followed by deprotonation to form nitrone 15 and hydroxylamine 1,22 the later entering again in 
the oxidation-cycle. Lastly, the cycloaddition between the generated nitrone 15 and 2a takes place 
to form the final isoxazoline product 3. 
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Scheme 7. Mechanistic proposal 
Finally, to obtain more mechanistic insights into the two proposed possible pathways a) 
and b) for the formation of the nitroxide intermediate 14, the generation of the by-product 4a and 
nitrone 15, and the subsequent 1,3-DC step, DFT-calculations were performed (Scheme 6).23 
Consequently, in order to complete the formation of nitroxide 10, one of the two possible 
endothermic intermediate steps has to take place. However, pathways a) and b) are similar in 
energy, not allowing the exclusion of one of them since no transition state (TS) could be found for 
the formation of the radicals 13 and 14, respectively. The calculations also indicate that the 
following disproportionation of 14 is an exothermic process. Additionally, the subsequent 
cycloaddition has an activation barrier of just 4.4 kcal/mol. Nitrone 15 should then react fast in 
the 1,3-DC step and thus, as previously postulated, only be present in low concentrations in the 
reaction media. This explains why nitrone 11 could not be detected by NMR, GC or MS during the 
mechanistic studies. Furthermore, all this implies that the final cycloaddition step is not likely to 
be the rate determining, but instead one involved in the formation of the intermediate nitroxide 
14 or nitrone 15.  
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Scheme 7. DFT gas-phase (B2PLYP-D3/def2-TZVP//BP86-D3/def2-TZVP) calculated relative 
enthalpy profiles for the formation of nitroxide 14, nitrone 15 and by-product 4aa, as well as for 
the 1,3-DC reaction.  
 
2.1.6 Conclusions and Outlooks 
In summary, we have developed a novel and potent methodology for the synthesis of N-
carbamoyl/-acyl 4-isoxazolines by a TEMPO-mediated in situ formation and trapping via 1,3-
dipolar cycloaddition of unstable N-protected nitrones. Carbamates were superior to simple acyl 
protecting groups, leading to good yields on the corresponding aryl, allyl and alkyl substituted 
isoxazolines (up to 87%). However, the approach resulted restricted to strongly electron-poor 
dipolarophile, which rapidly undergoes the cycloaddition reaction with the nitrone, limiting the 
formation of undesired side-product. Even though we could not achieve to date any 
functionalization or deprotection of 3, the intrinsic reactivity of such substrate may lead to 
interesting application or rearrangement. Moreover, the employed dipolarophile showed an 
important assistant role on the slowly generation of the active, unstable N-protected nitrone.  
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2.2 Two-steps one-pot azidonation/CuAAC reaction studies 
2.2.1 Introduction 
“Click chemistry” is a term introduced by K. B. Sharpless in 20011 to describe reactions 
which are simple to make, wide in scope, high yielding and carried out with an overall optimal 
atom economy. Indeed, the “click chemistry” approach might be called the research of perfect 
reactions. Following this purpose, the copper catalyzed azide-alkyne cycloaddition (CuAAC) 
reaction (Scheme 1), a regioselective version of the thermal Huisgen azide-alkyne 1,3-dipolar 
cycloaddition, was elevated to be one of the most prominent example on this field, and its 
application was extended to a broad variety of synthetic strategies, conditions and substrates.2 
The 1,4-substituted triazole is obtained as only product, and the achievement of such selectivity 
in the CuAAC process is driven by the copper acetylide intermediate (Scheme 1, bottom). It is 
interesting to note that two atoms of copper are involved in the activation of the system, leading 
to a concerned di-nuclear copper intermediate (II). 
 
Scheme 1. Husigen Azide-Alkyne 1,3-dipolar cycloaddition vs. CuAAC.2b 
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The CuAAC approach has shown an incredible potential to cover the non-reactivity gap of 
standard methods used in molecule discovery, especially when soft or aqueous condition are 
needed, as well as when complicated or harsh purification processes are not suitable with the 
desire product. In addition, it gives to chemists a practical tool for the design and synthesis of 
multitude of new 1,2,3-triazole-based core structures, with relevant proprieties in several fields, 
such as medicinal (figure 1, top) or material chemistry.3 1,2,3-Triazole have also demonstrated 
promising proprieties in asymmetric and supramolecular-based catalysis, such as in the 
asymmetric dearomatization of heterocycles (Figure 1, bottom).4 
 
 
Figure 1. Examples of triazole applications in medicinal chemistry and catalysis. 
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Another important aspect to consider following a “click chemistry” point of view is the 
accessibility of all the reaction partners. Indeed, even if the alkyne and azide are generally easily 
available, in some cases the preparation of the starting materials, in particular regarding the 
azide-containing substrates, might become a real limitation. Although the chemistry beyond the 
insertion of azide moieties is well-established,5 most procedures are still based on nucleophilic 
substitutions or diazo transfers when the target is a Csp3 atom. Consequently, most standard 
azido-functionalization are limited to substrates in which a pre-installed leaving group is present, 
limiting the application in late stage reactions or in systems presenting regioselective issues. This 
was translated in a large number of target-specific strategies, and only in the last 30 years new 
methodologies on the direct Csp3-H bond azido-functionalization have been established.5 From the 
pioneering works reported by P. Magnus on the direct azido-derivatization mediated by in situ 
formed (diazideiodo)benzene (Scheme 2),6 several hypervalent iodine-azide reagents has been 
enrolled for the direct Csp3-H bond azidonation of a broad variety of substrate.  
 
 
Scheme 2. A selection of Magnus work on azidonation. 
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Beside the P. Magnus contributions, in which iodosobenzene (PhIO)/trimethylazide 
(TMSN3) reagents combination has been employed in α-N-alkyl and β-enol ether azidonation, 
stable azido cyclic iodinanes, such as IV and V, have also shown a wide potential in direct azido-
derivatization (Scheme 3). Among the reported works, it is interesting to noticed that the 
azidonation of relative inert targets, such as tertiary Csp3 alkyl carbon is also possible in the 
presence of a catalytic amounts of a radical starter and/or a metal catalyst.7  
 
Scheme 3. Azido cyclic iodinanes mediated azidonation of various Csp3 targets. 
In this context, in 2015 J. F. Hartwig and coworker displayed the effectiveness of 2 azide 
1,2-benziodoxol-3(1H)-one as regioselective azidonation agent under iron catalysis on complex 
alkylic scaffold, as well as in late stage functionalization (Scheme 4).8 Several functional groups 
were well tolerated, even acid and free-hydroxy group. Surprisingly, the presence of such groups 
leads to only one isomer, and the obtained yields resulted higher respect with standard substrate. 
Thus, -OH free moieties are efficient directing groups in this strategy.   
 
 
Scheme 4. A summary of the work reported by J. F. Hartwig. 
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2.2.2 Objectives 
After this short overview, it is evident the potential of azido-iodine reagents in organic 
synthesis. However, there are some limitation when a “click-chemistry” approach is aimed towards 
a combined direct azidonation/CuAAC process for the creation of an even more efficient procedure. 
Indeed, to the best of our knowledge, no procedure of one-pot direct azidonation of Csp3-H 
bond/copper catalysed alkyne azide cycloaddition, even performed in a 2-step 1-pot strategy, has 
been reported so far in the literature. This restraint hailed from the interaction within the copper 
catalyst and the iodine-containing reagents and by-products of the azidonation step, which 
deactivate the copper for the CuAAC catalytic cycle. From this point of view, considering also the 
probable formation of unwanted azide-isomers, it is evident that, right now, the isolation of the 
desire azide is still best solution to conduct such azidonation/CuAAC processes. However, azide 
moieties are sensitive substrates, which could undergo uncontrolled degradation reactions, even 
in an explosive manner. As follow, trapping the azide in situ could be essential when the target 
azide is difficult to handle in the required environment for the work-up, the purification and the 
cycloaddition steps. Therefore, it outcomes that a procedure for the direct Csp3-H bonds 
azidonation/cyclization in which the reagents are compatible with the next CuAAC process, is 
highly demanding. In this context, our efforts focused to the extension of this “click-chemistry” 
approach to involve the whole process, from the azide synthesis to the triazole purification. More 
in detail, our main goal was the development of a 2-step 1-pot procedure for the Csp3-H oxidative 
functionalization/azide addition enrolling copper, coupled with common and easy-to-remove 
reagents suitable with the consecutive trapping of the stable or unstable azide intermediates by 
CuAAC process (Scheme 5). In addition, we want to develop a process that is also applicable in a 
late stage functionalization, as well as for the synthesis of biomarkers or biosensors. 
 
Scheme 5. The main goal of this project. 
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2.2.3 Results and Discussion 
To ensure the highest conversion into the desire azide avoiding unwanted side-product, the 
azidonation step was initially investigated. Xanthene (1a) was chosen as model substrate for 
various reasons: i) the experience on Csp3-H bond functionalization of xanthene and acridane 
moieties acquired in our laboratory;9 ii) it resulted an unexplored target in direct azidonation 
reaction; iii) it facilitated the first screening of the reaction, since the product 2a is a known 
molecule prepared following other multi-step procedures.10 As mentioned above, our research 
group have already developed a direct Csp3-H bond functionalization of xanthene and acridane 
with TMSCHN2 under oxidative condition to conduct a ring expansion reaction (Scheme 6).9 
Scheme 6. Summary of our previous work on C-H functionalization of xanthene and acridane. 
Based on this previous work, 1a was enrolled in the reaction using TMSN3 under the same 
oxidative system (BPO/Cu(OTf)2/bpy).9 Unfortunately, the conversion into desire product was 
unsatisfying after 18 h (Table 1, entry 1).  
Table 1. Optimization of the first step[a] 
 
Entry oxidant (equiv.) 
“Cu” cat.  
(10 mol%)  
Temp. 
(°C) 
Time (h) 
Conversion 
(%)[b] 
1 BPO (1.2) Cu(OTf)2[c] rt 18 33% 
2 BPO (1.2) CuBr  50 °C 18 >99% 
3 tBuOOH (1.2)[d] CuBr  50 °C 2 >99% 
4 tBuOOH (1.2)[e] CuBr [f] 50 °C 24 51% 
5 tBuOOH (1.2)[d] CuSO4*5H2O 50 °C 24 92% 
6[g] tBuOOH (1.2)[d] CuBr  50 °C 24 20% 
7[h] tBuOOH (1.2)[d] CuBr  50 °C 2 >99% 
8[h] tBuOOH (1.2)[e] CuBr  50 °C 2 >99% 
[a] 1a (0.4 mmol, 1 equiv.), TMSN3 (2 equiv.), oxidant and catalyst (10 mol%) in MeCN (0.4 M) at the corresponding 
temperature until disappearance of 1a. [b] Conversion evaluated by NMR analysis. [c] Bipyridyl (30 mol%) was used as 
ligand. [d] tBuOOH 70% in water. [e] dry tBuOOH 5.5 M in decane. [f] FeCl3 (20 mol%) was used as co-catalyst. [g] NaN3 
(2 equiv.) was used instead of TMSN3. [h] 1.2 equiv. of N3TMS was used.  
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Increasing the temperature to 50 °C and changing the oxidative system to tBuOOH under 
CuBr catalysis, full conversion was achieved in 2 hours (Table 1, entry 3). Interestingly, the 
performance did not change when the amount of TMSN3 was decreased to 1.2 equivalent or when 
water free tBuOOH was used (Table 1, entries 7 and 8). The addition of FeCl3 as co-catalys, as 
well as switching the azidonation agent to more nucleophilic species such as NaN3, led to low 
conversion even after 24 h (Table 1, entries 4 and 6). It is important to noticed that the crude 
product resulted almost pure when full conversion was achieved. 
Having in hand the accomplishment of the first step, the cyclization step was next 
investigated (Scheme 7).  
 
Scheme 7. Exploration of the 2-step 1-pot azidonation/CuAAC reaction. 
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Thus, the CuAAC was performed with the isolated azide 2a under standard click condition 
using CuSO4*5H2O as catalyst in the presence of sodium ascorbate, providing the desired triazole 
product in 49% isolate yield (Scheme 7, eq. i). Then, the 2-step 1-pot approach was examined. 
Initially, after the oxidative azidonation step, the addition of a second species of copper 
(CuSO4*5H2O) was explored (Scheme 7, eq. ii). The CuAAC reaction was carried out adding all 
the required reagents and an auxiliary solvent without any additional work-up. However, this 2-
copper system led to significantly lower yield of the product. Then, the reaction was enrolled only 
with the initial CuBr catalyst, without charging any other copper species during the second step 
(Scheme 7, eq. iii). To our delight, this 2-step 1-pot version worked very efficiently (62% yield), 
avoiding the need of additional metal species, and therefore, generating less waste.  
The reaction of xanthene with different dipolarophile partners was then investigated 
(Table 2). The yields were good with all the aromatic substituted alkynes (up to 62%), and steric 
hindrance was well tolerated as well (es. 4d, 45%). Instead, the employment of alkylic substituted 
alkynes led to lower performance and longer reaction times (29-39%, 48h). Interestingly, the 
trimethylsilylacetylene product (4i) resulted very unstable, being difficult to discriminate the 
reason for the obtained low 22% yield. 
Table 2. Scope of the reaction: Alkyne partner variation.[a],[b] 
 
[a] 1a (0.4 mmol, 1 equiv.), TMSN3 (1.2 equiv.), tBuOOH 70% in water (1.2 equiv.) and CuBr (10 mol%) in MeCN (0.4 
M) at 50 °C for 2 h, then 3 (1.2 equiv.), sodium ascorbate (0.4 equiv.) and tBuOH (0.4 M) at rt for 18 h. [b] Isolated yields. 
[c] CuAAC step was performed for 48 h. 
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Next, several different classes of substrate were explored in the reaction, involving 
phenylacetylene (3a) as alkynyl partner (Table 3). While dimethoxy xanthene 1k provided the 
triazole in 4k in high 65% yield, amine containing electron rich xanthene like 4l and 4m appear 
not suitable for reaction. In one hand, both azido intermediate 2l and triazole 4l are not stable 
under poor oxidative condition. In the other hand, 9-azido N-methyl acridane intermediate 2m, 
obtained almost quantitative, but presented a poor participation in the cycloaddition step. In 
addition, 4m resulted unstable and impossible to isolate, decomposing rapidly to give the 
corresponding acridone. Interestingly, even though tetrahydroisoquinoline 1n gave the azido-
intermediate 2n, after the second step it was observed just the addition product of the alkyne 3a 
to 1n. Finally, fluorene, isochromane and adamantane needed harsher conditions to achieve a 
significant amount of azide to enroll in the CuAAC step. 
Table 3. Substrates scope. 
 
[a] 1 (0.4 mmol, 1 equiv.), TMSN3 (1.2 equiv.), tBuOOH 70% in water or 5.5M in decane (1.2 equiv.) and CuBr (10 mol%) 
in MeCN (0.4 M) at 50°C for 2 h then 3a (1.2 equiv.), sodium ascorbate (0.4 equiv.) and tBuOH (0.4 M) at rt for 18h. [b] 
Isolated yields. [c] Azidonation step was performed for 24h. 
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2.2.4 Conclusion and Outlooks 
In summary, in this early study, important advances for the development of an efficient 
and easy procedure to extend a classical “click-chemistry” process were carried out. Thus, the 
CuAAC approach was extended to a 2-step 1-pot procedure, from the synthesis of the starting 
material (azide) to the effective target (triazole), involving a direct Csp3-H bond functionalization. 
Furthermore, as far as we know, the easy and direct synthesis of several triazole-substituted 
heterocycles, such as 4n and xanthene-based triazoles 4a-l, we efficiently achieved for the first 
time. However, taking into account the modarate yields and some limitation in the scope, 
especially concerning the CuAAC step, it is evident that further studies on the optimization are 
needed. In this regard, we are already testing other copper species, as well as different auxiliary 
solvents. 
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2.3 Experimental Part. 
2.3.1 Trapping Unstable Nitrones to form Isoxazolines  
General Information and Materials: 
 
1H and 13C NMR spectra were recorded in CDCl3, (reference signal: 1H = 7.26 ppm, 13C = 77.16 
ppm, CDCl3) on Brucker Avance 300 MHz spectometer. Chemical shifts (δ) are given in ppm and 
spin-spin coupling constants (J) are given in Hz. Analytical thin layer chromatography was 
performed using silica gel 60 F254 and a solution of KMnO4 or a Iodine camera served as staining 
agent. Column chromatography was performed on silica gel 60 (0.040-0.063 mm). Exact masses 
(HRMS (ES)) were recorded on an Agilent Q-TOF 6540 UHD spectrometer (samples in CH3OH 
as solvent). CH2Cl2 and Et3N were dried over molecular sieves; THF was distilled and dried over 
Na. TEMPO was purified by sublimation under reduced pressure. Other solvents and 
commercially available reagents were used without further purification. All the flasks were dried 
under vacuum using a heating gun. 
 
General Procedure: 
 
In a screw-cap schlenk tube, the corresponding N-protected N-benzylhydroxyamine derivative 1 
(1.00 equiv.) was dissolved in dry CH2Cl2 (2.00 mL). Acetylenedicarboxylate (2) (4.00 equiv.) and 
TEMPO (2.00 equiv.) were added and the reaction mixture was stirred at 70 °C for 24 h. The 
solvent was removed under reduced pressure and the obtained crude product was purified by flash 
column chromatography on silica gel eluting with pentane/AcOEt to give the corresponding N-
protected isoxazoline 3. 
 
2-tert-Butyl 4,5-dimethyl 3-phenylisoxazole-2,4,5-tricarboxylate (3aa)  
According to the general procedure, N-Boc N-benzyl hydroxylamine (1a) (0.25 
mmol, 63.3 mg, 1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 4.00 
equiv.) and TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were reacted. The 
crude product was purified by flash column chromatography on silica gel 
eluting with pentane/AcOEt [(%AcOEt): 1% (30 mL); 5% (50 mL); 15% (300 mL) 25% (200 mL)] to 
give 3aa as a viscous solid (0.22 mmol, 79.3 mg, 84%).1H NMR (300 MHz, CDCl3) δ/ppm 7.34 – 
7.20 (m, 5H), 6.06 (s, 1H), 3.87 (s, 3H), 3.57 (s, 3H), 1.39 (s, 9H). 13C NMR (75 MHz, CDCl3) δ/ppm: 
161.4, 158.1, 155.2, 149.9, 138.7, 128.81, 127.3, 111.0, 84.3, 68.9 53.6, 52.2, 28.1. MS-ESI: m/z 
calculated for [C18H21NO7Na]+ = 386.1210; found m/z  = 386.1207 
 
Dimethyl 2-((2,2,6,6-tetramethylpiperidin-1-yl)oxy)maleate (4aa)  
1H-NMR (300 MHz, CDCl3) δ/ppm: 5.94 (s, 1H), 6.43 (s, 1H), 3.91 (s, 3H), 
3.68 (s, 3H), 1.60-1.52 (m, 6H), 1.17 (s, 6H), 1.12 (s, 6H). 13C-NMR (75 MHz, 
CDCl3) δ/ppm: 167.4, 165.6, 95.6, 61.4, 52.9, 51.4, 39.7, 31.9, 20.5, 16.8. GC-
MS (T0 50°C_20°C/min_Tmax 280°C): for [C15H25NO5]; tR 10.4 min = m/z 300 
(MH+, 23), 269 (M+ - C2H6, 100).  
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2-Pivaloyl 4,5-dimethyl 3-phenylisoxazole-4,5-dicarboxylate (3ba) 
According to the general procedure, hydroxylamine 1b (0.50 mmol, 104.0 mg, 
1.00 equiv.), dry CH2Cl2 (4 mL), 2a (245 μL, 2.00 mmol, 4.00 equiv.) and 
TEMPO (157.6 mg, 1.00 mmol, 2.00 equiv.) were reacted. The crude product 
was purified by flash column chromatography on silica gel eluting with 
pentane/AcOEt [(%AcOEt): 1% (30 mL); 5% (50 mL); 20% (200 mL)] to give 
3ba as a viscous solid (0.090 mmol, 31.3 mg, 17%).1H NMR (300 MHz, CDCl3) δ/ppm: 7.40 – 7.31 
(m, 5H), 6.43 (s, 1H), 3.98 (s, 3H), 3.65 (s, 3H), 1.27 (s, 9H). 13C NMR (75 MHz, CDCl3) δ/ppm: 
178.6, 161.1, 157.8, 148.4, 138.1, 128.7, 128.7, 127.3, 111.9, 67.28, 53.6, 52.2, 39.6, 26.3. MS-ESI: 
m/z calculated for [C18H21NO6Na]+ = 370.1261; found m/z  = 370.1257. 
 
2-Ethyl 4,5-dimethyl 3-phenylisoxazole-2,4,5-tricarboxylate (3ca)  
According to the general procedure, hydroxylamine 1c (0.25 mmol, 63.3 
mg, 1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 4.00 equiv.) 
and TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were reacted. The crude 
product was purified by flash column chromatography on silica gel eluting 
with pentane/AcOEt [(%AcOEt): 1% (30 mL); 5% (50 mL); 15% (300 mL) 25% (200 mL)] to give 
3ca as a white viscous solid (0.21 mmol, 69.9 mg, 84%). 1H NMR (300 MHz, CDCl3) δ 7.46 – 7.28 
(m, 5H), 6.22 (s, 1H), 4.28 (qq, J = 10.6, 7.1 Hz, 2H), 3.95 (s, 3H), 3.65 (s, 3H), 1.30 (t, J = 7.1 Hz, 
3H). 13C NMR (75 MHz, CDCl3) δ 161.1, 157.9, 155.0, 150.0, 137.8, 131.9, 129.0, 122.8, 110.3, 84.6, 
68.3, 53.6, 52.2, 28.0. MS-ESI: m/z calculated for [C16H17NO7Na]+ = 358.0897; found m/z  = 
358.0903. 
 
2-Benzyl 4,5-dimethyl 3-phenylisoxazole-2,4,5-tricarboxylate (3da) 
According to the general procedure, hydroxylamine 1d (0.25 mmol, 064.2 
mg, 1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 4.00 equiv.) and 
TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were reacted. The crude product 
was purified by flash column chromatography on silica gel eluting with 
pentane/AcOEt [(%AcOEt): 1% (30 mL); 5% (50 mL); 15% (300 mL) 25% (200 mL)] to give 3da as 
viscous solid (0.10 mmol, 39.7 mg, 40%).1H NMR (400 MHz, CDCl3) δ/ppm: 7.35 – 7.16 (m, 10H), 
6.15 (s, 1H), 5.19 (d, J = 12.2 Hz, 1H), 5.12 (d, J = 12.2 Hz, 1H), 3.87 (s, 3H), 3.56 (s, 3H).13C NMR 
(101 MHz, CDCl3) δ/ppm: 161.0, 157.8, 156.3, 149.65, 138.0, 134.8, 128.9, 128.8, 128.6, 128.3, 
127.3, 111.1, 110.0, 69.0, 68.9, 53.6, 52.2, 29.7. MS-ESI: m/z calculated for [C21H19NO7Na]+ = 
420.1054; found m/z  = 420.1058 
 
2-(2,2,2-Trichloroethyl) 4,5-dimethyl 3-phenylisoxazole-4,5-tricarboxylate (3ea) 
According to the general procedure, hydroxylamine 1e (0.25 mmol, 74.7 mg, 
1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 4.00 equiv.) and 
TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were reacted. The crude product 
was purified by flash column chromatography on silica gel eluting with 
pentane/AcOEt [(%AcOEt): 1% (50 mL), 5% (50 mL), 10% (200 mL), 15% 
(300 mL)] to give 3ea as a white viscous solid (0.05 mmol, 22.9 mg, 21%). 1H-NMR (300 MHz, 
CDCl3) δ/ppm: 7.42 – 7.36 (m, 5H), 6.27 (s, 1H), 4.88 (d, J = 11.8 Hz, 1H), 4.72 (d, J = 4.6 Hz, 1H), 
3.97 (s, 3H), 3.66 (s, 3H). 13C-NMR (75 MHz, CDCl3) δ/ppm: 160.8, 157.5, 149.4, 137.3, 128.9, 
128.2, 127.4, 111.3, 94.2, 75.7, 69.1, 53.7, 52.4. MS-ESI: m/z calculated for [C21H19 Cl3NO7Na]+ = 
459.9728; found m/z  = 459.9729. 
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2-tert-Butyl 4,5-diethyl 3-phenylisoxazole-2,4,5-tricarboxylate (3ab) 
According to the general procedure, hydroxylamine 1a (0.25 mmol, 55.8 mg, 
1.00 equiv.), dry CH2Cl2 (2 mL), 2b (160 μL, 1.00 mmol, 4.00 equiv.) and 
TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were reacted. The crude product 
was purified by flash column chromatography on silica gel eluting with 
pentane/AcOEt [(%AcOEt): 1% (50 mL), 5% (50 mL), 10% (100 mL), 15% (400 mL)] to give 3ab as 
light yellow oil (0.21 mmol, 82.2 mg, 84%).  1H-NMR (300 MHz, CDCl3) δ/ppm: 7.42 – 7.29 (m, 5H), 
6.11 (s, 1H), 4.41 (q, J = 7.2 Hz, 2H), 4.15 – 4.02 (m, 2H), 1.46 (s, 9H), 1.40 (t, J = 7.2 Hz, 3H), 1.13 
(t, J = 7.1 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ/ppm: 161.0, 157.9, 155.3, 150.1, 138.9, 128.8, 
127.5, 110.7, 84.3, 69.0, 63.2, 61.2, 28.2. MS-ESI: m/z calculated for [C20H26NO7]+ = 392.1704; 
found m/z  = 392.1710. 
 
2,4,5-tri-tert-Butyl 3-phenylisoxazole-2,4,5-tricarboxylate (3ac) 
According to the general procedure, hydroxylamine 1a (0.25 mmol, 55.8 mg, 
1.00 equiv.), dry CH2Cl2 (2 mL), 2c (226.3 mg, 1.00 mmol, 4.00 equiv.) and 
TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were reacted. The crude product 
was purified by flash column chromatography on silica gel eluting with 
pentane/AcOEt [(%AcOEt): 1% (100 mL), 5% (100 mL), 10% (200 mL), 15% (200 mL), 20% (200 
mL)] to give 3ac as light yellow oil (0.13 mmol, 58.1 mg, 52%). 1H-NMR (300 MHz, CDCl3) δ/ppm: 
7.42 – 7.33 (m, 5H), 6.05 (s, 1H), 1.62 (s, 9H), 1.49 (s, 9H), 1.32 (s, 9H). 13C-NMR (75 MHz, CDCl3) 
δ/ppm: 160.1, 156.6, 155.3, 149.9, 139.3, 128.5, 128.5, 127.6, 111.5, 85.0, 83.8, 81.9, 69.2, 28.1, 28.0, 
27.9. MS-ESI: m/z calculated for [C24H33NO7Na]+ = 470.2149; found m/z  = 470.2152. 
 
2-tert-Butyl-4,6-dioxo-3-phenyl-5-methylhexahydro-2H-pyrrolo[3,4-d] isoxazole-2 
carboxylate (3ae) 
In a screw cap schlenk tube, hydroxylamine 1a (0.50 mmol, 112.0 mg, 1.00 
equiv.), N-methylmaleimide (2e) (1.00 mmol, 173.0 mg, 2.00 equiv.), 2a (1.00 
mmol, 122 µL, 2.00 equiv.) and TEMPO (1.00 mmol, 142.2 mg, 2.00 equiv.) were 
dissolved in dry CH2Cl2 (4 mL), and the reaction mixture was stirred at 70 °C 
for 4 days. The solvent was removed under reduced pressure and the obtained 
crude product was purified by flash column chromatography on silica gel eluting with 
pentane/AcOEt [(%AcOEt): 0% (200 mL), 5% (200 mL), 10% (200 mL), 15% (200 mL), 20% (200 
mL)] to give 3ae as light yellow oil (0.25 mmol, 83.0 mg, 50%). 1H-NMR (300 MHz, CDCl3) δ/ppm: 
7.44 – 7.31 (m, 5H), 5.74 (s, 1H), 4.94 (d, J = 7.3 Hz, 1H), 3.76 (d, J = 7.3 Hz, 1H), 3.01 (s, 3H), 1.41 
(s, 9H). 13C-NMR (75 MHz, CDCl3) δ/ppm: 174.3, 172.1, 156.7, 138.1, 129.0, 128.2, 126.0, 83.7, 
78.2, 65.9, 56.2, 27.8, 25.5. MS-ESI: m/z calculated for [C16H25NO7Na]+ = 366.1523; found m/z  = 
366.1527. 
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2-tert-Butyl-4,6-dioxo-3,5-diphenylhexahydro-2H-pyrrolo[3,4-d] isoxazole-2 carboxylate 
(3af)  
In a screw cap schlenk tube, hydroxylamine 1a (0.50 mmol, 112.0 mg, 1.00 
equiv.), 2a (1.00 mmol, 122 µL, 2.00 equiv.), N-phenylmaleimide (2f) (1.00 mmol, 
173.0 mg, 2.00 equiv.) and TEMPO (1.00 mmol, 142.2 mg, 2.00 equiv.) were 
dissolved in dry CH2Cl2 (4 mL), and the reaction mixture was stirred at 70 °C 
for 4 days. The solvent was removed under reduced pressure and the obtained 
crude product was purified by flash column chromatography on silica gel eluting with 
pentane/AcOEt [(%AcOEt): 5% (100 mL), 5% (100 mL), 15% (200 mL), 20% (500 mL)] to give 3af 
as a 1:7 mixture of diasteroisomers (0.22 mmol, 86.3 mg, 44%). Major diasteroisomer: 1H-NMR 
(300 MHz, CDCl3) δ/ppm: 7.53 – 7.26 (m, 10H), 5.90 (s, 1H), 5.09 (d, J = 7.4 Hz, 1H), 3.93 (d, J = 
7.4 Hz, 1H), 1.34 (s, 9H). 13C-NMR (75 MHz, CDCl3) δ/ppm: 173.5, 171.1, 157.0, 138.2, 134.3, 129.2, 
129.2, 129.0, 126.3, 126.1, 126.1, 125.9, 84.1, 78.4, 66.34, 56.4, 27.9. MS-ESI: m/z calculated for 
[C22H22N2O5Na]+ = 417.1421; found m/z  = 417.1419. 
 
2-tert-Butyl 4,5-dimethyl 3-(4-tert-butylphenyl)isoxazole-2,4,5-tricarboxylate (3ga)  
According to the general procedure, hydroxylamine 1g (0.25 mmol, 
72.8 mg, 1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 
4.00 equiv.) and TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were 
reacted. The crude product was purified by flash column 
chromatography on silica gel eluting with pentane/AcOEt 
[(%AcOEt): 1% (50 mL), 5% (50 mL), 10% (200 mL), 25% (200 mL)] 
to give 3ga as pale yellow viscous oil (0.16 mmol, 53.3 mg, 51%). 1H NMR (300 MHz, CDCl3) 
δ/ppm: 7.40 – 7.29 (m, 4H), 6.12 (s, 1H), 3.95 (s, 3H), 3.66 (s, 3H), 1.46 (s, 9H), 1.30 (s, 9H). 13C 
NMR (75 MHz, CDCl3) δ/ppm: 161.4, 158.1, 155.4, 151.6, 149.8, 135.5, 126.8, 125.7, 125.5, 111.0, 
84.2, 68.6, 53.5, 52.1, 34.6, 31.4, 31.3, 28.0. MS-ESI: m/z calculated for [C22H30NO7]+ = 420.2018; 
found m/z  = 420.2017. 
 
2-tert-Butyl 4,5-dimethyl 3-(4-methoxyphenyl)isoxazole-2,4,5-tricarboxylate (3ia)  
According to the general procedure, hydroxylamine 1i (0.25 mmol, 
63.3 mg, 1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 4.00 
equiv.) and TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were reacted. 
The crude product was purified by flash column chromatography on 
silica gel eluting with pentane/AcOEt [(%AcOEt): 1% (50 mL), 5% (50 
mL), 10% (200 mL), 15% (300 mL), 25% (200.00 mL)] to give 3ia as a white viscous solid (0.21 
mmol, 82.5 mg, 84%). 1H NMR (300 MHz, CDCl3) δ/ppm: 7.33 – 7.26 (m, 2H), 6.91 – 6.83 (m, 2H), 
6.08 (s, 1H), 3.94 (s, 3H), 3.79 (s, 3H), 3.64 (s, 3H), 1.46 (s, 8H). 13C NMR (75 MHz, CDCl3) δ/ppm: 
161.4, 159.9, 158.1, 155.2, 149.6, 130.79, 128.6, 114.1, 110.9, 84.17, 68.5, 55.3, 53.5, 52.1, 28.0. MS-
ESI: m/z calculated for [C19H23NO8Na]+ = 416.1316; found m/z  = 416.1315 
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2-tert-Butyl 4,5-dimethyl 3-(3-methoxyphenyl)isoxazole-2,4,5-tricarboxylate (3ja)  
According to the general procedure, hydroxylamine 1j (0.25 mmol, 
63.3 mg, 1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 
4.00 equiv.) and TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were 
reacted. The crude product was purified by flash column 
chromatography on silica gel eluting with pentane/AcOEt 
[(%AcOEt): 1% (50 mL), 5% (50 mL), 10% (200 mL), 15% (300 mL)] to give 3ja as a pale yellow 
viscous oil (0.18 mmol, 69.8 mg, 71%).1H NMR (300 MHz, CDCl3) δ/ppm: 7.26 – 7.20 (m, 1H), 7.02 
– 6.70 (m, 3H), 6.06 (s, 1H), 3.91 (s, 3H), 3.76 (s, 3H), 3.61 (s, 3H), 1.43 (s, 9H). 13C NMR (75 MHz, 
CDCl3) δ/ppm: 161.3, 159.9, 158.0, 155.2, 149.8, 140.1, 129.8, 119.5, 114.3, 112.8, 110.9, 84.3, 68.8, 
55.3, 53.5, 52.2, 28.1. MS-ESI: m/z calculated for [C19H23NO8Na]+ = 416.1316; found m/z  = 
416.1314. 
 
2-tert-Butyl 4,5-dimethyl 3-(2-methoxyphenyl)isoxazole-2,4,5-tricarboxylate (3ka)  
According to the general procedure, hydroxylamine 1k (0.25 mmol, 63.3 g, 
1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 4.00 equiv.) and 
TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were reacted. The crude product 
was purified by flash column chromatography on silica eluting with 
pentane/AcOEt [(%AcOEt): 1% (50 mL), 5% (50 mL), 15% (200 mL), 20% 
(300 mL)] to give 3ka as light yellow oil (0.11 mmol, 42.4 mg, 43%).1H NMR (300 MHz, CDCl3) 
δ/ppm: 7.33 – 7.27 (m, 2H), 6.99 – 6.86 (m, 2H), 6.51 (s, 1H), 3.94 (s, 3H), 3.85 (s, 3H), 3.63 (s, 3H), 
1.43 (s, 9H). 13C NMR 161.6, 158.4, 157.4, 155.4, 149.7, 130.1, 129.1, 126.5, 120.9, 111.2, 111.1, 
83.9, 64.4, 55.8, 53.5, 52.1, 28.1. MS-ESI: m/z calculated for [C19H23NO8Na]+ = 416.1316; found 
m/z  = 416.1317. 
 
2-tert-butyl 4,5-dimethyl 3-(benzo[d][1,3]dioxol-5-yl)isoxazole-2,4,5)-tricarboxylate (3la)  
According to the general procedure, hydroxylamine 1l (0.25 mmol, 66.8 
mg, 1.00 equiv.), dry CH2Cl2 (2.00 mL), 2a (122 μL, 1.00 mmol, 4.00 
equiv.) and TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were reacted. The 
crude product was purified by flash column chromatography on silica gel 
eluting with pentane/AcOEt [(%AcOEt): 1% (50 mL), 5% (50 mL), 15% 
(300 mL), 20% (500 mL)] to give 3la as a yellow low melting point solid 
(0.08 mmol, 31.6 mg, 31%). 1H NMR (300 MHz, CDCl3) δ/ppm: 6.89 – 6.74 (m, 3H), 6.05 (s, 1H), 
5.95 (s, 2H), 3.94 (s, 3H), 3.66 (s, 3H), 1.48 (s, 9H). 13C NMR (75 MHz, CDCl3) δ/ppm: 161.3, 158.0, 
155.2, 149.7, 148.03, 148.0, 132.5, 121.1, 110.7, 108.3, 107.7, 101.3, 84.3, 68.7, 53.5, 52.18, 28.1. 
MS-ESI: m/z calculated for [C19H21NO9Na]+ = 430.1109; found m/z  = 430,1113 
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2-tert-Butyl 4,5-dimethyl 3-(4-bromophenyl)isoxazole-2,4,5-tricarboxylate (3ma) 
According to the general procedure, hydroxylamine 1m (0.25 mmol, 
75.5 mg, 1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 
4.00 equiv.) and TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were 
reacted. The crude product was purified by flash column 
chromatography on silica gel eluting with pentane/AcOEt 
[(%AcOEt): 1% (50 mL), 5% (50 mL), 10% (200 mL), 15% (300 mL)] 
to give 3ma as light yellow oil (0.16 mmol, 70.6 mg, 80%). 1H NMR (300 MHz, CDCl3) δ/ppm: 7.52 
– 7.45 (m, 2H), 7.30 – 7.24 (m, 2H), 6.09 (s, 1H), 3.95 (s, 3H), 3.65 (s, 3H), 1.47 (s, 9H). 13C NMR 
(75 MHz, CDCl3) δ/ppm: 161.1, 157.9, 155.0, 150.0, 137.8, 131.9, 129.0, 122.8, 110.3, 84.6, 68.3, 
53.6, 52.2, 28.0.  
MS-ESI: m/z calculated for [C18H20BrNO7Na]+ = 464.0315; found m/z  = 464.0312. 
 
2-tert-Butyl 4,5-dimethyl 3-(4-chlorophenyl)isoxazole-2,4,5-tricarboxylate (3na)  
According to the general procedure, hydroxylamine 1na (0.25 mmol, 
64.4 mg, 1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 
4.00 equiv.) and TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were 
reacted. The crude product was purified by flash column 
chromatography on silica gel eluting with pentane/AcOEt 
[(%AcOEt): 1% (50 mL), 5% (50 mL), 10% (200 mL), 15% (300 mL)] 
to give 3na as viscous solid (0.16 mmol, 64.6 mg, 65%).1H NMR (300 MHz, CDCl3) δ/ppm: 7.33 (s, 
4H), 6.10 (s, 1H), 3.95 (s, 3H), 3.65 (s, 3H), 1.47 (s, 9H).13C NMR (75 MHz, CDCl3) δ/ppm: 161.3, 
158.0, 155.2, 150.1, 137.4, 134.7, 129.1, 128.8, 110.5, 84.70, 68.3, 53.7, 52.3, 28.2. MS-ESI: m/z 
calculated for [C18H21ClNO7]+ = 398.1001; found m/z  = 398.1000 
 
2-tert-Butyl 4,5-dimethyl 3-(4-trifluoromethylphenyl)isoxazole-2,4,5-tricarboxylate 
(3oa)  
According to the general procedure, hydroxylamine 1o (0.25 mmol, 
72.8 mg, 1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 
4.00 equiv.) and TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were 
reacted. The crude product was purified by flash column 
chromatography on silica gel eluting with pentane/AcOEt 
[(%AcOEt): 1% (50 mL), 5% (50 mL), 10% (200 mL), 15% (300 mL)] 
to give 3oa as viscous solid (0.16 mmol, 67.9 mg, 63%). 1H NMR (300 MHz, CDCl3) δ/ppm: 7.62 (d, 
J = 8.3 Hz, 2H), 7.52 (d, J = 8.2 Hz, 2H), 6.18 (s, 1H), 3.95 (s, 3H), 3.65 (s, 3H), 1.47 (s, 9H). 13C 
NMR (75 MHz, CDCl3) δ/ppm: 161.0, 157.9, 155.0, 150.3, 142.5, 127.69, 125.8, 125.7, 125.7, 125.6, 
110.0, 84.7, 68.2, 53.6, 52.2, 28.0. MS-ESI: m/z calculated for [C19H20F3NO7Na]+ = 454.1084; found 
m/z  = 454.1073. 
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2-tert-Butyl 4,5-dimethyl 3-cyclohexylsoxazole-2,4,5-tricarboxylate (3pa)  
According to the general procedure, hydroxylamine 1p (0.25 mmol, 50.8 
mg, 1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 4.00 equiv.) 
and TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were reacted. The crude 
product was purified by flash column chromatography on silica gel 
eluting with pentane/AcOEt [(%AcOEt): 1% (100 mL), 5% (50 mL), 10% 
(300 mL)] to give 3pa as light yellow oil (0.19 mmol, 68.6 mg, 74%). 1H-NMR (400 MHz, 
CDCl3) δ/ppm: 5.07 (d, J = 2.8 Hz, 1H), 3.89 (s, 3H), 3.76 (s, 3H), 1.68 (m, 5H), 1.50 (s, 9H), 
1.20 – 0.84 (m, 6H). 13C-NMR (100 MHz, CDCl3) δ/ppm: 162.1, 158.3, 157.2, 150.7, 109.3, 84.0, 
70.7, 53.3, 52.2, 41.2, 30.0, 29.8, 28.1, 26.3, 26.2, 26.0, 25.8. MS-ESI: m/z calculated for 
[C18H28NO7]+ = 370.1860; found m/z = 370.1855. 
  
2-tert-Butyl 4,5-dimethyl 3-ethylisoxazole-2,4,5-tricarboxylate (3qa)  
According to the general procedure, hydroxylamine 1q (0.25 mmol, 43.8 
mg, 1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 4.00 equiv.) 
and TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were reacted. The crude 
product was purified by flash column chromatography on silica gel eluting 
with pentane/AcOEt [(%AcOEt): 1% (100 mL), 5% (100 mL), 10% (300 mL)] to give 3qa as 
light yellow oil (0.13 mmol, 39.1 mg, 50%). 1H-NMR (300 MHz, CDCl3) δ/ppm: 5.16 (dd, J = 
6.8, 3.4 Hz, 1H), 3.91 (s, 3H), 3.77 (s, 3H), 1.86 (m, 1H), 1.70 (m, 1H), 1.52 (s, 9H), 0.96 (t, J = 
7.4 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ/ppm: 161.8, 158.20, 156.5, 150.6, 118.7, 110.1, 83.9, 
67.2, 53.3, 52.2, 28.1, 27.0, 8.8. MS-ESI: m/z calculated for [C14H21NO7]+ = 316.1391; found 
m/z = 316.1387. 
 
2-tert-Butyl 4,5-dimethyl 3-isobutylisoxazole-2,4,5-tricarboxylate (3ra) 
According to the general procedure, hydroxylamine 1r (0.25 mmol, 50.8 
mg, 1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 4.00 equiv.) 
and TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were reacted. The crude 
product was purified by flash column chromatography on silica gel 
eluting with pentane/AcOEt [(%AcOEt): 1% (100 mL), 5% (50 mL), 10% (300 mL)] to give 3ra 
as light yellow oil (0.08 mmol, 27.8 mg, 32%). 1H-NMR (300 MHz, CDCl3) δ/ppm: 5.24 – 5.03 
(m, 1H), 3.86 (s, 3H), 3.72 (s, 3H), 1.87 – 1.47 (m, 3H), 1.46 (s, 9H), 0.95 (d, J = 6.5 Hz, 3H), 
0.88 (d, J = 6.7 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ/ppm: 160.7, 157.2, 156.0, 149.8, 110.7, 
83.0, 63.8, 52.3, 51.1, 42.3, 27.0, 23.5, 22.5, 20.3. MS-ESI: m/z calculated for [C16H25NO7Na]+ 
= 366.1523; found m/z  = 366.1527 
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2-tert-Butyl 4,5-dimethyl 3-vinylisoxazole-2,4,5-tricarboxylate (3sa)  
According to the general procedure, hydroxylamine 1s (0.25 mmol, 43.3 
mg, 1.00 equiv.), dry CH2Cl2 (2 mL), 2a (122 μL, 1.00 mmol, 4.00 equiv.) 
and TEMPO (78.8 mg, 0.50 mmol, 2.00 equiv.) were reacted. The crude 
product was purified by flash column chromatography on silica gel eluting 
with pentane/AcOEt [(%AcOEt): 1% (100 mL), 5% (100 mL), 10% (300 mL)] to give 3sa as 
light yellow oil (0.13 mmol, 39.1 mg, 50%). 1H-NMR (300 MHz, CDCl3) δ/ppm: 6.00 – 5.84 (m, 
1H), 5.63 (d, J = 6.1 Hz, 1H), 5.43 (d, J = 17.0 Hz, 1H), 5.27 (d, J = 10.2 Hz, 1H), 3.92 (s, 3H), 
3.77 (s, 3H), 1.52 (s, 9H). 13C-NMR (100 MHz, CDCl3) δ/ppm: 161.5, 158.0, 155.7, 150.2, 133.8, 
118.2, 109.8, 84.3, 67.31, 53.5, 52.2, 28.1. MS-ESI: m/z calculated for [C14H20NO7]+ = 314.1234; 
found m/z = 314.1234. 
 
General Procedure for the Synthesis of the Hydroxylamine (1) 
 
General Experimental Procedure for the Synthesis of Benzyl Hydroxylamine (A): 
[2] The corresponding N-benzylhydroxylamine (25.04 mmol, 1.00 equiv.) was dissolved in 
THF-H2O (1:1 mixture, 20 mL, 1.25 M) and cooled to 0 °C. Then, K2CO3 (0.50 equiv.) was 
slowly added, the mixture was strongly stirred and a solution (Boc)2O (1.10 equiv.) in THF 
(60 mL, 0.5 M) was added dropwise during 2 h. The reaction mixture was allowed to reach 
r.t. and was further stirred for 12 h. The crude mixture was diluted with CH2Cl2 (150 mL), 
washed with water (3 x 100 mL) and brine (250 mL). The organic layer was dried over MgSO4 
and the solvent was removed under reduced pressure. The obtained crude product was 
purified by flash column chromatography on silica gel eluting with pentane/AcOEt mixtures. 
 
General Experimental Procedure for the Synthesis of Alkyl Hydroxylamine (B):  
In round bottom flask, alkylaldehayde (10.00 mmol, 2.00 equiv.), tert-butyl N-
hydroxycarbamate (5.00 mmol, 0.666 g, 1.00 equiv.), formic acid (15.00 mmol, 0.690 g, 0.566 
mL, 3.00 equiv.) and a 1:2 methanol/water mixture (30 mL) were added. The obtain solution 
was stirred for 15 minute at room temperature, then sodium cyanoborohydride (30 mmol, 
1.885 g, 6 equiv.) was added. The obtain suspension was stirred overnight still at room 
temperature. The crude was diluted with an aq. sat. solution of NaHCO3, and the obtain water 
solution was washed 3 times with ethyl acetate. The organic layers were collected and dried 
with MgSO4. The solvent was removed under reduced pressure and the obtained crude 
product was purified by flash column chromatography on silica gel eluting with 
pentane/AcOEt mixtures. 
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Selected examples: 
 
tert-Butyl hydroxy(phenyl)carbamate (1a)[2]  
 According to the general procedure A for hydroxylamine, N-
benzylhydroxylamine (25.04 mmol, 4.00 g, 1.00 equiv.), K2CO3 (12.50 mmol, 1.73 
g, 0.50 equiv.) and (Boc)2O (27.50 mmol, 6.00 g, 1.10 equiv.) were reacted. The 
obtained crude product was purified by flash column chromatography on silica gel eluting 
with pentane/AcOEt [%AcOEt: 0% (500 mL); 2.5% (800 mL); 5% (400 mL); 10% (400 mL); 20% 
(800 mL); 40% (400 mL)] to give 1a as a white solid (15.25 mmol, 3.43 g, 61%). 1H-NMR (300 
MHz, CDCl3) δ/ppm: 7.37 – 7.24 (m, 5H), 4.65 (s, 2H), 1.45 (s, 9H). 13C-NMR (75 MHz, CDCl3) 
δ/ppm: 157.0, 136.7, 128.5, 128.1, 127.5, 82.10, 54.4, 28.3. MS-ESI: m/z calculated for 
[C12H17NO3Na]+ = 246.1101; found m/z = 246.1107. 
 
tert-Butyl hydroxyl(cyclohexyl)carbamate (1p)  
 According to the general procedure B for hydroxylamine, 
cyclohexanecarbaldehyde (10.00 mmol, 1.122 g, 1.21 mL, 2.00 equiv.) was 
reacted. The crude product was purified by flash column chromatography on 
silica gel eluting with pentane/AcOEt (20% AcOEt) to give 1p as colorless liquid 
(1.18 mmol, 0.424 g, 37%). 1H-NMR (300 MHz, CDCl3) δ/ppm: 3.32 (d, J = 6.9 Hz, 2H), 1.81 – 
1.60 (m, 5H), 1.48 (s, 9H), 1.33 – 1.11 (m, 4H), 1.00 – 0.85 (m, 2H). 13C-NMR (100 MHz, CDCl3) 
δ/ppm: 156.8, 81.7, 55.9, 35.8, 30.7, 28.4, 26.5, 25.9. MS-ESI: m/z calculated for [C12H24NO3]+ 
= 230.1751; found m/z = 230.1751. 
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Selected NMR spectra 
2-tert-Butyl 4,5-Dimethyl 3-phenylisoxazole-2,4,5-tricarboxylate (3aa) 
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Dimethyl 2-((2,2,6,6-tetramethylpiperidin-1-yl)oxy)maleate (4aa)  
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2.3.2 Two steps one-pot azidonation/CuAAC reaction studies. 
 
General Information and Materials: 
 
1H and 13C NMR spectra were recorded in CDCl3, (reference signal: 1H = 7.26 ppm, 13C = 
77.16 ppm, CDCl3) on Brucker Avance 300 MHz spectometer. Chemical shifts (δ) are given in 
ppm and spin-spin coupling constants (J) are given in Hz. Analytical thin layer 
chromatography was performed using silica gel 60 F254 and a solution of KMnO4 or a Iodine 
camera served as staining agent. Column chromatography was performed on silica gel 60 
(0.040-0.063 mm). Exact masses (HRMS (ES)) were recorded on an Agilent Q-TOF 6540 UHD 
spectrometer (samples in CH3OH as solvent). MeCN was distilled over CaH2. Other solvents 
and commercially available reagents were used without further purification. 
 
General procedure for the formation of the azide (A): 
 
In a screw-cap schlenk tube, the corresponding target 1 (0.4 mmol, 1.00 equiv.), CuBr (10 
mol%) were dissolved in distilled MeCN (1.00 mL). TMSN3 (1.2 equiv.) and tBuOOH 70% in 
water or 5.5M in decane (1.2 equiv.) were added and the reaction mixture was stirred at 50 °C 
for 2 h. DCM was added in the crude mixture and the obtained organic phase was washed 2 
times with water and 1 with brine. Then the organic phase was collected, dried under MgSO4, 
the solvent removed under reduced pressure to give the corresponding crude azide 2 as a 
colorless oil. 
 
General procedure for the 2-step reaction (B): 
 
In a screw-cap schlenk tube, the corresponding target 1 (0.4 mmol, 1.00 equiv.), CuBr (10 
mol%) were dissolved in distilled MeCN (1.00 mL). TMSN3 (1.2 equiv.) and tBuOOH 70% in 
water or 5.5M in decane (1.2 equiv.) were added and the reaction mixture was stirred at 50 °C 
for 2 h. DCM was added in the crude mixture and the obtained organic phase was washed 2 
times with water and 1 with brine. Then the organic phase was collected, dried under MgSO4, 
the solvent removed under reduced pressure to give the corresponding crude azide 2 as a 
colorless oil. Then, without further purification, 2, sodium ascorbate (0.4 equiv.) and the 
terminal alkyne 3 (1.2 equiv.) were dissolved in a mixture 1:1 water/tBuOH (1.2 mL) and the 
reaction mixture was stirred at room temperature overnight. DCM and a NH3 10% w/w in 
water solution and stirred for a couple of minutes, then the organic phase was separated ad 
washed 2 times with a NH3 10% w/w in water solution, 1 time with water and 1 with brine 
(The crude mixture was washed 2 times with water and 1 with brine. The organic phase was 
collected, dried under MgSO4, and the solvent was removed under reduced pressure. The 
obtained crude product, if not enough pure, was purified by re-crystallization or flash column 
chromatography on silica gel eluting with pentane/AcOEt or DCM/AcOEt. 
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General procedure for the 2-step 1-pot reaction (C): 
 
In a screw-cap schlenk tube, the corresponding target 1 (0.4 mmol, 1.00 equiv.), CuBr (10 
mol%) were dissolved in distilled MeCN (1.00 mL). TMSN3 (1.2 equiv.) and tBuOOH 70% in 
water or 5.5M in decane (1.2 equiv.) were added and the reaction mixture was stirred at 50 °C 
for 2 h. Then the reaction mixture was let cool down and tert-butanol (1.00 mL), sodium 
ascorbate (0.4 equiv.) and the terminal alkyne 3 (1.2 equiv.) and the new reaction mixture 
was stirred at room temperature overnight. DCM and a NH3 10% w/w in water solution and 
stirred for a couple of minutes, then the organic phase was separated ad washed 2 times with 
a NH3 10% w/w in water solution, 1 time with water and 1 with brine (The crude mixture was 
washed 2 times with water and 1 with brine. The organic phase was collected, dried under 
MgSO4, and the solvent was removed under reduced pressure. The obtained crude product, if 
not enough pure, was purified by re-crystallization or flash column chromatography on silica 
gel eluting with pentane/AcOEt or DCM/AcOEt. 
 
9-Azido-xanthene (2a)  
According to the general procedure (A), xanthene (1a) (72.9 mg, 0.40 mmol, 1.00 
equiv.), CuBr (5.7 mg, 0.04 mmol, 10 mol%), TMSN3 (63.1 μL, 0.48 mmol, 1.20 
equiv.) and tBuOOH 70% in water (66.4 μL, 0.48 mmol, 1.20 equiv.) were 
reacted to give 2a as a colorless oil without further purification. 1H NMR (300 
MHz, CDCl3) δ/ppm δ 7.52 – 7.47 (m, 2H), 7.43 – 7.36 (m, 2H), 7.24 – 7.17 (m, 4H), 5.58 (s, 1H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 151.7, 130.3, 129.7, 123.9, 118.1, 117.2, 57.2.  
4-Phenyl-1-(xanthen-9-yl)-1H-1,2,3-triazole (4a)  
According to the general procedure (C), xanthene (1a) (72.9 mg, 0.40 mmol, 1.00 
equiv.), CuBr (5.7 mg, 0.04 mmol, 10 mol%), TMSN3 (63.1 μL, 0.48 mmol, 1.20 
equiv.), tBuOOH 70% in water (66.4 μL, 0.48 mmol, 1.20 equiv.), sodium 
ascorbate (31.7 mg, 0.16 mmol, 0.4 equiv.) and phenylacetylene (3a) (52.7 μL, 
0.48 mmol, 1.2 equiv.) were reacted. The crude product was purified by flash 
column chromatography on silica gel eluting with DCM/AcOEt [(%AcOEt): 0% 
(100 mL), 5% (300 mL)] to give 4a as white solid (0.25 mmol, 80.7 mg, 62%). 1H 
NMR (300 MHz, CDCl3) δ/ppm: 7.73 – 7.69 (m, 2H), 7.44 – 7.31 (m, 8H), 7.29 – 7.27 (m, 2H), 7.16 
– 7.10 (m, 2H). 13C NMR (75 MHz, CDCl3) δ/ppm: 151.0, 148.8, 130.8, 130.5, 129.7, 128.9, 128.3, 
125.8, 124.9, 118.0, 117.7, 117.4, 56.3. MS-ESI: m/z calculated for [C21H15N3ONa]+ = 348.1107; 
found m/z = 348.1107. 
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4-(2-Cyanophenyl)-1-(xanthen-9-yl)-1H-1,2,3-triazole (4b)  
According to the general procedure (C), xanthene (1a) (72.9 mg, 0.40 mmol, 
1.00 equiv.), CuBr (5.7 mg, 0.04 mmol, 10 mol%), TMSN3 (63.1 μL, 0.48 mmol, 
1.20 equiv.), tBuOOH 70% in water (66.4 μL, 0.48 mmol, 1.20 equiv.) sodium 
ascorbate (31.7 mg, 0.16 mmol, 0.4 equiv.) and (2-cyanophenyl)acetylene (3b) 
(61.0 mg, 0.48 mmol, 1.2 equiv.) were reacted. The crude product was purified 
by flash column chromatography on silica gel eluting with DCM/AcOEt 
[(%AcOEt): 0% (100 mL), 10% (100 mL), 20% (150 mL)] to give 4b as white 
solid (0.21 mmol, 74.3 mg, 57%). 1H NMR (300 MHz, CDCl3) δ/ppm: 8.19 (s, 
1H), 7.91 – 7.88 (m, 1H), 7.74 – 7.71 (m, 2H), 7.66 – 7.58 (m, 2H), 7.41 – 7.36 (m, 4H), 7.30 – 7.27 
(m, 3H), 7.17 (s, 1H), 7.14 – 7.11 (m, 2H). 13C NMR (75 MHz, CDCl3) δ/ppm: 151.5, 144.5, 134.1, 
133.7, 133.6, 133.1, 130.5, 129.4, 128.8, 128.6, 123.7, 118.7, 117.7, 117.4, 109.8, 61.1. MS-ESI: m/z 
calculated for [C22H14N4ONa]+ = 373.1060; found m/z = 373.1063. 
4-(3,5-Bis(trifluoromethyl)phenyl)-1-(xanthen-9-yl)-1H-1,2,3-triazole (4c)  
According to the general procedure (C), xanthene (1a) (72.9 mg, 0.40 mmol, 
1.00 equiv.), CuBr (5.7 mg, 0.04 mmol, 10 mol%), TMSN3 (63.1 μL, 0.48 
mmol, 1.20 equiv.), tBuOOH 70% in water (66.4 μL, 0.48 mmol, 1.20 
equiv.) sodium ascorbate (31.7 mg, 0.16 mmol, 0.4 equiv.) and (3,5-
bis(trifluoromethyl)phenyl)acetylene (3c) (114.3 mg, 0.48 mmol, 1.2 equiv.) 
were reacted. The crude product was purified by flash column 
chromatography on silica gel eluting with hexane/AcOEt [(%AcOEt): 0% 
(100 mL), 10% (100 mL), 20% (150 mL)] to give 4cas white solid (0.21 
mmol, 97.8 mg, 53%). 1H NMR (300 MHz, CDCl3) δ/ppm: 8.21 – 8.13 (m, 
2H), 7.90 (s, 1H), 7.82 (s, 1H), 7.43 – 7.38 (m, 2H), 7.37 – 7.33 (m, 2H), 7.31 – 7.28 (m, 2H), 7.15 (s, 
1H), 7.14 – 7.09 (m, 2H). 13C NMR (75 MHz, CDCl3) δ/ppm: 151.4, 145.2, 138.5, 134.9, 133.7, 132.6, 
132.5, 132.3, 132.1, 131.0, 130.5, 129.5, 129.2, 126.8, 126.1, 126.0, 126.0, 125.9, 124.4, 124.0, 123.7, 
122.0, 121.9, 121.9, 121.8, 119.2, 119.1, 118.1, 117.5, 61.2. MS-ESI: m/z calculated for 
[C23H13F6N3ONa]+ = 484.0855; found m/z = 484.0858. 
4-(Benzamidomethyl)-1-(xanthen-9-yl)-1H-1,2,3-triazole (4f)  
According to the general procedure (C), xanthene (1a) (72.9 mg, 0.40 mmol, 
1.00 equiv.), CuBr (5.7 mg, 0.04 mmol, 10 mol%), TMSN3 (63.1 μL, 0.48 
mmol, 1.20 equiv.), tBuOOH 70% in water (66.4 μL, 0.48 mmol, 1.20 equiv.) 
sodium ascorbate (31.7 mg, 0.16 mmol, 0.4 equiv.) and N-(prop-2-yn-1-
yl)benzamide (3f) (76.4 mg, 0.48 mmol, 1.2 equiv.) were reacted. The crude 
product was washed with small portion of cold AcOEt and hexane to give 4f 
as white solid (0.18 mmol, 67.3 mg, 44%). 1H NMR (300 MHz, CDCl3) δ/ppm: 
7.75 – 7.70 (m, 2H), 7.56 (s, 1H), 7.52 – 7.46 (m, 1H), 7.44 – 7.34 (m, 5H), 7.31 – 7.23 (m, 3H), 7.12 
– 7.06 (m, 2H), 7.04 (s, 1H), 6.52 (bs, 1H), 4.63 (d, 2H). 13C NMR (75 MHz, CDCl3) δ/ppm: 167.5, 
151.5, 145.7, 134.2, 133.7, 131.8, 130.3, 129.3, 128.7, 127.1, 123.7, 117.9, 117.4, 60.6, 35.5. MS-
ESI: m/z calculated for [C23H18N4O2Na]+ = 405.1322; found m/z = 405.1324. 
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4-(Benzamidomethyl)-1-(xanthen-9-yl)-1H-1,2,3-triazole (4i)  
 According to the general procedure (C), xanthene (1a) (72.9 mg, 0.40 mmol, 1.00 
equiv.), CuBr (5.7 mg, 0.04 mmol, 10 mol%), TMSN3 (63.1 μL, 0.48 mmol, 1.20 
equiv.), tBuOOH 70% in water (66.4 μL, 0.48 mmol, 1.20 equiv.) sodium 
ascorbate (31.7 mg, 0.16 mmol, 0.4 equiv.) and ethynyltrimethylsilane (3i) (47.1 
mg, 0.48 mmol, 1.2 equiv.) were reacted. The crude product was purified by flash 
column chromatography on silica gel eluting with hexane/AcOEt [(%AcOEt): 0% 
(100 mL), 10% (100 mL), 20% (200 mL)] to give 4i as colorless oil (0.09 mmol, 
28.3 mg, 22%). 1H NMR (300 MHz, CDCl3) δ/ppm: 7.54 (s, 1H), 7.40 – 7.31 (m, 3H), 7.25 – 7.21 (m, 
3H), 7.15 (s, 1H), 7.08 – 7.04 (m, 2H), 0.29 (s, 9H). 13C NMR (75 MHz, CDCl3) δ/ppm: 151.3, 146.5, 
141.27, 134.9, 130.0, 129.1, 123.5, 117.3, 60.0, -1.0. MS-ESI: m/z calculated for [C18H19N3OSiNa]+ 
= 344.1195; found m/z = 344.1193. 
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Selected NMR spectra 
9-Azido-xanthene (2a)  
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N-Phenyl-1-(xanthen-9-yl)-1H-1,2,3-triazole (4a) 
 71 
 
3 
 
C-H oxidative functionalization/expansion ring 
tandem reactions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3.1 
[1] Reproduced with the permission from: A. Gini, O. García Mancheño, Synlett, 2016, 27, 526. Copyright 2016 Georg 
Thieme Verlag KG; schemes, figures and text may differ from the published version. 
Chapter 3.2 
[1] Reproduced with the permission from: A. Gini, J. Bamberger, J. Luis-Barrera, M. Zurro, R. Mas-Ballesté, J. Alemán 
and O. García Mancheño, Adv. Synt. Catal., 2016, 358, 4049. Copyright 2015 WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim; schemes, figures and text may differ from the published version. 
[2] Contents of table 2, entries 3e, 3g, 3i, 3j, 3k, 3n, 3o and 3p were performed by J. Bamberger and J. Luis-Barrera. 
[3] Asymmetric synthesis of Lorcaserin (Scheme 4) were performed by M. Zurro. 
[4] Contents of the chapter 3.2.5 “Reactivity and Mechanistic Studies” were performed by J. Luis-Barrera and Ruben 
Mas-Ballasté. 
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3.1 The idea beyond the expansion ring 
3.1.1 C-based expansion ring reaction of xanthene-like structures: An overview 
As an introduction for the last results we achieved on oxidative Csp3-H bond 
functionalization/expansion ring tandem reaction, it is worth to mention and shortly discuss our 
previously publication on expansion ring of xanthene-like structures.1 As it was reported in the 
main introduction, the C-H bond-dissocation energy (DCE) on C-9 of xanthene and acridane is  
low, around 75 Kcal/mol, resulting one of the weakest Csp3-H bond energies among the common 
substrates enrolled in oxidative C-H bond functionalization. Despite the easy C-H bond cleavage 
in those substrates, the scope in the following coupling reaction is still considerable limited by the 
nucleophile nature (Scheme 1).2 
 
Scheme 1. Oxidative C-H bond functionalization of xanthenes and acridanes.  
Enolizable moieties such as carbonyls and nitroalkanes are the most common classes of 
nucleophiles employed in the oxidative C-H functionalization of xanthenes and acridanes. 
However, when different transformations are desired, in most of the cases it is necessary to enroll 
organometallic compounds such as a Grignard or an organoboron reagent.3 Thus, the potential 
incompatibility among classical nucleophilic alkylating agents and other involved reagents in a C-
H functionalization approach may lead to twisted multi-step processes when a C9-alkyl 
substituted compound is required.4 The Garcia’s group decided to tackle this problem by 
investigating for the first time the less explosive and toxic version of diazomethane, trimethylsilyl-
diazomethane (TMSCHN2), as methylating or methylenating reagent in the C-H functionalization 
of xanthenes.5,6 
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TMSCHN2 presents various attractive advantages respect to the less benign and 
“explosive” diazomethane while conserving the carbene reactivity: i) a lower reactivity than 
diazomethane,7 ii) a higher selectivity respect to the classical methylating agents,8 and iii) it 
presents a second good leaving group, TMS, which can be eliminated or promote further 
transformations. Having in mind the development of a new methylation or methenylation 
methodology, a copper catalyst was initially explored to promote the formation of a reactive 
copper-carbene.9 In fact, during the preliminary reactivity screening, the product resulted a 
completely different species, and even more interesting compare to what was searched in first 
instance. The xanthene underwent an expansion ring process, which gave a highly valuable 
dibenzoxepine product 4a (Scheme 2). The structure of 4a could be confirmed by X-ray.   
 
 
Scheme 2. Our initial oxidative C-H methylation/methenylation desire product vs the real formed 
ring-expansion product. 
Although this result deviated from the initial targeted transformation, this synthetic 
approach to form dibenzoxepines that was casually found was really appealing. These molecules 
are an important class of bioactive compounds,10 which lack of literature reported easy and fast 
synthetic methods for their preparation. The classical synthesis of dibenzoxepines and 
dibenzazepines from xanthenes and acridanes implies multistep processes to functionalize the 
benzylic position and introduce a CH2-LG (LG= leaving group) unit (Scheme 3).11 Furthermore, 
harsh heating and acidic conditions are then required to promote the elimination of the 
incorporated LG and subsequent Wagner–Meerwein type rearrangement to obtain the desire 
product. 11  
 
 
Scheme 3.  Dibenzoxepine/azepine synthesis by a multi-step approach implying a Wagner-
Meerwein type rearrangement. 
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Taking into account the limitation of common procedures for the expansion ring of such O- 
and N-heterocycle structures, as well as the preliminary but promising outcomes, it was decided 
to shift the efforts into the development and optimization of this unexpected novel Csp3-H 
oxidative functionalization/expansion ring tandem reaction strategy. In addition, it is interesting 
to note that such C-H oxidative functionalization/expansion ring tandem reaction are not 
satisfactorily explored even on other classes of substrates. During the preliminary screening, 
various oxidants were tested with xanthene (1a) and TMSCHN2 in the presence of Cu(II) triflate, 
which it could be involved into a reductive process mediated by the diazo compound to give the 
corresponding Cu(I) species.12 As expected, the typical oxidants such as TBHP, TEMPO+BF4- and 
DDQ were inefficient, most probably because they oxidize more readily the TMSCHN2 than the 
desire target. Next, benzoyl peroxide (BPO) was tried as non-protic mild, stable organic peroxide, 
in the presence of Cu(II)triflate (Cu(OTf)2) as catalyst to allow the homolytic O-O bond cleavage 
at room temperature.13 BPO results strong enough to activate the substrate but, at the same time, 
mild enough to avoid the complete decomposition of TMSCHN2. To improve the performance of 
the copper catalyst, available, cheap and simple N,N-ligands such as 2,2’-bipyridine were tested. 
The best result was obtained with 2,2’-bipyridine, leading to 4a in a good 55% yield (Table 1). This 
methodology could be extended to different substituted xanthenes and acridanes, as well as the 
less reactive sulfur-derivative thioxanthene. 
Table 1. Scope of the reaction.[a][b] 
 
[a] Conditions: 1 (0.2 mmol), TMSCHN2 (0.48 mmol), (PhCO2)2 (0.24 mmol), Cu(OTf)2 (10 mol%), and bpy (30 
mol%) in MeCN (2.0 mL) at r.t. for 18 h under argon atmosphere. [b] Yields are of isolated products. [c] Reaction in the 
presence of KF (1.1 equiv.). 
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Xanthenes provided dibenzoxepines in moderate to good yields (40-55%), whereas aryl and 
alkyl N-substituted acridanes led to dibenzazepines in typically higher yields (58-75%).14 
Interestingly, the N-Boc protected acridane also participated in this reaction, providing with a 
benzazepine with an easily removable protecting group (4f, 41%). Both electron-withdrawing and 
-donating substituents at the aromatic rings in acridanes were well tolerated, providing 4 in good 
yields. Conversely, a substitution in the C9 position was not tolerated, leading to no reaction (e.g. 
4m was not observed). An interesting point is the potential competitive elimination between the 
TMS group and a proton for the final formation of the double bond, which would lead to a mixture 
of two benzazepines. Accordingly, in some cases the use of 1.1 equivalents of KF provided higher 
yields on the desired product 4. The presence of KF might then help in the removal of the TMS, 
especially for substrates where the elimination of the TMS group is slow. It is important to 
mention that a critical issue in this transformation is the presence of water. Even traces in the 
catalyst, wet reagents and/or solvent can hinder the reaction, leading almost exclusively to 9-oxo-
compounds in significant amounts. Based on all the experimental observations, a reaction 
mechanism was postulated (Scheme 4). The exact role of the metal catalyst is still not fully 
understood, however we have excluded a carbene intermediate since similar results were obtained 
with different transition metals.1 Consequently, a first copper(I)-catalyzed reductive homolytic 
cleavage of the O-O bond of the benzoyl peroxide, giving benzoyl radical and copper(II) benzoate 
was prepared. Then, benzoyl radical abstracts a hydrogen from the C9 position of 1, forming the 
radical intermediate A. The copper(II) species will then oxidize the intermediate A to generate the 
carbocation B and regenerate the copper(I) catalyst. Besides this copper reduction step, it cannot 
be excluded that the excess of TMSCHN2 operates as the main reducing agent, helping the metal 
species to return to the catalytic active oxidation state. 
 
Scheme 4. The proposed mechanism. 
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Thus, an alternative mechanism may be involved in the formation of the carbocation C. 
This carbocation can also be formed by the reaction between the benzoyl radical and A. Then, an 
unstable covalent intermediate B will be formed, which is in equilibrium with the reactive ionic 
form C. Next, the TMSCHN2 react as a nucleophile with the carbocationic intermediate. After the 
addition, the reaction evolves to a three-member ring system E promoted by the elimination of 
nitrogen. Ring expansion and restore of the aromaticity leads to the carbocationic species F, which 
provided the final product by subsequent elimination of the silyl group upon assistance of the 
phenyl benzoate. This was supported by the formation of trimethylsilyl benzoate, which presence 
was confirmed by NMR analysis.  
3.1.2 Conclusions and Outlooks 
In this chapter I wanted to show the unexpressed potentiality of TMSCHN2 as expansion 
ring reagent combined with oxidative C-H functionalization. This unexplored approach is far to 
be exhausted, and the investigation of other substrates that might undergoe in similar expansion 
process is a demanding challenge we want to continue to face off. In this regard, the main issue 
relies in the choice of the appropriate oxidant, which should be capable of a selective activation on 
the desire target, preventing over-oxidations or undesired reactions of the diazo reagent. In 
addition, considering that seven members heterocycles are important biological scaffolds, general 
and easy approaches that not involve several steps and harsh conditions are still missing. In 
conclusion, in the next sections, our last results on the development of new diazocompound-based 
Csp3-H functionalization/expansion ring methodologies are presented. 
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3.2 C-Based expansion ring of THIQs 
3.2.1 Introduction 
3-Benzazepines are a unique class of compounds important in drug discovery. In particular, 
the tetrahydro-3-benzazepine is a common skeleton in a number of natural and pharmaceutical 
products.1 In the last half century, these compounds have been explored as a potent 
dopaminometic and antidopaminergic agents.2 They also present other pharmacological activities 
such as analgesic, antihypertensive or anticancer properties.3 Thus, e.g. (Figure 1) Lorcaserin has 
serotonergic properties and acts as an anorectic compound, which is currently used as a weight-
loss drug.4 Furthermore, Fenoldopam is employed as antihypertensive agent,5 whereas Ivabradine 
is a cardiotonic agent used for the symptomatic management of angina pectoris by inhibition of 
the funny channel.6 
 
Figure 1. Selected examples of biologically active 3-benzazepines. 
The main strategy to synthesize the 3-benzazepine core is based on a Lewis-acid mediated 
Friedel-Crafts-type cyclization approach (Scheme 1, top).7,8 In all these cases, the 2-arylethyl 
amines are used as starting materials, which must be derived to an acyclic key intermediate for 
the final cyclization through several synthetic steps. Recently, N-alkyl 3-benzazepines have been 
afforded by an osmium-catalyzed hydroamination reaction.9 This methodology also requires a 
multi-step synthesis of the substrates and is limited to N-alkyl derivatives. Besides these principal 
approaches, other synthetic routes include Pummerer cyclizations, electrophilic aromatic 
substitutions or the condensation of ketoacids with amines, among few others.8 However, most of 
these methods required: i) several steps, ii) harsh conditions, iii) prolonged reaction times and iv) 
do not tolerate a broad substitution pattern on the nitrogen atom and the aromatic ring (e.g. need 
of electron-rich groups). These issues limit the preparation of diverse substituted 3-benzazepines. 
Therefore, there is still a need of simple, mild and direct synthetic methods for their synthesis.  
 
Scheme 1. Classical synthetic approach to 3-benzoazepines. 
 80 
 
3.2.2 Objectives 
Based on the previously discussed TMSCHN2-based direct C-H functionalization/expansion 
ring process for the synthesis of dibenz[b,f]oxepines/azepines (Chapter 3.1), the extension to THIQ 
substrates was aimed. In this regard, THIQs are ready available and easy to handle substrates, 
and the intrinsic proprieties of their C1-H bond open the way for several valid options for the 
selective oxidative activation. Indeed, the main challenge consisted again in the choice of the right 
oxidant, considering the natural reaction of diazomethanes into carbonyls under oxidative 
conditions (Scheme 2). Thus, the employed oxidant should activate the target in a selective 
manner, meanwhile interacting with the sensitive diazocompound slowly and weakly.  
 
Scheme 2. Diazo compound decomposition vs. Target activation 
More in detail, our main goal is the development of a novel one-pot oxidative Csp3-H bond 
functionalization/expansion ring tandem reaction applied to THIQS, for the formation of valuable 
benzoazepine scaffolds (Scheme 3).10,11 In addition, we will also value the potential of the 
methodology in a synthetic application of demanding drugs, such as the anorectic medicine 
Lorcaserin.  
 
Scheme 3. Our direct Csp3-H functionalization/expansion ring tandem reaction proposal. 
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3.2.3 Results and Discussion 
We started our screening with N-phenyl-THIQ 1a as model substrate and TMSCHN2 as 
nucleophile for the optimization study of the reaction conditions (Table 1). A variety of standard 
oxidants in C-H functionalization were tested in dichloromethane at room temperature (Table 1, 
entries 1-8). DDQ (I) and tBuOOH (II) led to a complex mixture or no conversion, respectively. To 
our delight, the use of 1.2 equivalents of the TEMPO oxoammonium salt III (T+BF4-)12 provided 
for the first time the desired benzazepine 3a (Table 1, entry 3). The initial low conversion of 43% 
was enhanced to 88% by employing 1.5 equivalents of the oxidant (Table 1, entry 4). Other TEMPO 
salts (IV-VI) with different counter-anions and substitution in the backbone also promoted this 
reaction (Table 1, entries 5-7). With the best oxoammonium salt III, the temperature was 
increased to 60 and 80 °C, finding full conversion and good isolated yields (77-78%) in both cases 
after 4 and 1 hours, respectively (entries 8 and 9). However, when the amount of 2a was decreased 
to 1.5 equivalents, lower conversions were found at both temperatures (Table 1, entries 10 and 
11).  An important thing to mention is that the oxidative system (Cu(OTf)2, bipyridyne, BPO) 
previously employed in our lab for the expansion ring of xanthene and acridane moieties (Chapter 
3.2) lead to a complex mixture of methylation and esterification THIQ side-products (Table 1, 
entry 12). 
Table 1. Optimization of the reaction conditions.[a] 
 
[a] 1a (0.2 mmol), oxidant and TMSCHN2 (2a) in DCM (0.1 M) at the desired temperature in a sealed tube. [b] 
Conversion of 1a determined by 1H-NMR. Isolated yield in brackets. [c] Complex mixture. [d] No reaction observed. [e] 
Reaction in MeCN. (TEMPO =2,2,6,6-Tetramethyl-piperidin-1-yl)oxyl). [f] Cu(OTf)2 (10 mol%) and bipyridyl (30 mol%) 
were enrolled in the reaction. 
Entry Oxidant (x equiv.) 2a (equiv.) T [°C] t [h] 
Conversion 
(yield)[b] [%] 
1 DDQ (I) (1.2) 2.4 r.t. 18 --[c] 
2 t-BuOOH (II) (1.2) 2.4 r.t. 18 --[d], [e] 
3 T+BF4- (III) (1.2) 2.4 r.t. 18 43(26) 
4 T+BF4- (III) (1.5) 2.4 r.t. 18 88 
5 T+ClO4- (IV) (1.5) 2.4 r.t. 18 45 
6 T+OTf- (V) (1.5) 2.4 r.t. 18 88 
7 AcNH-T+BF4- (VI) (1.5) 2.4 r.t. 18 8 
8 T+BF4- (III) (1.5) 2.4 60 4 >99(78) 
9 T+BF4- (III) (1.5) 2.4 80 1 >99(77) 
10 T+BF4- (III) (1.5) 1.5 60 4 75 
11 T+BF4- (III) (1.5) 1.5 80 1 88 
12[f] BPO (VII) (1.2) 2.4 r.t 18 --[c] 
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Under the optimized conditions (Table 1, entry 9), the scope of the reaction was investigated 
(Table 2). Although we focussed on the synthesis of highly versatile 1,2-unsubstituted unsaturated 
3-benzazepines, which allows a rich variety of further functionalization of the double bond, other 
commercially available diazomethanes were also tested to show the generality of the method. 
Thus, the reaction of 1a with less nucleophilic diazoacetates such as ethyl (2b), benzyl (2c) and 
tert-butyl (2d) led to a mixture of the corresponding isomeric C1- and C2-substituted 3-
benzazepines 3/3’ in good yields (3b/3b’ 1:1.2, 63%; 3c/3c’ 1:1, 68%; 3d/3d’ 1.6:1, 66%). Table 2. 
Substrate scope.[a],[b] 
 
[a] 1 (0.2 mmol), T+BF4- (1.5 equiv.) and RCHN2 (1.5-2.4 equiv.) in DCM (0.1 M) at 80 °C for 1-4 h. [b] Isolated yield. [c] 
Isomeric ratio determined by 1H-NMR. [d] 1.0 mmol scale. [e] Concomitant formation of the corresponding N-methylated 
salts. 
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Next, different substituted THIQ derivatives 1 were explored. The reaction with N-aryl 
THIQs bearing both electron donating and withdrawing groups proceeded efficiently, providing 
the 3-benzazepines 3e-g in 50-72% yield. Furthermore, the reaction tolerated different common 
N-protecting groups like Boc or Cbz (3h and 3i) or acyl groups like pivaloyl (3j), and it could be 
scaled-up to 1.0 mmol with no significant detriment in the final yield (64 vs. 69%, 3h). Further 
derivatives bearing bulky carbamates like adamantyl derivatives 3k-l were obtained in moderate 
to good yields, whereas the alkylic substituted amine 3m was formed in a lower 27% yield. We 
next explored the substitution at the aromatic unit of the THIQ.  Because many 3-benzazepines 
contains methoxy or oxygenated groups (see e.g. Fenoldopam or Ivabradine, Figure 1), different 
oxygenated derivatives (1n-1r) were next studied. The reaction with the 6-methoxy substituted 
THIQ (3n, 74%), as well as with 6,8-dimethoxy (3p, 50%) and two methoxy groups at the 6 and 7 
positions with both a N-Boc (3o, 72%) and a N-adamadyl carbamate (3r, 52%) as protecting groups 
proceeded smoothly. The methylene bridge compound 1q was also supported without observing 
partial demethylenation under the oxidative reaction conditions and the structure of 3q was 
confirmed by X-ray analysis.13 Substrates with deactivating electron withdrawing groups such as 
fluoro or bromo also provided 3-benzazepines 3s-t. 
 
3.2.4 A new proposal for the synthesis of Lorcaserin 
The synthetic applicability of the developed methodology was demonstrated by the 
synthesis of the drug Lorcaserin (Scheme 4). Initially, the synthesis the racemic drug was carried 
out. Therefore, the corresponding THIQ 1u was prepared in gram scale in three steps from cheap 
p-chlorobenzaldehyde following a literature procedure.14 The enantioenriched version was also 
accomplished in a longer sequence to achieve (S)-1u in 90% ee.17 The reaction of 1u under the 
developed ring expansion methodology led to the 3-benzazepine 3u or (S)-3u in a moderate 30% 
yield. A further one-pot enamine reduction and N-Boc deprotection of 3u with Et3SiH in 
trifluoroacetic acid/dichloromethane, followed by treatment with HCl (1M in dioxane), provided 
the targeted derivative Lorcaserin hydrochloride salt in a quantitative yield. 
 
Scheme 4. Synthetic application: Synthesis of the drug Lorcaserin. 
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3.2.5 Unsuccessful applications on special substrates 
In this section, some of the most interesting unsuccessful attempts to extend the 
application of the developed strategy are listed (Table 3). In first instance, the reaction with 
unprotected THIQ (1v) gave a complex mixture of oxidation side-products together with N-
methylated THIQ salts (Table 3). A similar behavior was observed with N-alk THIQs, such as 1w 
and 1x, where a difficult to separate mixture of starting material and products, both N-methylated 
or not, was obtained. Thus, only in the case of N-benzyl THIQ 1x it was possible to collect the pure 
product 3x in low 17% of yield. Next, the strategy was applied to a highly demanding and complex 
substrate such as tetrahydropalmatine 1y. Although the oxidation was successful and a small 
amount of the corresponding methylated salt was observed, a competitive oxidation for the 
formation of palmatine salt was recognize as main product and the desired 7-member ring product 
3y could be isolated in <22% yield. In addition, 3y was found as a not air stable molecule. 
Table 3. Attempts for the application on N-Free and N-Alk THIQ 
 
[a] 1 (0.2 mmol), T+BF4- (1.5 equiv.) and TMSCHN2 (2.4 equiv.) in DCM (0.1 M) at 80 °C for 1-4 h. [b] Isolated yield. [c] 
4.8 equiv. of TMSCHN2 was used. 
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 Besides THIQ, many different structures bearing a α-Csp3-H bond to nitrogen or oxygen 
were enrolled in the developed methodology (Table 4). In several cases, the oxidative system was 
not capable to activate the desire target (Table 4, eq. i, ii, v, vi and vii) and the starting material 
was almost completely recovered. Instead, TEMPO+BF4- turned out to be a potent oxidant with 4c 
and 4d, but TMSCHN2 resulted an inefficient reagent, most probably for its low nucleophilic 
proprieties. Indeed, although the starting material was half consumed, no traces of the desire 
product were observed (entry Table 4, entries iii and iv). 
Table 4. Unreactive THIQ-like tested species. 
 
[a] 1 (0.2 mmol), T+BF4- (1.5 equiv.) and TMSCHN2 (2.4 equiv.) in DCM (0.1 M) at 80 °C for 1-4 h. [b] Isolated yield. 
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3.2.6 Reactivity and Mechanistic Studies 
Aiming at bringing some light into the mechanism of the reaction, several experiments 
were carried out. Considering the observed substrate-dependent 3:3’ selectivity with substituted 
diazomethanes (Table 2, e.g. 3b:3b’ vs. 3l as single isomer), further experiments with 
representative deuterium containing N-Boc precursors were carried out. This study indicates two 
possible competitive parallel mechanisms for the second step with TMSCHN2. In particular, the 
reactivity of labelled 1h, 1n and 1z with dissimilar substituents at para position to the reactive 
centre were investigated (Scheme 5). Differences on the performances were found, showing a 
higher reactivity for the more electron rich derivative 1n-D2 bearing the p-MeO substituent (58% 
yield), whereas the p-Br substituted THIQ 1z-D2 was the last reactive (8% yield). However, only 
slightly changes in the final isomeric ratio of the two possible labelled deuterated compounds were 
found. Thus, in all cases a mixture nearly to 70:30 of the regioisomers, presenting the deuterium 
atom in the proximal (3) and distal (3’) position respect to the nitrogen moiety, was obtained. 
 
 
Scheme 5. Mechanistic studies with D-labeled THIQs 1.  
To get a deeper understanding of such pathways, DFT calculations using the M06 
functional and 6-31G(d,p) basis set were performed by J. Luis-Barrera and Ruben Mas-Ballasté 
at UAM. In particular, the reactions of 1h, 1n and 1z with TMSCHN2 were studied. For each 
substrate, we considered the (R,R) and (S,R) diateroisomers, which have been specifically oriented 
to allow the aromatic C-atom or the N-atom to act as the nucleophilic centre, respectively (Figure 
2). For simplicity, the scenario found for the starting material 1h is primarily presented. First, 
the (S,R) diastereoisomer is significantly more stable (~2 kcal/mol) than the (R,R). It is also 
observed that the activation energies of the nucleophilic attack are just slightly lower for the initial 
C-C bond formation (from the most stable (S,R) isomer, Ea = 6.8 kcal/mol for C-C pathway and 8.6 
kcal/mol for C-N pathway, see Figure 2). Interestingly, while the N-attack results on the formation 
of an aziridine intermediate, the cyclopropane analogue (C-attack) has not been found as a 
minimum in the potential energy surface. An exhaustive exploration of the reaction coordinates 
indicated that, although a saddle region corresponding to geometries close to the cyclopropane 
putative intermediate is found, an energy minimum cannot be located with such structure. 
Therefore, when the initial step consists in the formation of the C-C bond, the system evolves 
barrier-less towards the benzazepine product. In contrast, when the initial step consists in the C-
N bond formation, an aziridine intermediate is produced, which further evolves through a ring 
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expansion process to generate the final benzazepine product. Such process from the aziridine 
intermediate has a significant activation energy of 16-17 kcal/mol. The high thermodynamic 
stability of the aziridine II intermediate (18 kcal/mol more stable than I), makes very improbable 
the backward reaction to I, which should overpass the activation energy of ~27 kcal/mol. Thus, 
regardless of the pathway followed, once the first transition state is overpassed, the reaction 
proceeds irreversibly towards the benzazepine product. Therefore, the formation of aziridine 
intermediate does not affect the overall tendency of the system to evolve through one or another 
pathway.  
 
 
 
Figure 2. DFT-calculated reaction pathways for THIQ 1h. 
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In fact, the comparable values for the initial activation energies suggest that both pathways 
are plausible and that the disappearance of the substrate 1h through one or another pathway 
should follow similar kinetics. Interestingly, while the consumption of 1h by means of the C-C 
pathway proceeds to the direct formation of the product, in the case of the C-N pathway the 
accumulation of the aziridine intermediate could result in a slower rate for the benzazepine 
production.15 One of the most surprising results of the mechanistic investigations shown above is 
the fact that the occurrence of one or another pathway is independent on the presence of the 
electronic nature of the phenyl ring. A priori, if the reaction pathways were triggered by the initial 
nucleophilic attack of either the aromatic carbon or the nitrogen center, the substitution on the 
aromatic ring should direct the reactivity towards one or another mechanism. In particular, 
electron-donating groups should enhance the C-C pathway and electron-withdrawing groups 
should tip the scales towards the C-N mechanism. However, such tendency was not observed 
experimentally. Regarding the analysis of the values of natural charges and the geometries in 
relevant atoms present in reagents and transition states,16 we found that the extrusion of the 
nitrogen molecule is the driven force for the formation of the species III from the intermediate I. 
Once the N2 fragment is taking place, the formation of the carbocation and the C- or N-driven 
nucleophilic attack takes place in a barrier-less concerted asynchronic process. In consequence, 
the modulation of the nucleophilicity of the aromatic carbon has a minor effect on the reaction 
pathway that results in the formation of the 3-benzazepine structures. 
 
3.2.7 Conclusions and Outlooks 
In conclusion, we achieved the oxidative Csp3-H functionalization/ring expansion tandem 
reaction on THIQs. However, some significant modifications regarding the oxidative system were 
required. Indeed, the oxidant resulted again a main feature in the strategy planning. Thus, mild 
TEMPO+BF4- revealed itself the best oxidant, whereas the previous developed Cu(I)/BPO system 
for xanthene and acridane was inefficient for mediate the reaction with THIQs. Beside its poor 
nucleophilicity, TMSCHN2 emerged again as privileged agent. In addition, several examples 
involving other diazocompounds were reported, and the challenging regioselectivity issue was 
explored. We have shown two concurrent possible operative mechanistic pathways based on 
experimental proofs and DFT calculations. Finally, the synthetic utility of this methodology was 
proven by the preparation of the 3-benzazepine drug Lorcaserin.  
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3.3 N-Based expansion ring reaction 
3.3.1 Introduction 
Dibenzodiazepines and dibenzooxazepines and their structural analogues have been 
revealed themselves as common cores in many potent drugs with a broad variety of bioactivities 
(Figure 1).1  
 
Figure 1. Selected examples of biologically active dibenzodiazepine and dibenzooxoazepines. 
Unfortunately, the complex multistep procedures commonly needed for the synthesis of 
these heterocycles limits the access to a broad number of structurally derivatives. Generally, the 
existing synthetic strategies rely on hetero cross-coupling reactions and a next imine or amide 
formation reaction, which usually involve both harsh conditions and the application of protecting 
groups (Scheme 1).2 For example, in most reported pathways the intermediate has to carry a NO2 
group as a protected amine. Therefore, a consecutive reduction is required, limiting the 
compatibility with other functional groups (Scheme 1, above). Thus, it is evident the drawback of 
enrolling such a complex strategy, which make practically impossible its application to a late stage 
functionalization. 
 
 
Scheme 1. Typical route for the synthesis of dibenzo(oxo/di)azepine and analogues. 
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Another possible approach for the synthesis of such substrates is the N-based expansion 
ring of xanthenes or acridanes, employing a Beckmann-like or Schmidt-like rearrangement 
(Scheme 2, eq. i and ii).3,4 In this context, not many methods are reported. The most relevant 
example involved a Beckmann-like rearrangement of 9-acridine-oxime with diisobutylalluminium 
hydride (DIBAL-H) (Scheme 2, eq. iii).5 Despite the potential of the application, the multi-step 
approach required for obtaining the oxime intermediate and the strong involved reactants limit 
extraordinarily the strategy.  
 
Scheme 2. Beckmann and Schmidt rearrangement. 
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3.3.2 Objectives 
The demand of new strategies for the synthesis of dibenzodiazepines or dibenzoxoazepines 
and analogues is still high, especially taking in consideration that there are not available reactions 
for the N-based expansion ring applicable in late stage functionalization. To tackle this challenge, 
a similar procedure to what we developed for the C-based expansion ring reaction was envisioned 
as a reasonable option. Thus, we aimed at starting from a nitrogen-based nucleophile, which 
contains a good leaving group that could promote the rearrangement. In this context, to the best 
of our knowledge, only one similar approach based on the C-H functionalization/Beckmann 
rearrangement was developed by J. Qiu and R. Zhang in recent years. The procedure involved a 
DDQ mediated Csp3-H bond functionalization of allyl/propargyl-benzyl or dibenzyl moiety, which 
undergoes an oxime formation followed in the acid catalysed Beckmann rearrangement (Scheme 
3).6  
 
Scheme 3.  Example of Csp3-H functionalization/Beckmann rearrangement reported by J. Qiu 
and R. Zhang. 
 Following this perspective, it is evident that the application of a nitrogen-based expansion 
ring rearrangement in a Csp3-H bond functionalization contest is still an unexplored field, even 
with standard targets employed in the C-H bond activation. Thus, inspired by well-known process, 
such as Beckmann or Schmidt rearrangements, we envisioned several reagents and oxidative 
systems for achieving the expansion ring reaction on the xanthene and acridane core (Scheme 4). 
 
Scheme 4. Our proposed strategy. 
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3.3.3 Results and discussion 
 In first instance, we tested o-trimethylsilyl hydroxylamine as reagent for the N-based 
expansion ring (Table 1). Following our experience, a benzoylperoxide/copper(II) triflate system 
was initially enrolled in the activation of xanthene (1a). However, no desire product was detected. 
Only a small amount of possible N-addition products 4 were observed (Table 1, entry 1).  
Table 1. Reaction screening involving TMSONH2.[a] 
 
Entry X 
Oxidant 
(x equiv.) 
Cat. 
(x mol%) 
T [°C] 
Additive 
(x equiv.) 
Conversion [%][c] 
2/3/4/5/6 
1[d] O BPO (1.2) Cu(OTf)2 (10%) r.t. - -/-/16/9/- 
2 O BPO (2) - 110 - -/-/-/-/-[e] 
3 O PIDA (1.2) - r.t. - -/-/70/30/- 
4 O tBuOOH[g] (2) CuBr (10%) 50 - -/-/48(28)/27/7[f] 
5 O tBuOOH[h] (2) CuBr (10%) 50 LiOH (2) -/-/17/17/- 
6[i][j] O TEMPO (2) - r.t. - -/-/5/-/- 
7[k] O DDQ (2) - 80 - -/-/-/62/- 
8[d] NMe BPO (1.2) Cu(OTf)2 (10%) r.t. - -/-/-/99/- 
9[i] NMe T+BF4- FeCl3 (20%) r.t. - -/-/-/-/- 
10 NMe tBuOOH[h] (2) CuBr (10%) 50 - -/-/-/99/- 
[a] 1 (0.4 mmol), oxidant, additive, catalyst and TMSONH2 (2 equiv.) in MeCN (0.1 M) at the desired temperature in a 
sealed tube. [b] Our hypothesis of possible by-products formed among the desire product. [c] Conversion of 1 determined 
by 1H-NMR respect to the products observed. [d] Bipyridyl (30 mol%) was enrolled in the reaction. [e] Full conversion in 
opening ring product. [f] Conversion of 4aa reported in brackets. [f] Cu(OTf)2 (10 mol%) and bipyridyl (30 mol%) were 
enrolled in the reaction. [g] tBuOOH 70% in water was used as oxidant. [h] tBuOOH 3M in iso-octane was used as 
oxidant. [i] The reaction was performed in DCM (0.1 M). [j] The reaction was performed under O2 atmosphere (1 atm). 
[k] The reaction was performed in HCOOH/MeCN 1:1 (0.1 M). 
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Instead, the use of PIDA as oxidant lead to full conversion, giving a mixture of addition 
products 4 and xanthone 5a (Table 1, entry 3). When, tBuOOH and CuBr were enrolled in the 
reaction, several side products were observed (Table 1, entry 4). In this case, we could clearly 
identify for the first time one of the addition products by NMR analysis. Thus, we decide to repeat 
the reaction adding LiOH, which should have a double role as Lewis acid for mediating the 
rearrangement and as a base for enhance the nucleophicility of TMSONH2. Unfortunately, a lower 
reactivity was detected (Table 1, entry 5). DDQ and a TEMPO/O2 systems didn’t allowed the 
addition of TMSONH2 on the target (Table 1, entries 6-7). Finally, acridane 1b gave no interesting 
result, leading exclusively the oxidized by-product acridone 5 (Table 1, entries 8-10).  
Next, trimethylsylil azide was enrolled for the N-based expansion ring reaction mediated 
by peroxides (Table 2).  
Table 2. Attempts involving TMSN3.[a] 
 
Entry X 
Oxidant 
(x equiv.) 
Cat. 
(x mol%) 
T [°C] 
Additive 
(x equiv.) 
Conversion [%][c] 
2/3/4/5/6 
1 O tBuOOH[d] (1.2) CuBr (10%) 50 - -/-/99/-/- 
2 O tBuOOH[e] (1.2) FeCl3 (20%) 50 - -/-/-/31/- 
3 O tBuOOH[e] (1.2) FeCl3 (100%) 50 - -/-/-/24/- 
4 O tBuOOH[e] (1.2) - 50 AlCl3 (1) -/-/-/-/- 
5 O tBuOOH[e] (1.2) - 50 BF3*OEt2 (1) -/-/-/-/- 
6 O tBuOOtBu (1.2) FeCl3 (20%) 50 - -/-/-/-/- 
7 O tBuOOtBu (1.2) FeCl3 (20%) 80 - -/-/-/-/- 
8 O tBuOOH[e] (1.2) ZnClO4 (10%) 50 - -/-/-/-/- 
9 O tBuOOH[e] (1.2) CuBr (10%) 50 FeCl3 (20%) -/-/50/-/- 
[a] 1 (0.4 mmol), oxidant, additive, catalyst and TMSN3 (2 equiv.) in MeCN (0.1 M) at the desired temperature in a 
sealed tube. [b] Our hypothesis of possible by-product formed among the desire product. [c] Conversion of 1 determined 
by 1H-NMR respect to the products observed.  [d] tBuOOH 70% in water was used as oxidant. [e]tBuOOH 3M in iso-
octane was used as oxidant. 
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In this case, to achieve both the functionalization and the rearrangement process, several 
lewis acids capable of the activation of both the oxidant and the azide intermediate were tested. 
Although we observed full conversion into 4ad when the reaction was mediated by 
copper(I)bromide (Table 2, entry 1, see also chapter 2.2), the enrolling of other lewis acids did not 
allowed even the formation of the azide intermediate 4ad. Finally, a loss of conversion of 4ad was 
observed when both copper(I)bromide and iron(III)chloride were involved (Table 2, entry 9). 
 
3.3.4 Conclusion and Outlook. 
Herein several preliminary results on the Csp3-H functionalization/N-based expansion ring 
reaction were showed. Even though we could not observe any of the desire products, some 
interesting addition by-products were detected. Those, especially when TMSONH2 was employed, 
could potentially be enrolled in a subsequent rearrangement reaction. Thus, it is evident that, in 
order to mediate the achievement and the activation of the addition intermediate 4, other lewis 
acids have to be tested in the reaction. 
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3.4 Experimental part 
3.4.1 C-Based expansion ring of THIQs 
General Information and Materials: 
 
1H, 13C and 19F NMR spectra were recorded in CDCl3 and DMSO-D6 (reference signals: 1H = 7.26 
ppm, 13C = 77.16 ppm, CDCl3) on a Bruker ARX-300 and a Varian AV-300, 400 or 600 MHz. 
Chemical shifts (δ) are given in ppm and spin-spin coupling constants (J) are given in Hz. 
Analytical thin layer chromatography was performed using silica gel 60 F254 and a solution of 
KMnO4 or phosphomolybdic acid served as staining agent. Column chromatography was 
performed on silica gel 60 (0.040-0.063 mm). Exact masses (HRMS) were recorded on an Agilent 
Q-TOF 6540 UHD spectrometer (samples in CH3OH as solvent) using electrospray (ES) or 
chemical (CI) ionization techniques. Chiral High Pressure Liquid Chromatography (HPLC) 
analyses were performed on an Agilent 1200 series instrument. 
CH2Cl2 and Et3N were distilled over CaH2. THF and Et2O were distilled and dried over Na. The 
starting materials and the oxoammonium salts such as T+BF4- were prepared following known 
literature procedures.1,2,3,4 Other solvents and commercially available reagents were used without 
further purification. 
 
General Procedure: 
 
In a flame-dried pressure schlenk tube, the TEMPO oxoammonium salt T+BF4- (72.9 mg, 0.30 
mmol, 1.5 equiv.) and the corresponding tetrahydroisoquinoline 1 (0.20 mmol, 1.0 equiv.) were 
suspended in dry DCM (0.1 M) under argon atmosphere. Afterwards the nucleophile TMS-CHN2 
(2) or EtO2C-CHN2 (0.48 mmol, 2.4 equiv.) was added dropwise (exothermic reaction, fumes!). 
Depending on the substrate, the reaction mixture was stirred at 80 °C for 1 h, 4 h or overnight. 
After evaporating the solvent, the crude product was purified by flash column chromatography.  
 
3-Phenyl-2,3-dihydro-1H-benzo[d]azepine (3a)  
According to the general procedure, using T+BF4- (72.9 mg, 0.3 mmol, 1.5 equiv.), 
THIQ 1a (41.8 mg, 0.20 mmol, 1.0 equiv.) and TMSCHN2 (2 M in hexane, 240 µL, 
0.48 mmol, 2.4 equiv.), the title compound was obtained after 1 h by flash column 
chromatography (cyclohexane/EtOAc, 50:1) as a slightly brown solid (34.1 mg, 0.15 mmol, 77%). 
1H NMR (300 MHz, CDCl3): δ/ppm= 7.32 (t, J = 7.9 Hz, 2H), 7.21-7.13 (m, 2H), 7.10-7.00 (m, 4H), 
6.53 (d, J = 10.0 Hz, 1H), 5.47 (d, J = 10.0 Hz, 1H), 3.99-3.88 (m, 2H), 3.13-3.02 (m, 2H); 13C NMR 
(75 MHz, CDCl3): δ/ppm = 147.9, 138.5, 136.7, 132.3, 129.3, 128.9, 127.3, 126.3, 125.6, 124.0, 122.1, 
119.6, 103.7, 50.8, 38.1. HRMS (ESI-MS): Mass calc. for C17H23NO4. [M+]+: m/z = 221.1199, found: 
m/z = 211.1195. 
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Ethyl 3-phenyl-2,3-dihydro-1H-benzo[d]azepine-5-carboxylate (3b) and ethyl 3-phenyl-
2,3-dihydro-1H-benzo[d]azepine-4-carboxylate (3b’)  
According to the general procedure, using T+BF4- (72.9 mg, 0.3 mmol, 1.5 equiv.), THIQ 1a (41.8 
mg, 0.20 mmol, 1.0 equiv.) and EtO2C-CHN2 (51 µL, 0.48 mmol, 2.4 equiv.), a 1:1.2 mixture of the 
title compounds 3b:3b’ was obtained as after 1 h by flash column chromatography 
(cyclohexane/EtOAc, 50:1).  
3b: Colorless oil (12.5 mg, 0.056 mmol, 28%). 1H NMR (300 MHz, CDCl3): δ/ppm = 
8.10 (s, 1H), 7.63 (dd, J = 7.9, 1.0 Hz, 1H), 7.37 (dd, J = 8.6, 7.4 Hz, 2H), 7.24 (dt, J 
= 8.0, 2.0 Hz, 1H), 7.19 – 7.05 (m, 5H), 4.28 (q, J = 7.1 Hz, 2H), 4.06 – 3.99 (m, 2H), 
3.20 – 3.11 (m, 2H), 1.33 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ/ppm = 
169.5, 148.1, 143.3, 140.1, 134.4, 130.5, 129.8, 129.4, 128.0, 126.0, 125.7, 124.4, 120.8, 103.7, 60.2, 
55.7, 35.7, 14.6; HRMS (EI): Mass calc. for C19H19NO2 [M+.]: m/z = 293.1410, found: m/z = 
293.1409.  
3b’: Yellow oil (15.3 mg, 0.069 mmol, 35%). 1H NMR (300 MHz, CDCl3): δ/ppm = 
7.43 (d, J = 7.5 Hz, 1H), 7.32 – 7.21 (m, 3H), 7.19 – 7.15 (m, 2H), 7.06 – 6.94 (m, 
4H), 4.06 (q, J = 7.1 Hz, 2H), 3.84 – 3.75 (m, 2H), 3.00 – 2.89 (m, 2H), 0.97 (t, J = 
7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ/ppm = 167.2, 148.5, 140.8, 135.5, 133.5, 
133.2, 129.9, 129.3, 126.8, 126.3, 123.0, 122.6, 121.7, 61.3, 51.8, 36.6, 13.9; HRMS (EI): Mass calc. 
for C19H19NO2 [M+.]: m/z = 293.1410, found: m/z = 293.1413.  
 
Benzyl 3-phenyl-2,3-dihydro-1H-benzo[d]azepine-5-carboxylate (3c) and benzyl 3-
phenyl-2,3-dihydro-1H-benzo[d]azepine-4-carboxylate (3c’)  
According to the general procedure, using T+BF4- (72.9 mg, 0.3 mmol, 1.5 equiv.), THIQ 1a (41.8 
mg, 0.20 mmol, 1.0 equiv.) and BnO2C-CHN2 (72 µL, 0.48 mmol, 2.4 equiv.), a 1:1 mixture of the 
title compounds 3c:3c’ was obtained as after 1 h by flash column chromatography (PE  
PE/EtOAc 9:1). 
3c: Yellow oil (24.8 mg, 0.070 mmol, 35%). 1H NMR (300 MHz, CDCl3): δ/ppm = 
8.14 (s, 1H), 7.63 (d, J = 7.8 Hz, 1H), 7.42 – 7.37 (m, 2H), 7.37 – 7.31 (m, 5H), 7.31 
– 7.27 (m, 1H), 7.23 – 7.18 (m, 1H), 7.16 – 7.10 (m, 3H), 7.10 – 7.03 (m, 1H), 5.27 (s, 
2H), 4.05 – 3.95 (m, 2H), 3.19 – 3.07 (m, 2H); 13C NMR (75 MHz, CDCl3): δ/ppm = 
169.2, 148.2, 143.8, 140.1, 137.1, 134.4, 130.6, 129.5, 128.5, 128.1, 128.0, 127.9, 126.0, 125.8, 124.6, 
121.0, 103.3, 66.0, 55.9, 35.8; HRMS (EI): Mass calc. for C24H21NO2 [M+.]: m/z = 355.1572, found: 
m/z = 355.1575.  
3c’: Yellow oil (23.6 mg, 0.066 mmol, 33%). 1H NMR (300 MHz, CDCl3): δ/ppm= 
7.41 (d, J = 7.5 Hz, 1H), 7.37 – 7.34 (m, 2H), 7.33 (s, 1H), 7.24 – 7.19 (m, 4H), 7.15 
(d, J = 4.0 Hz, 2H), 7.05 (s, 1H), 7.03 – 6.98 (m, 1H), 6.95 – 6.91 (m, 3H), 5.02 (s, 
2H), 3.80 – 3.75 (m, 2H), 2.95 – 2.90 (m, 2H); 13C NMR (75 MHz, CDCl3): δ/ppm = 167.1, 148.3, 
140.8, 135.6, 135.0, 133.3, 129.9, 129.4, 128.8, 128.6, 128.4, 128.14, 128.0, 126.9, 126.3, 122.9, 
122.4, 67.2, 51.6, 36.5; HRMS (EI): Mass calc. for C24H21NO2 [M+.]: m/z = 355.1572, found: m/z = 
355.1577.  
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tert-Butyl 3-phenyl-2,3-dihydro-1H-benzo[d]azepine-5-carboxylate (3d) and tert-butyl 3-
phenyl-2,3-dihydro-1H-benzo[d]azepine-4-carboxylate (3d’)  
According to the general procedure, using T+BF4- (72.9 mg, 0.3 mmol, 1.5 equiv.), THIQ 1a (41.8 
mg, 0.20 mmol, 1.0 equiv.) and tBuO2C-CHN2 (67 µL, 0.48 mmol, 2.4 equiv.), a 1.6:1 mixture of 
the title compounds 3d:3d’ was obtained as after 1 h by flash column chromatography (PE  
PE/EtOAc 9:1). 
3d: Yellow oil (26.9 mg, 0.084 mmol, 41%). 1H NMR (300 MHz, CDCl3): δ/ppm= 8.04 
(s, 1H), 7.57 (d, J = 8.1 Hz, 1H), 7.41 – 7.30 (m, 2H), 7.24 – 7.18 (m, 1H), 7.16 – 7.01 
(m, 5H), 4.03 – 3.96 (m, 2H), 3.19 - 3.10 (m, 2H), 1.53 (s, 9H). 13C NMR (75 MHz, 
CDCl3): δ/ppm = 168.8, 148.2, 142.7, 140.1, 134.8, 130.7, 129.4, 127.9, 125.8, 125.6, 
124.1, 120.4, 105.6, 79.9, 55.7, 35.7, 28.5; HRMS (EI): Mass calc. for C21H23NO4 [M+.]: m/z = 
321.1729, found: m/z = 321.1727. 
3d’: Yellow oil (16.7 mg, 0.052 mmol, 25%). 1H NMR (300 MHz, CDCl3): δ/ppm= 
δ 7.40 (d, J = 7.7 Hz, 1H), 7.30 – 7.27 (m, 2H), 7.22 – 7.18 (m, 1H), 7.14 – 7.12 (m, 
2H), 7.04 – 6.99 (m, 1H), 6.98 – 6.95 (m, 2H), 6.90 (s, 1H), 3.86 – 3.68 (m, 2H), 
2.98 – 2.81 (m, 2H), 1.20 (s, 9H); 13C NMR (75 MHz, CDCl3): δ/ppm = 166.1, 148.9, 140.6, 136.8, 
133.8, 132.9, 129.8, 129.2, 126.4, 126.2, 123.2, 123.0, 120.3, 81.2, 52.0, 36.6, 27.6; HRMS (EI): 
Mass calc. for C21H23NO4 [M+.]: m/z = 321.1729, found: m/z = 321.1733. 
 
3-(4-Fluorophenyl)-2,3-dihydro-1H-benzo[d]azepine (3f) 
According to the general procedure, using T+BF4- (72.9 mg, 0.3 mmol, 1.5 
equiv.), THIQ 1c (45.5 mg, 0.20 mmol, 1.0 equiv.) and TMSCHN2 (2 M in 
hexane, 240 µL, 0.48 mmol, 2.4 equiv.), the title compound was obtained after 
1 h by flash column chromatography (cyclohexane/EtOAc, 40:1  20:1) as yellow solid (24.2 mg, 
0.10 mmol, 50%). 1H NMR (300 MHz, CDCl3): δ/ppm = 7.18 – 7.11 (m, 2H), 7.07 – 7.02 (m, 1H), 
7.02 – 6.97 (m, 5H), 6.47 – 6.34 (m, 1H), 5.49 – 5.39 (m, 1H), 3.92 – 3.81 (m, 2H), 3.09 – 2.97 (m, 
2H); 13C NMR (75 MHz, CDCl3): δ/ppm = 158.5 (d, J = 243.5 Hz), 144.6, 138.5, 132.5, 129.0, 128.7, 
126.6, 126.4, 124.0, 121.5 (d, J = 6.1 Hz), 115.9 (d, J = 21.0 Hz), 103.6, 51.6, 38.0; 19F NMR (282 
MHz, CDCl3): δ/ppm = -121.4; HRMS (EI): Mass calc. for C16H14NF [M+.]: m/z = 239.1105, found: 
m/z = 239.1108. 
 
tert-Butyl 1,2-dihydro-3H-benzo[d]azepine-3-carboxylate (3h) 
 According to the general procedure, using T+BF4- (72.9 mg, 0.30 mmol, 1.5 equiv.), 
THIQ 1d (46.60 mg, 0.20 mmol, 1.0 equiv.) and TMSCHN2 (2 M in Et2O, 240 µL, 
0.48 mmol, 2.4 equiv.), the title compound was obtained after 1 h by flash column 
chromatography (PE  PE/EtOAc, 20:1) as a slightly yellow solid (33.2 mg, 0.14 mmol, 68%). Note: 
The reaction was also carried out in a 1.0 mmol scale with a reaction time of 2 h and a reproducible 
result is reported (66 %). 1H-NMR (400 MHz, CDCl3): δ/ppm = 7.20-7.15 (m, 2H), 7.10-7.05 (m, 
2H), 6.93 (bs, 1H), 5.56 (bs, 1H), 3.95-3.90 (m, 2H), 3.06-3.00 (m, 2H), 1.53 (s, 9H); 13C NMR (100 
MHz, CDCl3): δ/ppm = 152.2, 139.2, 135.1, 130.2, 128.9, 126.6, 126.4, 125.8, 108.3, 81.7, 39.5, 37.2, 
28.3; HRMS (ESI): Mass calc. for C15H19NO2.Na [M+Na]+: m/z = 268.1308 found: m/z = 268.1310. 
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3-(Adamantan-1-yl) 1-ethyl 4,5-dihydro-3H-benzo[d]azepine-1,3-dicarboxylate (3l) 
According to the general procedure, using T+BF4- (72.9 mg, 0.30 mmol, 1.5 
equiv.), THIQ 1g (62.3 mg, 0.20 mmol, 1.0 equiv.) and EtO2C-CHN2 (51 µL, 
0.48 mmol, 2.4 equiv.), the title compound was obtained after 1 h by flash 
column chromatography (PE  PE/EtOAc, 20:1) as a white solid (30.5 mg, 
0.079 mmol, 40%). 1H NMR (400 MHz, CDCl3): δ/ppm = 8.42 (s, 1H), 7.49 (dd, J = 7.7, 1.2 Hz, 
1H), 7.22 (td, J = 7.7, 1.5 Hz, 1H), 7.17 (td, J = 7.3, 1.5 Hz, 1H), 7.08 (dd, J = 7.4, 1.3 Hz, 1H), 
4.28 (q, J = 7.1 Hz, 2H), 3.98 – 3.87 (m, 2H), 3.06 – 2.77 (m, 2H), 2.20 (bs, 3H), 2.16 (bs, 6H), 
1.67 (bs, 6H), 1.34 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ/ppm =  168.6, 151.9, 
140.4, 137.0, 132.8, 130.5, 129.8, 127.9, 127.1, 126.1, 82.9, 60.8, 51.3, 41.3, 36.1, 34.0, 30.9, 
14.4; HRMS (ESI): Mass calc. for C24H29NO4.H [M+H]+: m/z = 396.2169, found: m/z = 
396.2173.  
 
3-Butyl-2,3-dihydro-1H-benzo[d]azepine (3m)  
According to the general procedure using T+BF4- (72.9 mg, 0.30 mmol, 1.5 equiv.), 
THIQ 1h (39 µL, 37.9 mg, 0.200 mmol, 1.0 equiv.) and TMSCHN2 (2 M in Et2O, 
150 µL, 0.30 mmol, 1.5 equiv.), the title compound was obtained after 4 h by flash 
column chromatography (petroleum ether  petroleum ether: ethyl acetate 30:1) as a brown oil 
(11.3 mg, 0.06 mmol, 28%). 1H NRM (300 MHz, CDCl3): δ/ppm = 7.10-7.00 (m, 2H), 6.95-6.90 (m, 
1H), 6.90-6.84 (m, 1H), 6.04 (d, J = 9.8 Hz, 1H), 4.99 (d, J = 9.8 Hz, 1H), 3.45-3.30 (m, 2H), 3.07 (t, 
J = 7.1 Hz, 2H), 3-00-2.90 (m, 2H), 1.51 (m, 4H), 1.31 (m, 3H), 0.91 (t, J = 7.3 Hz, 3H); 13C NMR 
(75 MHz, CDCl3): δ/ppm = 138.5, 137.8, 137.5, 128.8, 127.8, 126.2, 122.7, 96.4, 57.8, 51.3, 38.2, 
31.3, 20.1, 13.9; HRMS (ESI-MS): Mass calc. for C14H19N [M]+: m/z = 201.1512, found: m/z = 
201.1515. 
 
(3r)-Adamantan-1-yl 5,6-dihydro-7H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]azepine-7-
carboxylate (3q) 
According to the general procedure using T+BF4- (72.9 mg, 0.30 mmol, 
1.5 equiv.), THIQ 1n (70.9 mg, 0.200 mmol, 1.0 equiv.) and TMSCHN2 
(2 M in Et2O, 240 µL, 0.480 mmol, 2.4 equiv.), the title compound was 
obtained after 4 h by flash column chromatography (petroleum ether  petroleum ether: ethyl 
acetate 4:1) as a white solid (52.0 mg, 0.142 mmol, 71%). 1H NRM (300 MHz, CDCl3): δ/ppm 
= 6.86 (bs, 1H), 6.63 (s, 1H), 6.57 (s, 1H), 5.91 (s, 2H), 5.34 (bs, 1H), 3.90-3.85 (m, 2H), 2.95-
2.90 (m, 2H), 2.25-2.15 (m, 9H), 1.68 (bs, 6H); 13C NMR (75 MHz, CDCl3): δ/ppm = 151.7, 
146.2, 145.8, 133.5, 128.9, 125.3, 109.9, 109.4, 107.8, 101.0, 81.6, 46.6, 44.9, 41.6, 36.9, 36.2, 
31.0, 29.8; HRMS (ESI-MS): Mass calc. for C22H25NO4. [M]+: m/z = 368.1784, found: m/z = 
368.1782. 
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(3r)-Adamantan-1-yl 7,8-dimethoxy-1,2-dihydro-3H-benzo[d]azepine-3-carboxylate 
(3r)  
According to the general procedure using T+BF4- (72.9 mg, 0.30 mmol, 
1.5 equiv.), THIQ 1o (74.3 mg, 0.200 mmol, 1.0 equiv.) and TMSCHN2 
(2 M in Et2O, 240 µL, 0.480 mmol, 2.4 equiv.), the title compound was 
obtained after 4 h by flash column chromatography (petroleum ether  petroleum ether: ethyl 
acetate 4:1) as a white solid (39.8 mg, 0.104 mmol, 52 %). 1H NRM (300 MHz, CDCl3): δ/ppm 
= 6.85 (bs, 1H), 6.70-6.55 (m, 2H), 5.43 (bs, 1H), 3.90-3.80 (m, 2H), 3.86 (s, 6H), 2.97 (s, 2H), 
2.25-2.10 (m, 9H), 1.70-60 (m, 6H); 13C NMR (75 MHz, CDCl3): δ/ppm (presence of rotamers) 
= 154.7, 151.8 and 151.0 (rotamers), 147.2 and  147.1 (rotamers), 132.2, 127.6, 125.5, 113.5, 
112.6, 108.6 and 108.1 (rotamers), 81.5 and 81.5 (rotamers), 68.3, 56.0, 45.4, 41.6, 36.3, 36.2, 
31.0, 30.8, 29.8, 29.1, 22.7; HRMS (ESI-MS): Mass calc. for C23H29NO4.Na [M+Na]+: m/z = 
406.1987, found: m/z = 406.1989. 
 
tert-Butyl 6-fluoro-1,2-dihydro-3H-benzo[d]azepine-3-carboxylate (3s)  
 According to the general procedure using T+BF4- (72.9 mg, 0.30 mmol, 1.5 
equiv.), THIQ 1p (50.3 mg, 0.200 mmol, 1.0 equiv.) and TMSCHN2 (2 M in 
Et2O, 240 µL, 0.480 mmol, 2.4 equiv.), the title compound was obtained after 
1 h by flash column chromatography (petroleum ether  petroleum ether: ethyl acetate 20:1) 
as a yellow solid (20.7 mg, 0.074 mmol, 37%). 1H NRM (300 MHz, CDCl3): δ/ppm = 7.10 (dd, 
J = 8.5, 5.8 Hz, 1H), 6.88 (bs, 1H), 6.84 (td, J = 8.4, 2.7 Hz, 1H), 6.80-6.75 (m, 1H), 5.50 (bs, 
1H), 3.92-3.85 (m, 2H), 3.02-2.95 (m, 2H), 1.51 (s, 9H); 13C NMR (75 MHz, CDCl3): δ/ppm =  
160.98 (d, J = 245.6 Hz), 152.18, 131.7 (d, J = 4.7 Hz), 131.6 (d, J = 6.4 Hz), 131.3, 126.0 (d, J 
= 4.4 Hz), 115.7 (d, J = 20.2 Hz), 113.2 (d, J = 21.2 Hz), 107.2, 81.8, 37.1, 31.7, 28.3; 19F NMR 
(282 MHz, CDCl3): δ/ppm = -117.3 HRMS (ESI-MS): Mass calc. for C15H18FNO2.Na [M+Na]+: 
m/z = 286.1214, found: m/z = 286.1218. 
 
tert-Butyl 5-bromo-1,2-dihydro-3H-benzo[d]azepine-3-carboxylate (3t)  
According to the general procedure using T+BF4- (58.6 mg, 0.24 mmol, 1.5 
equiv.), THIQ 1q (50,0 mg, 0.16 mmol, 1.0 equiv.) and TMSCHN2 (2 M in Et2O, 
190 µL, 0.380 mmol, 2.4 equiv.), the title compound was obtained after 1 h by 
flash column chromatography (petroleum ether  petroleum ether: ethyl acetate 20:1) as a 
yellow oil (17.6 mg, 0.054 mmol, 34 %). 1H NRM (300 MHz, CDCl3): δ/ppm = 7.35 (d, J = 7.8 
Hz, 1H), 7.08 (d, J = 7.5 Hz, 1H), 7.03 (bs, 1H), 6.97 (t, J = 7.7 Hz, 1H), 5.49 (s, 1H), 3.88 (s, 
2H), 3.26 (s, 2H), 1.51 (s, 9H); 13C NMR (75 MHz, CDCl3): δ/ppm = 151.9, 137.5, 129.9, 129.7, 
129.1, 127.7, 127.5, 124.7, 107.5, 82.0, 53.5, 35.7, 28.3; HRMS (ESI-MS): Mass calc. for 
C15H19BrNO2.Na [M+H]+: m/z = 326.0575, found: m/z = 326.0575. 
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Application: Synthesis of Lorcaserin 
  
3-[(4-Chlorobenzyl)amino]-1-bromopropane hydrobromide4 
 In a flame-dried round bottom schlenk, a solution of 4-chloro benzaldehyde 
(7.00 g, 50.0 mmol, 1.00 equiv.), 3-amino-1-propanol (3.80 g, 3.80 mL, 50.0 
mmol, 1.00 equiv.) and EtOH (125 mL) was stirred under nitrogen at room 
temperature for 19 h. Solid NaBH4 (2.50 g, 65.0 mmol, 1.30 equiv.) was 
portion wise added over 1 h (foam formation!), and the obtained mixture was stirred for 
another 4 h. A 1 M HCl water solution was added, and after neutralization the product was 
extracted with EtOAc. The collected organic fractions were dried over MgSO4 and the solvent 
was removed under reduced pressure to afford the crude 1-(4-chloro-benzylamino)propyl 
alcohol, which was cooled in ice and dissolved in 48% HBr water solution (50 mL). The 
reaction mixture was concentrated (approx. 30 mL of solvent was distilled off) and the residue 
was cooled to 0 °C in an ice-bath. The resulting formed solid was filtered and recrystallized 
from MeOH-Et2O, affording the hydrobromide salt 4 as a white solid (7.01 g, 20.5 mmol, 41%). 
1H NMR (300 MHz, H2O): δ/ppm = 7.42-7.36 (m, 2H), 7.35-7.30 (m, 2H), 4.13 (s, 2H), 3.40 (t, 
J = 6.1 Hz, 2H), 3.12 (t, J = 6.2 Hz, 2H), 2.20-2.10 (m, 2H); 13C NMR (75 MHz, H2O): δ/ppm = 
148.3, 135.2, 131.4, 129.3, 50.4, 45.7, 29.5, 28.3; HRMS (ESI): Mass calc. for C10H14NClBr.H 
[M+H]+: m/z = 263.9970, found: m/z = 263.9974.  
 
tert-Butyl 6-methoxy-3,4-dihydroisoquinoline-2(1H)-carboxylate (1r) and tert-butyl 
7-chloro-1,2,4,5-tetrahydro-3H-benzo[d]azepine-3-carboxylate (4g)5 
 
The salt 4 (3.00 g, 8.70 mmol, 1 equiv.) and NH4Cl (0.48 g, 9.00 mmol, 1.05 equiv.) were added 
under nitrogen in a flame-dried pressure schlenk pre-heated at 160 °C. AlCl3 (5.80 g, 43.5 
mmol, 5.00 equiv.) was then added over 5-10 min, causing the mixture to liquefy with the 
evolution of gas. After 15 min, the mixture was dissolved in 50 mL of ice-cooled 3 N HCl and 
basified with 40% NaOH. The product was extracted with EtOAc, the extract was washed 
with brine, dried over MgSO4 and the solvent was removed under reduced pressure to afford 
the desired 6-membered ring cyclization product, along with the corresponding 7-membered 
ring product. Without further purification, the crude mixture was dissolved in DCM (50 mL) 
and di-tert-butyl dicarbonate (1.90 g, 0.87 mmol, 1.00 equiv.) was added. The result solution 
was stirred for 16 h at room temperature. The crude reaction mixture was washed with water 
and brine, dried over MgSO4 and the solvent removed under reduced pressure. After flash 
chromatography (petroleum ether  petroleum ether: ethyl acetate 4:1), 1r (1.25 g, 4.44 
mmol, 51%) was obtained as yellow oil, along with 4g (434.1 mg, 1.54 mmol, 18%).  
 
1r: 1H NMR (300 MHz, CDCl3): δ/ppm = 7.20-7.10 (m, 2H), 7.01 (bd, J = 7.0 
Hz, 1H), 4.80-4.50 (m, 1H), 4.39 (bs, 1H), 3.50 (bs, 2H), 2.90 (bs, 1H), 1.48 (s, 
8H), 1.25 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ/ppm = 155.1, 
141.8, 132.2, 131.6, 127.7, 127.53, 126.4, 80.0, 47.6, 45.0, 33.2, 28.5, 19.4; HRMS (CI-MS): 
Mass calc. for C15H20ClNO2.H [M+H]+: m/z = 282.1261, found: m/z = 282.1256.  
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5: 1H NMR (300 MHz, CDCl3): δ/ppm = 7.25-7.20 (m, 1H), 7.15-7.05 (m, 2H), 
4.40-4.30 (m, 2H), 3.68-3.64 (m, 2H), 2.90-2.85 (m, 2H), 1.80-1.70 (m, 2H), 
1.37 (s, 9H). 13C NMR (75 MHz, CDCl3): δ/ppm = 154.8, 144.0 and 143.5 
(rotamers), 137.5 and 137.2 (rotamers), 132.8, 131.0 and 130.39 (rotamers), 
129.6 and 129.4 (rotamers), 126.1 and 125.7 (rotamers), 79.8, 51.7 and 51.4 (rotamers), 50.7 
and 50.3 (rotamers), 31.7, 28.5 and 27.9 (rotamers), 22.7. 
 
tert-Butyl 8-chloro-1-methyl-1,2-dihydro-3H-benzo[d]azepine-3-carboxylate (3u) 
According to the general procedure for the expansion ring reaction, using 
T+BF4- (732.2 mg, 3.00 mmol, 1.5 equiv.), THIQ 1u (563.5 mg, 2.00 mmol, 
1.0 equiv.) and TMSCHN2 (2 M in Et2O, 2.40 mL, 4.80 mmol, 2.4 equiv.), 
dichloromethane (20 mL), the title compound was obtained after 1 h by flash 
column chromatography (petroleum ether  petroleum ether: ethyl acetate 19:1) as a yellow 
oil (159.0 mg, 0.54 mmol, 27%). 1H NRM (300 MHz, CDCl3): δ/ppm = 7.15-7.05 (m, 3H), 6.91 
(bs, 1H), 5.52 (bs, 1H), 4.52 (bs, 1H), 3.32-3.20 (m, 1H), 3.09 (d, J = 12.7 Hz, 1H), 1.52 (s, 9H), 
1.08 (d, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ/ppm = 152.9, 145.8, 132.4, 132.3, 131.2, 
128.4, 127.5, 126.4, 107.2, 81.8, 47.3, 40.8, 28.3, 16.6; HRMS (ESI-MS): Mass calc. for 
C17H23NO4.Na [M+Na]+: m/z = 316.1075, found: m/z = 316.1079 
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Selected NMR spectra 
 
3-Phenyl-2,3-dihydro-1H-benzo[d]azepine (3a) 
 
 
 
NPh
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3-(Adamantan-1-yl) 1-ethyl 4,5-dihydro-3H-benzo[d]azepine-1,3-dicarboxylate (3l) 
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3.4.2 N-Based expansion ring reactions 
 
General Information and Materials: 
 
1H and 13C NMR spectra were recorded in CDCl3, (reference signal: 1H = 7.26 ppm, 13C = 77.16 
ppm, CDCl3) on a Bruker ARX-300 and a Varian AV-300, 400 or 600 MHz. Chemical shifts (δ) are 
given in ppm and spin-spin coupling constants (J) are given in Hz. Analytical thin layer 
chromatography was performed using silica gel 60 F254 and a solution of KMnO4 or a Iodine 
camera served as staining agent. Column chromatography was performed on silica gel 60 (0.040-
0.063 mm). GM-MS (EI) analysis were performed with Shimadzu GC-MS QP 2010. MeCN was 
distilled over CaH2. Other solvents and commercially available reagents were used without 
further purification.  
 
General procedure involving TMSONH2: 
 
In a screw-cap schlenk tube, the corresponding target 1 (0.4 mmol, 1.00 equiv.), catalyst (10-20 
mol%) and additive were dissolved in distilled MeCN (1.00 mL). TMSONH2 (1.2 equiv.) and 
oxidant (1.2-2 equiv.) were added and the reaction mixture was stirred at the corresponding 
temperature for 18 h. The solvent was removed under reduced pressure to give the corresponding 
crude product. 
 
General procedure involving TMSN3: 
 
In a screw-cap schlenk tube, xanthene 1a (0.4 mmol, 1.00 equiv.), catalyst (10-20 mol%) and 
additive were dissolved in distilled MeCN (1.00 mL). TMSNH2 (1.2 equiv.) and tert-butyl peroxide 
or di-tert-butyl peroxide (1.2 equiv.) were added and the reaction mixture was stirred at the 
corresponding temperature for 18 h. The solvent was removed under reduced pressure to give the 
corresponding crude product. 
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4 
 
Oxidative C-H functionalization/Ugi-type 
tandem reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[1] Contents of table 6 entries 3qa, 3qf, 3ra and 3rf were performed by T. Brandhofer and S. Stockerl
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4.1 Introduction 
Multicomponent Reactions (MCRs) – sometimes referred to as a ”Multi-component 
Assembly Process” – imply the reaction of three or more reactants placed together in a single 
reaction vessel. The mechanism of such transformations involves linear and parallel sequences 
or a cascade of elementary chemical reactions to assemble a single product that contain 
essentially all or most of the atoms of the reactants in its final structure.1h,1i The main challenge 
in the design and discovery of new MRCs rely on the generated network of multiple pre-
equilibrated reactions between the different reactants. Therefore, it is crucial to carefully tune 
the reaction conditions (catalyst, temperature, solvent, nature of starting materials, etc), in 
order to drive the reaction into a main product, avoiding the formation of undesired side-
products (Figure 1).1d  
 
Figure 1. Concept of Multicomplonent Reaction (MRC) 
Among the MRCs, the Ugi-type reaction, discovered in 1959 by I. Ugi,1a is a potent and 
convenient methodology for the ready accessible synthesis of a large variety of bisamides 
(Scheme 1, top) and imides (Scheme 1, bottom).1 With this approach, in which amines, aldehydes 
(or ketones), isocyanides and carboxylic acids are combined, a wide range of natural products 
and bioactive compounds,2 as well as intermediates for the synthesis of different heterocycles,3 
are easy available. 
 
 
Scheme 1. Ugi and Ugi-type multicomponent reactions. 
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From the atom- and step-economy perspective of such transformation, the development 
of new processes based on the Ugi-type reaction is highly attractive. Especially interesting is 
the formation of the key imine or iminium salt intermediate by a direct C-H bond activation of 
a simple substrate or a more complex envisioned target (Scheme 2).  
 
 
Scheme 2. Oxidative Ugi-type reaction approach. 
Despite the multitude of diverse and outstanding applications developed in the past 
decades, examples of Ugi-type reactions, in which the imines or the iminium salts are formed 
in an oxidative manner, have only been reported in the last few years (Scheme 3).  In this 
context, even though the potential of such promising strategies, there are still some important 
limitations. As far as we known, the reported applications are limited to common substrates, 
such as tetrahydroisoquinolines (THIQs)4 (Scheme 3, i and iii) and N,N-dialkyl substituted 
anilines5 (Scheme 3, iv). In addition to those known targets in oxidative C-H functionalization, 
R. V. A Orru and co-workers recently reported a similar approach on bi/tri-cyclic NH-
pyrrolidines towards the corresponding bisamides (Scheme 3, ii).6 
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Scheme 3. Previously reported C-H functionalization/Ugi-type reaction in alpha to amines. 
More in detail, the two reported procedures concerning the functionalization of THIQs 
resulted very attractive, especially regarding the achieved yields and functional group tolerance 
(Scheme 2, eq. i and iii). Instead, N,N-dimethyl anilines resulted a less performing substrate 
class under the reported conditions, leading to moderate average yields on the Ugi-products. 
Furthermore, in the case of the procedure developed by T. Xie and co-workers using Cu-catalysis 
and TBHP as oxidant (Scheme 3, eq. iv-top conditions),5a the method was also limited to 
electron-neutral and electron-poor anilines. However, in all the reported substrates the 
functionalization takes place on the Csp3-H bond next to a nitrogen atom, leading to an iminium 
salt or an imine active intermediate. By this means, all the potentiality of the oxidative C-H 
bond functionalization to activate unusual substrate for Ugi-type reactions resulted 
unexpressed. In addition, difficult applications in many synthetic strategies towards highly 
valuable molecules might be achieved by fully exploiting the direct C-H bond functionalization 
technology. Following this perspective, it is evident the demand of new methodologies that can 
increase the number of accessible targets by a Csp3-H bond activation/Ugi-type approach. 
Moreover, it would provide new possibilities to employ this strategy in the ready-to-shape 
synthesis of products with relevant proprieties. 
 
4.2 Objectives 
Following our experience in the oxidative functionalization of dibenzyl Csp3-H bonds, we 
envisioned the suitability of the Ugi-type rearrangement on carbocation intermediates like the 
involved during the activation of acridane and xanthene derivatives previously described in 
section 3.1. To the best of our knowledge, the class of compounds that will be obtained in this 
way was not reported to date. 
Following this perspective, the main goal of this project was the development of a 
versatile methodology for the first oxidative benzylic C-H bond functionalization/Ugi-type 
reaction. In addition, we aimed at performing the reaction in an easy and green way, by 
employing diacylperoxide or acylalkylperoxide reagents as both the oxidant and the required 
source of carboxylic acid for this multicomponent transformation (Scheme 4). 
  
Scheme 4. Our direct Csp3-H functionalization/Ugi-type reaction proposal. 
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To proof the potentiality of this approach, the method will be extended to several diverse 
targets. Thus, further dibenzylic substrates such as xanthenes will be studied, as well as 
tetrahydrosioquinolines and N,N-dimethyl anilines to be able to compare the new developed 
method with the already reported systems (Scheme 5).  
 
 
 
Scheme 5. Extension to other target classes. 
 Finally, we envisioned that the imide-acridine products of the Ugi-type reaction will be 
highly interesting for the synthesis of novel “ready-to-shape” class of photocatalyst based on the 
acridane scaffold (Scheme 6).  
 
 
Scheme 6. Application of the Ugi-products for a novel photocatalyst-design. 
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We figured out this possibility starting from the several well established photocatalysts 
containing xanthene or acridane scaffolds as main core (Figure 2).7,8  
 
Figure 2. Example of acridinium- and xanthene-based dyes. 
In this context, one of the most recent developed and potent oxidant organo-photocatalyst 
is the 9-mesityl acridinium salt,8 also called Fukuzumi’s catalyst. This catalyst was designed by 
S. Fukuzumi in 2004 to solve the susceptibility of acridium salts to the nucleophilic and radical 
addition, by the introduction of a mesityl group in 9-position.8a However, although this 
protection highly stabilizes the catalyst, its remarkable electrochemical performances are still 
lower than the corresponding 10-methyl-acridinium salt.7e Thus, the development of novel class 
of 9-substituted acridinium derivatives is strongly demanding, both to preserve the stability of 
such potent class of photocatalysts and to enhance the electrochemical proprieties.  
 
4.3 Result and discussion 
4.3.1 Acridanes as target substrates 
 Based on our previous work on acridane and xanthene C-H functionalization, we started 
our screening on the C-H oxidation/Ugi-type reaction of 10-methyl acridane (1a) (Table 1). 
Accordingly, our developed Cu(OTf)2/bipyridyl/benzoyl peroxide (BPO) oxidative system was 
employed with 1.2 equivalents cyclohexyl isocyanide (2a) as nucleophilic reactant (entry 1). In 
this case, the reagent BPO has a double role as both the oxidant and the carboxylic acid or 
carboxylate source. Therefore, the addition of external carboxylic acids was not required to 
obtain the desired imide Ugi-products. The initial obtained result was very promising, leading 
to 3aa in 29% yield, but further improvements were needed. In order to optimise the reaction, 
several peroxide systems were then tested (Table 1, entries 2-3). Unexpectedly, when we used 
hydroperoxides such as tBuOOH (TBHP) in the presence of benzoic acid as additive,, which was 
already described in oxidative Ugi reactions with other type of targets, the formation of the 
desire product was not observed by 1H-NMR or GC-MS (Table 1, entry 2). Two of the main issues 
of this reaction are the low stability of the products 3 under oxidative conditions, as well as the 
competition between the desired Ugi-type reaction and the formation of oxidised side-products 
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such as 10-methylacridone. Thus, to avoid the formation of undesired by-products, a shorter 
reaction time and a higher amount of isocyanide were analysed.  
Table 1. Optimization of the reaction conditions.[a] 
 
Entry 
Cu(OTf)2 
(mol%)[b] 
Oxidant 
(equiv.) 
CyNC 
(equiv.) 
Time 
(h) 
Yield 
(%)[c] 
1 10% (PhCO2)2 (1.2) 1.2 18 29 
2 10% 
tBuOOH (1.2) 
/PhCO2H 
1.2 18 -- 
3 10% 
tBuO-OtBu (1.2) 
/PhCO2H 
1.2 18 -- 
4 10% (PhCO2)2 (1.2) 2.4 18 36 
5 10% (PhCO2)2 (1.2) 2.4 4 49 
6 10% (PhCO2)2 (1.2) 2 4 61 
7[d] 10% (PhCO2)2 (1.2) 2 4 66 
8[e] 10% (PhCO2)2 (1.2) 2 4 35 
9 15% (PhCO2)2 (1.2) 2 4 42 
10 5% (PhCO2)2 (1.2) 2 4 53 
11 10% (PhCO2)2 (1.5) 2 4 22 
[a] 1a (0.1-0.4 mmol), peroxide, Cu(OTf)2, bipyridyl, and CyNC in MeCN (0.1 M) at the room temperature in a sealed 
tube. [b] Cu(OTf)2 was pre-dried under vacuum at 60°C. [c] Isolated yields. [d] 2 mmol scale reaction. [e] Cu(OTf)2 
was not pre-dried. 
We found that the use of 2 equivalents of 2a and 4 hours reaction time led to the best 
results, providing the desire product 3aa in a synthetically useful 61% yield (Table 1, entry 6). 
Noteworthy, under the same conditions, a larger scale reaction (2.0 vs. 0.1 mmol) gave a slightly 
better result (66% yield, Table 1, entry 7). However, during the development of the strategy we 
encountered some important issues regarding the reproducibility of the methodology. For 
example, traces of moisture brought to a not efficient reactivity of the oxidative system, 
especially concerning the catalyst. The Cu(OTf)2 needed to be pre-dried for several hours at 
50/60 °C under vacuum to achieve an adequate and reproducible reactivity. In this context, 
under the best condition but involving wet or no properly dry catalysts, we observed various 
inconsistet performances with yields up to 35% were observed (Table 1). However, the use of a 
dried catalyst stored in the glove box did not improve the yield. It is interesting to note that the 
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reaction is also sensitive to the addition order of the reagents. To avoid undesired side-reaction 
of acridane, the oxidant must be the last component added, and it is recommended to mix the 
Cu(OTf)2 and the bpy before adding the other reagent to form a more active pre-catalyst. Finally, 
the increase of the amount of the isocyanide (2.4 equiv., entry 5), the catalyst (15 vs. 10 mol%, 
entry 9) or the oxidant (1.5 vs, 1.2 equiv., entry 11) led in all cases to a lower performance.  
Next, with the best conditions in our hand, several different substituted acridanes were 
enrolled in the process (Table 2). Methyl, benzyl and phenyl N-protecting groups were well 
tolerated, giving the desire products in good yields (61-70%). Instead, N-carbamoyl acridanes, 
such as N-Boc protected derivative 1d, were not participating in the reaction, leading mainly to 
over-oxidised and decomposition products. In one hand, the performances with acridanes 
containing weak electron donating (1e and 1i, R1 = Me and Ph) or weak electron withdrawing 
substituents (1g, R1 = Br) were comparable with the unsubstituted pattern substrate 1a. In 
other hand, strong electron donating (1f, R1 = OMe) or strong electron withdrawing groups (1h, 
R1 = F) lead to lower yields (32-41% yields). It is noteworthy to point out that the N-benzyl 
acridanes showed a superior reactivity than the N-methyl derivatives, giving better results even 
in the more demanding cases (3ja 52% vs. 3fa 41% and 3ka 41% vs. 3ha 32%). It is also 
interesting to note that the steric hindered substrate 1l (1,4-dimethyl substituted) was also well 
tolerated, leading to 3la in a good 57% yield. 
Table 2. Scope: Screening of different acridanes. [a][b] 
 
[a] 1 (0.1-0.4 mmol), BPO (1.2 equiv.), pre-dried Cu(OTf)2 (10 mol%), bipyridyl (30 mol%) and CyNC (2 equiv.) in 
MeCN (0.1 M) at the room temperature in a sealed tube. [b] Isolated yields. 
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We tested various isocyanides with both N-methyl (1a) and N-benzyl (1b) acridanes as 
targets for the C-H functionalization/Ugi-type reaction (Table 3). In this case, the steric 
hindrance showed an important role in the trend of the reaction. Indeed, when large isocyanide, 
such as naphtyl isocyanides (2f) or 1-((isocyanomethyl)sulfonyl)-4-methylbenzene (2g) were 
involved in the process, the product was observed in traces among several decomposition side-
products. Furthermore, the steric hindrance influenced the performances of benzyl isocyanide 
(2b) and tert-butyl isocyanide (2c) when involved in the reaction. As consequence, comparing N-
methyl acridane (1a) and N-benzyl acridane (1b), a significant lower yield was observed with 
1b due to the bigger protecting group (3ab 52% vs. 3bb 36%, 3ac 53% vs. 3bc 37%). Instead, 
the less steric hindered n-butyl isocyanide (2d) and para-methoxy phenyl isocyanide (2e) gave 
better results with N-benzyl acridane 1b, following the same trend that we observed with the 
cyclohexyl isocyanide.  
Table 3. Scope: Screening of different isocyanides. [a][b] 
 
[a] 1 (0.1-0.4 mmol), BPO (1.2 equiv.), pre-dried Cu(OTf)2 (10 mol%), bipyridyl (30 mol%) and CyNC (2 equiv.) in 
MeCN (0.1 M) at the room temperature in a sealed tube. [b] Isolated yields. 
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Next, several acyl peroxides were tested using as target the N-benzyl acridane. First, we 
enrolled a dialkyl or a non-symmetric peroxide containing a benzoyl moiety, such as 
dilauroylperoxid and benzoyl tert-butyl peroxide, respectively (Table 4, entries 1 and 2). 
However, noon of them provided the Ugi product. Instead, the bis(2,4-dichlorobenzoyl) peroxide 
mediated the reaction, even though the desire product 4bb was obtained in a low 18% yield 
(Table 4, entry 3). The reason of this poor reactivity could be related to the polymer in which 
this commercial peroxide is stabilised (50% w/w in polysyloxane), from which it cannot be easily 
and safely separated 
Table 4. Scope: testing other peroxides. [a][b] 
 
Entry Oxidant R Yield (%)[b] 
1 (PhCO2)-OtBu  PhCO2- (3ba) -- 
2 (nC11H23CO2)2 nC11H23CO2- (4ba) -- 
3 [2,4-(Cl)₂C₆H₃CO2]2[c] 2,4-(Cl)₂C₆H₃CO2- (5ba) 18 
[a] 1a (0.15-0.2 mmol), oxidant (1.2 equiv.), pre-dried Cu(OTf)2 (10 mol%), bipyridyl (30 mol%) and CyNC 2a (2 equiv.) 
in MeCN (0.1 M) at the room temperature in a sealed tube. [b] Isolated yields. [c] 2,4-dichlorobenzoyl peroxide 50% 
w/w in polysiloxane. 
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4.3.2 Reactivity and Mechanistic Studies 
Aiming at bringing some light into the mechanism of the reaction, several experiments 
were carried out to understand which species were involved in the reaction (Scheme 7). In first 
instance, we prepared and isolated the N-methyl acridinium salt 1a’ by simple oxidation of the 
acridane 1a, using the mild oxidant trityl tetrafluoroborate (Scheme 7, eq. i). Next, 1a’ was 
enrolled in two classical Ugi-type reactions using only cyclohexyl isocyanide (2a) and p-toluic 
acid or sodium p-toluate (Scheme 7, eq. ii and iii). Even though a carboxylic acid is commonly 
used as reagent in the standard procedures for the Ugi-type methodology, when p-toluic acid 
was enrolled in the reaction with 1a’, just traces of the desire product among polymeric side-
products were observed (Scheme 7, eq. ii). Instead, the reaction with the corresponding 
carboxylate proceed efficiently, leading the Ugi product 6aa in 39% yield. Thus, These results 
strongly suggest that the acridinium salt is involved in the reaction as active acridane 
intermediate, and the carboxylate derived from the benzoyl peroxide resulted the real partner 
in our developed approach (Scheme 7, eq. iii). Next, an interesting competition experiment was 
performed between the in situ formed side product/reagent of the diacyl peroxide, such as 
benzoic acid and an external carboxylic acid with similar pKa, such as p-toluic acid (Scheme 7, 
eq. iv). We found both the possible Ugi-type products, 3aa and 6aa, in 49% yield overall, and a 
complete statistical ratio (3aa : 6aa, 66 : 33). Indeed, the optimized conditions were involving 
1.2 equivalent of benzoyl peroxide, forming at most 2.4 equivalents of a benzoic acid/benzoate 
mixture. Considering that 1.2 equivalents of the external carboxylic acid were added in the 
reaction mixture, the ratio between the two carboxylate sources (2:1) determine their 
contribution and observed outcome of the reaction. 
 
Scheme 7. Mechanistic experiments.  
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 Based on all the experimental observations and the experience of the García’s group 
regarding the oxidative functionalization of acridanes (Chapter 3.1), a reaction mechanism was 
postulated (Scheme 8). A first copper(I)-catalysed reductive homolytic cleavage of the O-O bond 
of the benzoyl peroxide gave a benzoyl radical, which can abstract one hydrogen atom from the 
acridane substrate 1a giving the radical intermediate A. Next, a second oxidation of A, promoted 
by the copper(II), formed the active carbocation intermediate C. Noteworthy, another possible 
pathway for the formation of C involved a radical coupling between the benzoyl radical and A, 
forming the unstable covalent intermediate B, which is in equilibrium with C. The addition of 
the isocyanide and the benzoate formed the intermediate E, which underwent rapidly in a 
rearrangement process to give the desire product 3aa. 
 
Scheme 8. Proposed mechanism.  
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4.3.3 Extension to other substrate classes 
To proof the potentiality of the above-developed oxidative Ugi-type methodology, several 
diverse targets were next explored under the standard conditions using cyclohexyl isocyanide 
(2a) or 2-naphthyl isocyanide (2m) as nucleophilic reagent. These two isocyanides were selected 
to control the standard reactivity and the influence of the steric hindrance. In first instance, 
further dibenzylic substrates, such as various substituted xanthenes, were enrolled in the 
process (Table 5). The pattern unsubstituted xanthene (1m), which is less electron rich than the 
corresponding acridanes, could be enrolled in the reaction, providing the Ugi-products in 
moderate (21%, R1 = Cy) and low yields (<10%, R1 = 2-naphth). Similarly, electron poor 
xanthenes such as 1n led to low conversions and yields. Interestingly, electron-rich xanthenes 
bearing methoxy groups granted good yields with 2a (3oa, 58% and 3pa, 67%). In addition, the 
bulky isocyanide 2f was also suitable with electron-rich xanthenes, providing the products in 
an only slightly lower yield (3pf, 49%).  
Table 5. Other dibenzylic substrates.[a][b] 
 
[a] 1 (0.2 mmol), BPO (1.2 equiv.), pre-dried Cu(OTf)2 (10 mol%), bipyridyl (30 mol%) and RNC (2 equiv.) in MeCN 
(0.1 M) at the room temperature in a sealed tube overnight. [b] Isolated yield. 
 
Common substrates in the C-H bond functionalization/Ugi-type approach, such as THIQ 
(1q) and N,N-dimethyl aniline (1r) were next investigated (Table 6). Surprisingly, those targets 
gave better results with the bulkier isocyanide 2m in comparison with 2a, leading to almost a 
quantitative yield in the case of the THIQs (3qf, 92%) and a good yield for the N,N-dimethyl 
aniline (3rf, 58%). The steric issue revealed itself as prominent on dibenzylic xanthene and 
acridane-like structures. Moreover, the steric demanding target 1s, also called the Tröger’s 
base,9 poorly reacted with 2a (3sa, 29%), and only traces of the desire product were observed 
when bulky 2f was enrolled in the process (3sf). However, when smallers substrate were 
employed, such as 1q and 1r, this effect was not observed.  
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Table 6. Other enrolled substrates with -Csp3-H bonds to a heteroatom [a][b] 
 
[a] 1 (0.2 mmol), BPO (1.2 equiv.), pre-dried Cu(OTf)2 (10 mol%), bipyridyl (30 mol%) and RNC (2 equiv.) in MeCN 
(0.1 M) at the room temperature in a sealed tube. [b] Isolated yield. 
It should be noticed that the employed oxidative system resulted not suitable for the 
activation of few other type of substrates. Thus, it was actually too weak for allowing the 
functionalization of isochromane. Furthermore, in the case of a more complex and highly 
oxidation-sensitive molecule and natural product 1u and 1v, respectively, our conditions 
resulted too strong. Consequently, we could only observe the decomposition (3ua) or the 
aromatization of the starting material (3va). 
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4.4 Conclusions and Outlooks  
In conclusion, we introduced a new general and high modulable strategy for the synthesis 
of a new class of C9-imide substituted acridanes by a novel oxidative Csp3-H bond 
functionalization/Ugi-type reaction. The method is very robust and applicable to a large variety 
of target molecules bearing different functional groups. Indeed, beside the acridane moiety, 
several diverse C-H functionalization/Ugi-type reactions on common and unusual targets were 
also achieved, leading in most cases to the desire imide-type products in good yields. 
Furthermore, in a green chemistry perspective, the involvement of the oxidant side-products in 
the Ugi-type step of the process is an outstanding innovation compare to the standard 
approaches in C-H bond activation/Ugi-type reaction, in which the crude product is given along 
with the excess of the oxidant and the unwanted oxidant by-products. This developed mild 
oxidative and atom-economic methodology could also be extended to xanthenes, 
tetrahydroisoquinolines, N,N-dimethyl anilines and further more complex substrates. 
Finally, the acridinium salts 4 – derived from the acridane Ugi-type products 3 upon a 
selective, mild second oxidation step – showed outstanding photochemical proprieties, eclipsing 
the most common commercial available acridinium photocatalyst in a test reaction (Scheme 9).  
 
Scheme 9. Preliminary results for the application in photocatalysis. 
These preliminary results in the group already showed the interesting properties and 
reactivity of these structural unprecedented imide-acridinium-based organophotocatalysts, 
providing new opportunities for the future development on innovative visible light driven 
transformations. It is evident that this promising class of organophotocatalysts has the potential 
to become a new standard structure motif in photocatalysis, and their easy-to-tune synthesis 
provide a potent tool in order to easily adapt the catalyst’s requirements for each targeted 
reaction. Thus, further photocatalytic tests with these derivatives, as well as computational 
studies in order to better understand their observed enhanced activity, are currently carrying 
out in collaboration with the group of Prof. Dr. J. Alemán at the Universidad Autónoma de 
Madrid (U.A.M.).  
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4.5 Experimental part 
General Information and Materials: 
 
1H, 13C and 19F NMR spectra were recorded in CDCl3 and DMSO-D6 (reference signals: 1H = 
7.26 ppm, 13C = 77.16 ppm, CDCl3) on a Bruker ARX-300 and a Varian AV-300 or  400 and Jeol 
JNM-ECS 400 MHz. Chemical shifts (δ) are given in ppm and spin-spin coupling constants (J) 
are given in Hz. Analytical thin layer chromatography was performed using silica gel 60 F254 
and a solution of KMnO4 or phosphomolybdic acid served as staining agent. Column 
chromatography was performed on silica gel 60 (0.040-0.063 mm). Exact masses (HRMS) were 
recorded on an Agilent Q-TOF 6540 UHD spectrometer (samples in CH3OH as solvent) using 
electrospray (ES) or chemical (CI) ionization techniques. Chiral High Pressure Liquid 
Chromatography (HPLC) analyses were performed on an Agilent 1200 series instrument. 
CH2Cl2 was distilled over CaH2. THF and Et2O were distilled and dried over Na. The starting 
materials were prepared following known literature procedures.1,2 Acridanes were stored at -
20°C. Other solvents and commercially available reagents were used without further 
purification if it is not listed. 
  
 Preparation of the commercial reagent: 
 
• Copper(II) Triflate was dried under vacuum at 50 °C for 48 hours (The color change from 
light blue to white). The obtained dry catalyst was stored under nitrogen.  
• Commercial available benzoyl peroxide contains the 30% w/w of water. In order to remove 
the water, the oxidant was dissolved in ethyl acetate and the obtained solution was washed 
3 times with brine. The obtained organic phase was dried under MgSO4, filtered, the solvent 
evaporated and the obtained white solid dried under vacuum.  
•  
General Procedure: 
 
In an oven-dried screw cap schlenk dry Cu(OTf)2 (10 mol %) (Copper triflate is slightly 
hydroscopic, weight and pour fast in the flask), 2,2’-bipyridyne (30 mol%) and target 1 (0.1-0.4 
mmol, 1 equiv.) were added following this order. The solid mixture was dissolved in acetonitrile 
(1-4 mL), then the isocyanide 2 (2 equiv.) and peroxide (1.2 equiv.) were added following this 
order. The obtained mixture was stirred at room temperature for 4 h. After evaporating the 
solvent, the crude product was purified by flash column chromatography using hexane/ethyl 
acetate as eluent.  
 
 
 
 
 
 
 
 
 
 
 
 126 
 
N-Benzoyl-N-cyclohexyl-10-methyl-acridane-9-carboxamide (3aa)  
According to the general procedure, using acridane 1a (39.0 mg, 0.2 mmol, 1 
equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-bipyridyne (9.4 mg, 
0.06 mmol, 30 mol%), MeCN (2 mL), cyclohexyl isocyanide 2a (49.7 µL, 0.40 
mmol, 2.0 equiv.), benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 equiv.) the title 
compound was obtained after 4 h by flash column chromatography 
(hexane/EtOAc, 9:1) as a white solid (51.8 mg, 0.122 mmol, 61%). 1H NMR (400 
MHz, CDCl3):  7.77 – 7.73 (m, 2H), 7.70 – 7.64 (m, 1H), 7.59 – 7.52 (m, 2H), 
7.26 – 7.20 (m, 2H), 6.96 – 6.91 (m, 2H), 6.88 – 6.83 (m, 2H), 6.76 – 6.71 (m, 
2H), 4.95 (s, 1H), 4.03 (tt, J = 12.0, 3.5 Hz, 1H), 3.40 (s, 3H), 1.80 – 1.67 (m, 2H), 1.65 – 1.56 (m, 
2H), 1.52 – 1.42 (m, 1H), 1.32 – 1.25 (m, 2H), 1.16 – 0.96 (m, 3H). 13C NMR (100 MHz, CDCl3): 
 176.8, 174.5, 142.7, 137.8, 132.9, 129.5, 129.2, 128.5, 128.4, 120.7, 120.5, 112.8, 59.4, 53.5, 
33.3, 29.6, 26.3, 25.2. HRMS (ESI-MS): Mass calc. for [C28H29N2O2]+: m/z = 425.2224, found: 
m/z = 425.2228. 
 
N-Benzoyl-N-cyclohexyl-10-benzyl-acridane-9-carboxamide (3ba)  
According to the general procedure, using acridane 1b (54.3 mg, 0.2 mmol, 1.0 
equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-bipyridyne (9.4 mg, 
0.06 mmol, 30 mol%), MeCN (2 mL), cyclohexyl isocyanide 2a (49.7 µL, 0.40 
mmol, 2.0 equiv.), benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 equiv.) the title 
compound was obtained after 4 h by flash column chromatography 
(hexane/EtOAc, 9:1) as a white solid (70.1 mg, 0.140 mmol, 70%). 1H NMR (400 
MHz, CDCl3): 7.85 – 7.75 (m, 2H), 7.75 – 7.67 (m, 1H), 7.64 – 7.55 (m, 2H), 7.33 
– 7.21 (m, 3H), 7.20 – 7.15 (m, 2H), 7.14 – 7.05 (m, 2H), 6.89 – 6.82 (m, 2H), 
6.79 – 6.73 (m, 4H), 5.20 (s, 2H), 5.02 (s, 1H), 4.14 – 4.02 (m, 1H), 1.82 – 1.69 (m, 2H), 1.67 – 
1.60 (m, 2H), 1.56 – 1.47 (m, 1H), 1.34 – 1.26 (m, 2H), 1.17 – 0.99 (m, 3H). 13C NMR (100 MHz, 
CDCl3):  176.4, 174.7, 141.6, 137.9, 137.0, 133.0, 129.5, 129.3, 128.8, 128.6, 128.5, 127.0, 126.2, 
120.7, 120.3, 114.0, 59.4, 53.1, 51.0, 29.7, 26.3, 25.2. HRMS (ESI-MS): Mass calc. for 
[C34H33N2O2]+: m/z = 501.2537, found: m/z = 501.2544. 
N-Benzoyl-N-cyclohexyl-10-phenyl-acridane-9-carboxamide (3ca)  
According to the general procedure, using acridane 1c (51.5 mg, 0.2 mmol, 1.0 
equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-bipyridyne (9.4 mg, 
0.06 mmol, 30 mol%), MeCN (2 mL), cyclohexyl isocyanide 2a (49.7 µL, 0.40 
mmol, 2.0 equiv.), benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 equiv.) the title 
compound was obtained after 4 h by flash column chromatography 
(hexane/EtOAc, 9:1) as slightly yellow solid (68.1 mg, 0.138 mmol, 69%). 1H 
NMR (400 MHz, CDCl3): 7.83 – 7.77 (m, 2H), 7.71 – 7.65 (m, 1H), 7.63 – 7.54 
(m, 4H), 7.53 – 7.45 (m, 1H), 7.42 – 7.35 (m, 2H), 7.03 – 6.95 (m, 2H), 6.85 – 
6.76 (m, 4H), 6.33 (d, J = 8.0 Hz, 2H), 5.09 (s, 1H), 4.15 – 3.99 (m, 1H), 1.84 – 1.73 (m, 2H), 1.66 
– 1.59 (m, 2H), 1.55 – 1.46 (m, 1H), 1.35 – 1.27 (m, 2H), 1.18 – 0.99 (m, 3H). 13C NMR (100 MHz, 
CDCl3):  176.4, 174.8, 142.2, 140.7, 137.8, 133.0, 131.3, 130.7, 129.5, 129.2, 128.5, 128.4, 128.1, 
120.6, 118.6, 114.8, 59.4, 52.7, 29.7, 26.3, 25.3. HRMS (ESI-MS): Mass calc. for [C33H31N2O2]+: 
m/z = 487.2380, found: m/z = 487.23874. 
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N-Benzoyl-N-cyclohexyl-2,10-dimethyl-acridane-9-carboxamide (3da)  
According to the general procedure, using acridane 1d (41.9 mg, 0.2 mmol, 
1.0 equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-bipyridyne (9.4 
mg, 0.06 mmol, 30 mol%), MeCN (2 mL), cyclohexyl isocyanide 2a (49.7 
µL, 0.40 mmol, 2.0 equiv.), benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 
equiv.) the title compound was obtained after 4 h by flash column 
chromatography (hexane/EtOAc, 9:1) as white solid (53.5 mg, 0.122 mmol, 
61%). 1H NMR (300 MHz, CDCl3): 7.77 – 7.72 (m, 2H), 7.71 – 7.65 (m, 1H), 
7.60 – 7.52 (m, 1H), 7.27 – 7.20 (m, 1H), 7.06 – 7.02 (m, 1H), 6.95 – 6.78 
(m, 4H), 6.45 – 6.41 (m, 1H), 4.95 (s, 1H), 4.01 (tt, J = 12.0, 3.6 Hz, 1H), 3.39 (s, 3H), 2.21 (s, 
3H), 1.90 – 1.57 (m, 4H), 1.52 – 1.43 (m, 1H), 1.39 – 1.23 (m, 3H), 1.10 – 1.00 (m, 2H). 13C NMR 
(75 MHz, CDCl3):  176.4, 174.6, 142.7, 140.4, 137.8, 132.8, 129.6, 129.4, 129.1, 129.0, 128.8, 
128.6, 128.3, 120.6, 120.4, 120.1, 112.6, 112.5, 59.3, 53.5, 33.1, 29.9, 29.2, 26.2, 26.2, 25.1, 20.4. 
HRMS (ESI-MS): Mass calc. for [C29H30N2O2Na]+: m/z = 461.2199, found: m/z = 461.2198. 
N-Benzoyl-N-cyclohexyl-2-methoxy-10-methyl-acridane-9-carboxamide (3fa)  
According to the general procedure, using acridane 1f (45.1 mg, 0.2 
mmol, 1.0 equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-
bipyridyne (9.4 mg, 0.06 mmol, 30 mol%), MeCN (2 mL), cyclohexyl 
isocyanide 2a (49.7 µL, 0.40 mmol, 2.0 equiv.), benzoyl peroxide (58.1 
mg, 0.24 mmol, 1.2 equiv.) the title compound was obtained after 4 h by 
flash column chromatography (hexane/EtOAc, 4:1) as white solid (37.3 
mg, 0.082 mmol, 41%). 1H NMR (300 MHz, CDCl3): 8.15 – 8.09 (m, 1H), 
7.79 – 7.73 (m, 2H), 7.71 – 7.63 (m, 1H), 7.62 – 7.53 (m, 2H), 7.52 – 7.44 
(m, 1H), 7.26 – 7.19 (m, 1H), 6.93 – 6.89 (m, 1H), 6.87 – 6.81 (m, 2H), 6.28 (d, J = 2.8 Hz, 1H), 
4.94 (s, 1H), 4.03 (tt, J = 12.0, 3.6 Hz, 1H), 3.70 (s, 3H), 3.38 (s, 3H), 1.87 – 1.27 (m, 8H), 1.08 – 
1.01 (m, 2H). 13C NMR (75 MHz, CDCl3): 176.0, 174.6, 154.0, 142.9, 137.8, 137.0, 133.8, 133.0, 
130.3, 129.5, 129.2, 128.7, 128.6, 128.5, 121.6, 120.1, 114.4, 113.7, 113.5, 112.5, 59.5, 55.8, 53.7, 
33.3, 30.0, 29.2, 26.3, 26.7, 25.2. HRMS (ESI-MS): Mass calc. for [C29H30N2O3Na]+: m/z 
=477.2149, found: m/z = 477.2152.  
N-Benzoyl-N-cyclohexyl-2-bromo-10-methyl-acridane-9-carboxamide (3ga)  
According to the general procedure, using acridane 1g (54.6 mg, 0.2 mmol, 
1.0 equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-bipyridyne (9.4 
mg, 0.06 mmol, 30 mol%), MeCN (2 mL), cyclohexyl isocyanide 2a (49.7 µL, 
0.40 mmol, 2.0 equiv.), benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 equiv.) 
the title compound was obtained after 4 h by flash column chromatography 
(hexane/EtOAc, 9:1) as white solid (63,7 mg, 0.126 mmol, 63%). 1H NMR 
(300 MHz, CDCl3): 7.79 – 7.67 (m, 3H), 7.64 – 7.55 (m, J = 10.3, 4.5 Hz, 
2H), 7.30 (dd, J = 8.7, 2.3 Hz, 1H), 7.28 – 7.22 (m, 1H), 6.98 – 6.88 (m, J = 
7.6, 5.6 Hz, 3H), 6.80 (d, J = 8.8 Hz, 1H), 6.56 (d, J = 2.3 Hz, 1H), 4.90 (s, 1H), 4.01 (tt, J = 11.9, 
3.6 Hz, 1H), 3.38 (s, 3H), 1.92 – 1.77 (m, 1H), 1.72 – 1.57 (m, 4H), 1.52 – 1.36 (m, 2H), 1.15 – 
1.00 (m, 3H). 13C NMR (75 MHz, CDCl3): 175.8, 174.6, 141.9, 141.8, 137.4, 133.2, 130.9, 129.5, 
129.2, 128.7, 128.6, 122.5, 120.8, 120.3, 114.3, 112.9, 112.4, 59.4, 53.0, 33.3, 30.4, 28.8, 26.2, 
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26.1, 25.1. HRMS (ESI-MS): Mass calc. for [C28H28BrN2O2]+: m/z =503.1329, found: m/z = 
503.1309. 
N-Benzoyl-N-cyclohexyl-2-fluoro-10-methyl-acridane-9-carboxamide (3ha)  
According to the general procedure, using acridane 1h (42.6 mg, 0.2 mmol, 
1.0 equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-bipyridyne (9.4 
mg, 0.06 mmol, 30 mol%), MeCN (2 mL), cyclohexyl isocyanide 2a (49.7 µL, 
0.40 mmol, 2.0 equiv.), benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 equiv.) 
the title compound was obtained after 4 h by flash column chromatography 
(hexane/EtOAc, 9:1) as white solid (28.4 mg, 0.06 mmol, 32%). 1H NMR (400 
MHz, CDCl3): 7.76 – 7.71 (m, 2H), 7.71 – 7.66 (m, 1H), 7.60 – 7.54 (m, 2H), 
7.23 – 7.20 (m, 1H), 6.97 – 6.82 (m, 5H), 6.35 (dd, J = 8.6, 2.8 Hz, 1H), 4.92 
(s, 1H), 4.01 (tt, J = 12.0, 3.6 Hz, 1H), 3.40 (s, 3H), 1.87 – 1.75 (m, 1H), 1.73 – 1.64 (m, 1H), 1.56 
– 1.35 (m, 4H), 1.15 – 0.93 (m, 4H). 13C NMR (100 MHz, CDCl3): 175.8, 174.6, 157.5 (d, JC-F = 
239.1 Hz), 142.6, 139.4, 137.6, 133.2, 129.6, 129.2, 128.8, 128.7, 122.2 (d, JC-F = 7.4.1 Hz), 120.6, 
120.1, 115.1 (d, JC-F = 23.0.1 Hz), 114.8 (d, JC-F = 22.4 Hz), 113.6 (d, JC-F = 7.8 Hz), 112.8, 59.6, 
53.3, 33.6, 30.4, 29.0, 26.4. 19F NMR (376 MHz, CDCl3): -124.7. HRMS (ESI-MS): Mass calc. for 
[C28H28FN2O2]+: m/z =443.2129, found: m/z = 443.2136. 
N-Benzoyl-N-cyclohexyl-2,10-dimethyl-acridane-9-carboxamide (3ia)  
According to the general procedure, using acridane 1i (54.3 mg, 0.2 mmol, 
1.0 equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-bipyridyne (9.4 
mg, 0.06 mmol, 30 mol%), MeCN (2 mL), cyclohexyl isocyanide 2a (49.7 
µL, 0.40 mmol, 2.0 equiv.), benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 
equiv.) the title compound was obtained after 4 h by flash column 
chromatography (hexane/EtOAc, 9:1) as white solid (68.1 mg, 0.136 mmol, 
68%). 1H NMR (300 MHz, CDCl3): 7.82 – 7.75 (m, 2H), 7.67 – 7.60 (m, 1H), 
7.55 – 7.39 (m, 7H), 7.34 – 7.23 (m, 2H), 7.02 (d, J = 8.5 Hz, 1H), 6.97 (d, J 
= 8.0 Hz, 1H), 6.93 – 6.83 (m, 3H), 5.03 (s, 1H), 4.06 (tt, J = 12.0, 3.5 Hz, 1H), 3.46 (s, 3H), 1.87 
– 1.69 (m, 2H), 1.62 – 1.50 (m, 4H), 1.39 – 1.32 (m, 2H), 1.09 – 1.01 (m, 2H). 13C NMR (75 MHz, 
CDCl3):  176.1, 174.6, 142.3, 141.9, 140.5, 137.8, 133.1, 133.0, 129.5, 129.2, 128.7, 128.6, 128.5, 
127.1, 126.9, 126.6, 126.5, 120.8, 120.6, 120.5, 113.1, 112.8, 59.3, 53.5, 33.3, 29.8, 26.2, 26.2, 
25.1. HRMS (ESI-MS): Mass calc. for [C34H33N2O2]+: m/z = 501.2537, found: m/z = 501.2540. 
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N-Benzoyl-N-cyclohexyl-2-methoxy-10-benzyl-acridane-9-carboxamide (3ja)  
According to the general procedure, using acridane 1j (60.3 mg, 0.2 
mmol, 1.0 equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-
bipyridyne (9.4 mg, 0.06 mmol, 30 mol%), MeCN (2 mL), cyclohexyl 
isocyanide 2a (49.7 µL, 0.40 mmol, 2.0 equiv.), benzoyl peroxide (58.1 
mg, 0.24 mmol, 1.2 equiv.) the title compound was obtained after 4 h by 
flash column chromatography (hexane/EtOAc, 4:1) as white solid (55.2 
mg, 0.101 mmol, 52%). 1H NMR (400 MHz, CDCl3): 7.84 – 7.79 (m, 2H), 
7.72 – 7.66 (m, 1H), 7.62 – 7.57 (m, 2H), 7.32 – 7.26 (m, 2H), 7.25 – 7.21 
(m, 1H), 7.18 – 7.13 (m, 2H), 7.12 – 7.04 (m, 1H), 6.86 – 6.82 (m, 2H), 6.73 – 6.69 (m, 1H), 6.69 
– 6.66 (m, 2H), 6.33 – 6.26 (m, 1H), 5.16 (s, 2H), 5.01 (s, 1H), 4.07 (t, J = 12.0, 3.5 Hz, 1H), 3.70 
(s, 3H), 1.87 – 1.60 (m, 5H), 1.54 – 1.47 (m, 1H), 1.41 – 1.33 (m, 1H), 1.18 – 0.99 (m, 3H). 13C 
NMR (100 MHz, CDCl3):  176.2, 174.8, 154.1, 141.9, 137.9, 137.3, 135.9, 133.1, 129.6, 129.3, 
128.9, 128.7, 128.6, 127.0, 126.3, 121.3, 120.2, 119.8, 114.9, 114.6, 113.7, 113.4, 59.4, 55.8, 53.3, 
51.1, 30.2, 29.3, 26.4, 26.3, 25.3. HRMS (ESI-MS): Mass calc. for [C35H34N2O3Na]+: m/z 
=531.2642, found: m/z = 531.238. 
 
N-Benzoyl-N-cyclohexyl-2-fluoro-10-benzyl-acridane-9-carboxamide (3ja)  
According to the general procedure, using acridane 1k (43.4 mg, 0.150 
mmol, 1.0 equiv.) dry Cu(OTf)2 (5.4 mg, 0.015 mmol, 10 mol %), 2,2’-
bipyridyne (7.0 mg, 0.045 mmol, 30 mol%), MeCN (1.5 mL), cyclohexyl 
isocyanide 2a (37.2 µL, 0.300 mmol, 2.0 equiv.), benzoyl peroxide (43.6 mg, 
0.180 mmol, 1.2 equiv.) the title compound was obtained after 4 h by flash 
column chromatography (hexane/EtOAc, 9:1) as white solid (55.2 mg, 0.104 
mmol, 52%). 1H NMR (300 MHz, CDCl3): (400 MHz, CDCl3): 7.83 – 7.78 (m, 
2H), 7.74 – 7.68 (m, 1H), 7.62 – 7.57 (m, 2H), 7.32 – 7.26 (m, 2H), 7.24 – 7.21 
(m, 1H), 7.17 – 7.13 (m, 2H), 7.12 – 7.06 (m, 1H), 6.92 – 6.84 (m, 2H), 6.80 (dt, J = 8.7, 3.0 Hz, 
1H), 6.74 (d, J = 8.2 Hz, 1H), 6.67 (dd, J = 9.1, 4.6 Hz, 1H), 6.36 (dd, J = 8.7, 2.9 Hz, 1H), 5.17 
(s, 2H), 4.99 (s, 1H), 4.06 (tt, J = 12.0, 3.5 Hz, 1H), 1.91 – 1.78 (m, 1H), 1.74 – 1.61 (m, 2H), 1.59 
– 1.47 (m, 2H), 1.44 – 1.38 (m, 1H), 1.14 – 0.98 (m, 4H). 13C NMR (100 MHz, CDCl3): 176.1, 
174.8, 157.5 (d, JC-F = 239.3 Hz), 153.9, 141.6, 138.4, 137.6, 136.9, 133.4, 129.7, 129.3, 129.0, 
128.8 (d, JC-F = 7.8 Hz), 127.2, 126.2, 121.8 (d, JC-F = 7.3 Hz), 120.8, 119.7, 115.0 (d, JC-F = 23.0 
Hz), 114.9 (d, JC-F = 22.9 Hz), 114.0, 59.6, 52.9, 51.4, 30.4, 29.1, 26.3. 19F NMR (376 MHz, CDCl3): 
-124.2. HRMS (ESI-MS): Mass calc. for [C34H31FN2O2Na]+: m/z =519.2442, found: m/z = 
519.2446.  
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N-Benzoyl-N-cyclohexyl-1,4,10-trimethyl-acridane-9-carboxamide (3la)  
According to the general procedure, using acridane 1l (44.3 mg, 0.2 mmol, 1.0 
equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-bipyridyne (9.4 mg, 
0.06 mmol, 30 mol%), MeCN (2 mL), cyclohexyl isocyanide 2a (49.7 µL, 0.40 
mmol, 2.0 equiv.), benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 equiv.) the title 
compound was obtained after 4 h by flash column chromatography 
(hexane/EtOAc, 9:1) as white solid (51.6 mg, 0.114 mmol, 57%). 1H NMR (300 
MHz, CDCl3): 7.64 – 7.45 (m, 5H), 7.25 – 7.19 (m, 1H), 7.13 – 7.08 (m, 1H), 7.01 
– 6.95 (m, 1H), 6.83 – 6.74 (m, 2H), 6.53 – 6.47 (m, 1H), 5.35 (s, 1H), 3.83 (tt, J 
= 12.0, 3.6 Hz, 1H), 3.55 (s, 3H), 2.39 (s, 3H), 2.33 (s, 3H), 1.91 – 1.71 (m, 2H), 1.62 (s, 2H), 1.51 
– 1.43 (m, 1H), 1.37 – 1.23 (m, 2H), 1.12 – 0.95 (m, 3H). 13C NMR (75 MHz, CDCl3): 177.0, 174.6, 
147.3, 144.0, 136.9, 133.3, 132.3, 131.1, 129.1, 128.7, 128.0, 127.0, 125.8, 125.7, 124.2, 120.9, 
117.3, 60.1, 49.7, 41.8, 29.9, 29.3, 26.3, 25.1, 20.7, 19.4. HRMS (ESI-MS): Mass calc. for 
[C29H30N2O2Na]+: m/z = 461.2199, found: m/z = 461.2198. 
N-Benzoyl-N-benzyl-10-methyl-acridane-9-carboxamide (3ab)  
According to the general procedure, using acridane 1a (39.0 mg, 0.2 mmol, 1.0 
equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-bipyridyne (9.4 mg, 
0.06 mmol, 30 mol%), MeCN (2 mL), benzyl isocyanide 2b (46.8 mg, 0.40 mmol, 
2.0 equiv.), benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 equiv.) the title 
compound was obtained after 4 h by flash column chromatography 
(hexane/EtOAc, 9:1) as white solid (45.0 mg, 0.104 mmol, 52%). 1H NMR ((300 
MHz, CDCl3): 7.64 – 7.55 (m, 3H), 7.51 – 7.44 (m, 2H), 7.31 – 7.24 (m, 2H), 7.17 
– 7.10 (m, 3H), 7.05 – 7.01 (m, 2H), 6.98 – 6.87 (m, 6H), 5.58 (s, 1H), 4.78 (s, 
2H), 3.38 (s, 3H). 13C NMR (75 MHz, CDCl3): 175.1, 173.8, 142.6, 137.9, 134.0, 130.6, 129.5, 
128.3, 128.2, 121.0, 120.4, 112.8, 60.0, 53.3, 28.8. HRMS (ESI-MS): Mass calc. for 
[C29H25N2O2Na]+: m/z = 433.1911, found: m/z = 433.1920.  
N-Benzoyl-N,10-dibenzyl--acridane-9-carboxamide (3bb)  
According to the general procedure, using acridane 1b (40.7 mg, 0.15 mmol, 1.0 
equiv.) dry Cu(OTf)2 (5.4 mg, 0.015 mmol, 10 mol %), 2,2’-bipyridyne (7 mg, 
0.045 mmol, 30 mol%), MeCN (1.5 mL), benzyl isocyanide 2b (35.1 mg, 0.30 
mmol, 2.0 equiv.), benzoyl peroxide (43.6 mg, 0.18 mmol, 1.2 equiv.) the title 
compound was obtained after 4 h by flash column chromatography 
(hexane/EtOAc, 9:1) as white solid (27.4 mg, 0.054 mmol, 36%). 1H NMR (400 
MHz, CDCl3): 7.63 – 7.56 (m, 3H), 7.49 – 7.44 (m, 2H), 7.30 – 7.21 (m, 3H), 7.17 
– 7.08 (m, 7H), 7.04 – 7.01 (m, 2H), 6.96 – 6.92 (m, 2H), 6.89 – 6.82 (m, 2H), 
6.77 – 6.73 (m, 2H), 5.64 (s, 1H), 5.14 (s, 2H), 4.82 (s, 2H). 13C NMR (100 MHz, CDCl3): 176.4, 
174.9, 141.9, 137.2, 136.9, 136.0, 134.5, 132.9, 129.2, 128.9, 128.6, 128.5, 127.8, 127.3, 127.0, 
126.3, 120.9, 120.8, 116.3, 114.2, 51.1, 50.7, 50.4. HRMS (ESI-MS): Mass calc. for [C35H29N2O2]+: 
m/z = 509.2229, found: m/z = 509.2231.  
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N-Benzoyl-N-tert-butyl-10-methyl-acridane-9-carboxamide (3ac)  
 According to the general procedure, using acridane 1a (39.0 mg, 0.2 mmol, 1.0 
equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-bipyridyne (9.4 mg, 
0.06 mmol, 30 mol%), MeCN (2 mL), tert-butyl isocyanide 2c (45.2 µL, 0.40 
mmol, 2.0 equiv.), benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 equiv.) the title 
compound was obtained after 4 h by flash column chromatography 
(hexane/EtOAc, 9:1) as white solid (42.2 mg, 0.106 mmol, 53%). 1H NMR (300 
MHz, CDCl3): 8.04 – 7.98 (m, 2H), 7.76 – 7.68 (m, 1H), 7.64 – 7.53 (m, 2H), 7.25 
– 7.17 (m, 2H), 6.95 – 6.88 (m, 2H), 6.87 – 6.79 (m, 2H), 6.68 – 6.60 (m, 2H), 
4.63 (s, 1H), 3.39 (s, 3H), 1.37 (s, 9H). 13C NMR (75 MHz, CDCl3): 175.1, 173.8, 142.6, 137.9, 
134.0, 130.6, 129.5, 128.3, 128.2, 121.0, 120.4, 112.8, 60.0, 53.3, 28.8. HRMS (ESI-MS): Mass 
calc. for [C26H27N2O2]+: m/z = 399.2067, found: m/z = 399.2072. 
 
N-Benzoyl-N-tert-butyl-10-benzyl-acridane-9-carboxamide (3bc)  
 According to the general procedure, using acridane 1b (54.3 mg, 0.2 mmol, 1.0 
equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-bipyridyne (9.4 mg, 
0.06 mmol, 30 mol%), MeCN (2 mL), tert-butyl isocyanide 2c (45.2 µL, 0.40 
mmol, 2.0 equiv.), benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 equiv.) the title 
compound was obtained after 4 h by flash column chromatography 
(hexane/EtOAc, 9:1) as white solid (35.5 mg, 0.075 mmol, 37%). 1H NMR (400 
MHz, CDCl3):  8.07 – 7.97 (m, 2H), 7.78 – 7.68 (m, 1H), 7.64 – 7.55 (m, 2H), 
7.31 – 7.27 (m, 2H), 7.25 – 7.20 (m, 1H), 7.18 – 7.10 (m, 2H), 7.11 – 6.98 (m, 
2H), 6.81 – 6.75 (m, 2H), 6.73 – 6.68 (m, 2H), 6.68 – 6.62 (m, 2H), 5.18 (s, 2H), 4.76 (s, 1H), 1.39 
(s, 9H). 13C NMR (100 MHz, CDCl3):  173.9, 173.2, 141.6, 140.1, 137.2, 134.2, 130.7, 129.5, 
128.8, 128.3, 128.2, 126.9, 126.2, 120.7, 120.5, 113.9, 59.9, 52.8, 51.2, 28.7. HRMS (ESI-MS): 
Mass calc. for [C32H30N2O2]+: m/z = 475.2380, found: m/z = 475.2385. 
 
N-Benzoyl-N-butyl-10-methyl-acridane-9-carboxamide (3ad)  
 According to the general procedure, using acridane 1a (29.3 mg, 0.15 mmol, 
1.0 equiv.) dry Cu(OTf)2 (5.4 mg, 0.015 mmol, 10 mol %), 2,2’-bipyridyne (7 mg, 
0.045 mmol, 30 mol%), MeCN (1.5 mL), butyl isocyanide 2d (31.4 µL, 0.30 
mmol, 2.0 equiv.), benzoyl peroxide (43.6 mg, 0.18 mmol, 1.2 equiv.) the title 
compound was obtained after 4 h by flash column chromatography 
(hexane/EtOAc, 9:1) as white solid (26.3 mg, 0.066 mmol, 44%). 1H NMR (400 
MHz, CDCl3): 7.68 – 7.60 (m, 3H), 7.55 – 7.50 (m, 2H), 7.29 – 7.23 (m, 2H), 7.06 
– 7.02 (m, 2H), 6.99 – 6.94 (m, 2H), 6.92 – 6.86 (m, 2H), 5.47 (s, 1H), 3.56 – 3.49 
(m, 2H), 3.43 (s, 3H), 1.30 – 1.20 (m, 2H), 1.16 – 1.02 (m, 2H), 0.71 (t, J = 7.3 Hz, 3H). 13C NMR 
(100 MHz, CDCl3): 176.4, 174.9, 142.8, 136.2, 132.7, 129.2, 128.9, 128.6, 128.4, 121.3, 120.6, 
112.9, 50.9, 47.8, 33.3, 30.7, 20.1, 13.7. HRMS (ESI-MS): Mass calc. for [C26H27N2O2]+: m/z = 
399.2067, found: m/z = 399.2067. 
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N-Benzoyl-N-butyl-10-benzyl-acridane-9-carboxamide (3bd)  
 According to the general procedure, using acridane 1b (40.7 mg, 0.15 mmol, 
1.0 equiv.) dry Cu(OTf)2 (5.4 mg, 0.015 mmol, 10 mol %), 2,2’-bipyridyne (7 mg, 
0.045 mmol, 30 mol%), MeCN (1.5 mL), butyl isocyanide 2d (31.4 µL, 0.30 
mmol, 2.0 equiv.), benzoyl peroxide (43.6 mg, 0.18 mmol, 1.2 equiv.) the title 
compound was obtained after 4 h by flash column chromatography 
(hexane/EtOAc, 9:1) as white solid (40.7 mg, 0.085 mmol, 57%). 1H NMR (300 
MHz, CDCl3): 7.75 – 7.69 (m, 2H), 7.68 – 7.62 (m, 1H), 7.59 – 7.53 (m, 2H), 7.34 
– 7.23 (m, 3H), 7.22 – 7.16 (m, 2H), 7.16 – 7.05 (m, 4H), 6.93 – 6.84 (m, 2H), 
6.83 – 6.72 (m, 2H), 5.55 (s, 1H), 5.22 (s, 2H), 3.62 – 3.53 (m, 2H), 1.35 – 1.21 (m, 2H), 1.19 – 
1.01 (m, 2H), 0.73 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3):  177.0, 175.0, 142.0, 137.1, 
136.2, 132.8, 129.3, 129.0, 128.9, 128.6, 127.0, 126.3, 121.0, 120.8, 114.1, 51.2, 50.4, 47.9, 30.7, 
20.1, 13.7. HRMS (ESI-MS): Mass calc. for [C32H30N2O2]+: m/z = 475.2380, found: m/z = 
475.2381. 
N-Benzoyl-N-(4-methoxyphenyl)-10-methyl-acridane-9-carboxamide (3ae)  
According to the general procedure, using acridane 1a (29.3 mg, 0.15 
mmol, 1.0 equiv.) dry Cu(OTf)2 (5.4 mg, 0.015 mmol, 10 mol %), 2,2’-
bipyridyne (7 mg, 0.045 mmol, 30 mol%), MeCN (1.5 mL),  4-
methoxyphenyl isocyanide 2e (39.0 mg, 0.30 mmol, 2.0 equiv.), benzoyl 
peroxide (43.6 mg, 0.18 mmol, 1.2 equiv.) the title compound was 
obtained after 4 h by flash column chromatography (hexane/EtOAc, 
4:1) as white solid (17.5 mg, 0.039 mmol, 26%). 1H NMR (300 MHz, 
CDCl3): 7.41 – 7.20 (m, 10H), 7.02 – 6.94 (m, 4H), 6.84 (s, 3H), 5.68 (s, 
1H), 3.76 (s, 3H), 3.39 (s, 3H). 13C NMR (75 MHz, CDCl3):  176.4, 173.4, 159.1, 142.8, 135.0, 
132.1, 131.9, 129.6, 128.9, 128.7, 128.6, 128.3, 121.1, 120.6, 114.9, 113.0, 55.5, 50.3, 33.3. HRMS 
(ESI-MS): Mass calc. for [C29H24N2O3]+: m/z = 449.1860, found: m/z = 449.1870. 
 
N-Benzoyl-N-(4-methoxyphenyl)-10-benzyl-acridane-9-carboxamide (3be)  
According to the general procedure, using acridane 1b (40.7 mg, 0.15 
mmol, 1.0 equiv.) dry Cu(OTf)2 (5.4 mg, 0.015 mmol, 10 mol %), 2,2’-
bipyridyne (7 mg, 0.045 mmol, 30 mol%), MeCN (1.5 mL),  4-
methoxyphenyl isocyanide 2e (39.0 mg, 0.30 mmol, 2.0 equiv.), benzoyl 
peroxide (43.6 mg, 0.18 mmol, 1.2 equiv.) the title compound was 
obtained after 4 h by flash column chromatography (hexane/EtOAc, 
4:1) as white solid (55.9 mg, 0.106 mmol, 71%). 1H NMR 7.45 – 7.37 
(m, 3H), 7.35 – 7.27 (m, 5H), 7.25 – 7.13 (m, 6H), 7.00 – 6.94 (m, 2H), 
6.87 – 6.83 (m, 4H), 6.80 – 6.76 (m, 2H), 5.73 (s, 1H), 5.12 (s, 2H), 3.78 (s, 3H). 13C NMR (100 
MHz, CDCl3):  177.0, 173.5, 159.2, 141.7, 137.1, 135.0, 132.1, 132.0, 129.7, 129.0, 128.9, 128.8, 
128.7, 128.4, 127.0, 126.2, 120.9, 120.8, 114.9, 114.2, 55.6, 51.3, 50.0. HRMS (ESI-MS): Mass 
calc. for [C35H28N2O3]+: m/z = 525.2173, found: m/z = 525.2178. 
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N-Benzoyl-N-(4-methoxyphenyl)-10-benzyl-acridane-9-carboxamide (5ba)  
According to the general procedure, using acridane 1b (40.7 mg, 0.15 
mmol, 1.0 equiv.) dry Cu(OTf)2 (5.4 mg, 0.015 mmol, 10 mol %), 2,2’-
bipyridyne (7 mg, 0.045 mmol, 30 mol%), MeCN (1.5 mL),  cyclohexyl 
isocyanide 2a (37.2 µL, 0.40 mmol, 2.0 equiv.), (2,4-diclorobenzoyl) 
peroxide (50% w/w in polysiyloxane, 136.8 mg, 0.18 mmol, 1.2 equiv.) the 
title compound was obtained after 4 h by flash column chromatography 
(hexane/EtOAc, 9:1) as white solid (15.4 mg, 0.027 mmol, 18%). 1H NMR 
(300 MHz, CDCl3): 7.59 (d, J = 2.0 Hz, 1H), 7.37 (d, J = 8.2, 1.9 Hz, 1H), 
7.33 – 7.27 (m, 3H), 7.25 – 7.17 (m, 4H), 7.16 – 7.10 (m, 2H), 7.07 – 7.00 
(m, 2H), 6.94 – 6.87 (m, 2H), 6.83 – 6.76 (m, 2H), 5.46 (s, 1H), 5.21 (s, 2H), 3.69 (tt, J = 11.9, 3.5 
Hz, 1H), 1.79 – 1.63 (m, 2H), 1.62 – 1.56 (m, 2H), 1.51 – 1.43 (m, 2H), 1.24 – 1.17 (m, 1H), 0.97 
– 0.77 (m, 3H). 13C NMR (75 MHz, CDCl3): 177.5, 169.9, 141.7, 137.4, 136.9, 135.4, 135.3, 132.8, 
130.8, 129.8, 129.0, 128.9, 128.8, 127.9, 127.1, 126.3, 120.9, 120.1, 114.1, 60.2, 53.3, 51.09, 29.7, 
26.3, 25.1. HRMS (ESI-MS): Mass calc. for [C34H31Cl2N2O2]+: m/z = 569.1763, found: m/z = 
569.1705. 
N-Benzoyl-N-cyclohexyl-xanthene-9-carboxamide (3ma) 
According to the general procedure, using xanthene 1m (36.4 mg, 0.2 mmol, 1 
equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-bipyridyne (9.4 mg, 
0.06 mmol, 30 mol%), MeCN (2 mL), cyclohexyl isocyanide 2a (49.7 µL, 0.40 
mmol, 2.0 equiv.), benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 equiv.) the title 
compound was obtained after 18 h by flash column chromatography 
(hexane/EtOAc, 9:1) as a white solid (17.3 mg, 0.042 mmol, 21%). 1H NMR (300 
MHz, CDCl3): 7.85 – 7.81 (m, 2H), 7.72 – 7.65 (m, 1H), 7.61 – 7.54 (m, 2H), 7.27 
– 7.22 (m, 2H), 7.14 – 7.11 (m, 2H), 7.04 – 6.98 (m, 2H), 6.95 – 6.91 (m, 2H), 4.98 (s, 1H), 4.05 
(tt, J = 12.0, 3.6 Hz, 1H), 1.86 – 1.71 (m, 3H), 1.66 – 1.59 (m, 2H), 1.45 – 1.37 (m, 2H), 1.13 – 
0.96 (m, 3H).13C NMR (75 MHz, CDCl3): 178.9, 175.2, 152.2, 133.5, 129.5, 129.4, 129.1, 128.4, 
123.2, 119.6, 117.2, 116.7, 59.7, 49.0, 29.8, 26.2, 25.1. HRMS (ESI-MS): Mass calc. for 
[C27H26NO3]+: m/z = 412.1907, found: m/z = 412.1912. 
N-Benzoyl-N-cyclohexyl-3methoxy-xanthene-9-carboxamide (3ma) 
According to the general procedure, using xanthene 1m (42.5 mg, 0.2 
mmol, 1 equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-
bipyridyne (9.4 mg, 0.06 mmol, 30 mol%), MeCN (2 mL), cyclohexyl 
isocyanide 2a (49.7 µL, 0.40 mmol, 2.0 equiv.), benzoyl peroxide (58.1 mg, 
0.24 mmol, 1.2 equiv.) the title compound was obtained after 18 h by 
flash column chromatography (hexane/EtOAc, 9:1) as a white solid (47.9 
mg, 0.116 mmol, 58%). 1H NMR (300 MHz, CDCl3): 7.87 – 7.81 (m, 2H), 
7.73 – 7.66 (m, 1H), 7.62 – 7.55 (m, 2H), 7.28 – 7.22 (m, 1H), 7.14 – 7.10 (m, 1H), 7.03 – 6.98 (m, 
1H), 6.95 – 6.91 (m, 1H), 6.84 (d, J = 8.6 Hz, 1H), 6.68 (d, J = 2.5 Hz, 1H), 6.60 (dd, J = 8.5, 2.6 
Hz, 1H), 4.92 (s, 1H), 4.12 – 4.02 (m, 1H), 3.80 (s, 3H), 1.88 – 1.74 (m, 2H), 1.70 – 1.61 (m, 2H), 
1.54 – 1.41 (m, 3H), 1.18 – 0.99 (m, 3H). 13C NMR (75 MHz, CDCl3): 176.3, 175.2, 160.3, 153.1, 
152.1, 137.2, 133.5, 129.5, 129.4, 129.0, 128.9, 128.4, 123.2, 119.8, 119.7, 117.1, 111.7, 111.6, 
110.2, 102.0, 59.6, 55.5, 48.4, 29.8, 29.8, 26.2, 25.2. 
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N-Benzoyl-N-cyclohexyl-3-methoxy-xanthene-9-carboxamide (3oa) 
According to the general procedure, using xanthene 1o (42.5 mg, 0.2 
mmol, 1 equiv., partially deuterated in 9-position circa 50%) dry 
Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 2,2’-bipyridyne (9.4 mg, 0.06 
mmol, 30 mol%), MeCN (2 mL), cyclohexyl isocyanide 2a (49.7 µL, 0.40 
mmol, 2.0 equiv.), benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 equiv.) the 
title compound was obtained after 18 h by flash column chromatography 
(hexane/EtOAc, 9:1) as a white solid (47.9 mg, 0.116 mmol, 58%). 1H 
NMR (400 MHz, CDCl3): 7.87 – 7.81 (m, 2H), 7.73 – 7.66 (m, 1H), 7.62 – 7.55 (m, 2H), 7.28 – 
7.22 (m, 1H), 7.11 (d, J = 8.1 Hz, 1H), 7.03 – 6.98 (m, 1H), 6.95 – 6.91 (m, 1H), 6.84 (d, J = 8.6 
Hz, 1H), 6.68 (d, J = 2.5 Hz, 1H), 6.60 (dd, J = 8.5, 2.6 Hz, 1H), 4.92 (s, 1H), 4.07 (tt, J = 12.1, 
3.1 Hz, 1H), 3.80 (s, 3H), 1.88 – 1.74 (m, 2H), 1.70 – 1.61 (m, 2H), 1.54 – 1.41 (m, 3H), 1.18 – 
0.99 (m, 3H). 13C NMR (101 MHz, CDCl3): 176.3, 175.2, 160.3, 153.1, 152.1, 137.2, 133.5, 129.5, 
129.4, 129.0, 128.9, 128.4, 123.2, 119.8, 119.7, 117.1, 111.7, 111.6, 110.2, 102.0, 59.6, 55.5, 48.4, 
29.8, 26.2, 25.2. HRMS (ESI-MS): Mass calc. for [C28H27NO4]+: m/z = 442.2013, found: m/z = 
442.2022. Deuterated portion. Mass calc. for [C28H26DNO4]+: m/z = 443.2076, found: m/z = 
443.2076 
N-Benzoyl-N-cyclohexyl-3,6-dimethoxy-xanthene-9-carboxamide (3pa) 
According to the general procedure, using xanthene 1p (48.5 mg, 
0.2 mmol, 1 equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 
2,2’-bipyridyne (9.4 mg, 0.06 mmol, 30 mol%), MeCN (2 mL), 
cyclohexyl isocyanide 2a (49.7 µL, 0.40 mmol, 2.0 equiv.), benzoyl 
peroxide (58.1 mg, 0.24 mmol, 1.2 equiv.) the title compound was 
obtained after 18 h by flash column chromatography 
(hexane/EtOAc, 4:1) as a white solid (63.3 mg, 0.134 mmol, 67%). 
1H NMR (400 MHz, CDCl3): 7.88 – 7.76 (m, 2H), 7.72 – 7.65 (m, 1H), 7.63 – 7.50 (m, 2H), 6.82 
(d, J = 8.5 Hz, 2H), 6.66 (d, J = 2.6 Hz, 2H), 6.60 (d, J = 2.5 Hz, 1H), 6.58 (d, J = 2.6 Hz, 1H), 
4.84 (s, 1H), 4.07 (tt, J = 12.0, 3.6 Hz, 1H), 1.88 – 1.74 (m, 2H), 1.69 – 1.62 (m, 2H), 1.53 – 1.42 
(m, 3H), 1.19 – 1.01 (m, 3H). 13C NMR (101 MHz, CDCl3): 176.7, 175.3, 160.3, 153.0, 137.3, 
133.5, 129.5, 129.5, 129.0, 111.91, 110.1, 102.0, 59.7, 55.6, 47.8, 29.9, 26.3, 25.2. HRMS (ESI-
MS): Mass calc. for [C29H29NO5]+: m/z = 472.2118, found: m/z = 472.2126. 
N-Benzoyl-N-(naphtalen-2-yl)-3,6-dimethoxy-xanthene-9-carboxamide (3pf) 
According to the general procedure, using xanthene 1p (48.5 mg, 
0.2 mmol, 1 equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 mol %), 
2,2’-bipyridyne (9.4 mg, 0.06 mmol, 30 mol%), MeCN (2 mL), 2- 
naphtalen-2-yl isocyanide 2f (49.7 µL, 0.40 mmol, 2.0 equiv.), 
benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 equiv.) the title 
compound was obtained after 18 h by flash column 
chromatography (hexane/EtOAc, 4:1) as a white solid (49.6 mg, 
0.097 mmol, 49%). 1H NMR (300 MHz, CDCl3): 7.79 – 7.75 (m, 1H), 7.73 (d, 1H), 7.65 – 7.59 (m, 
3H), 7.49 – 7.42 (m, 3H), 7.40 – 7.32 (m, 4H), 7.30 – 7.26 (m, 2H), 6.71 (dd, J = 8.5, 2.6 Hz, 2H), 
6.59 (d, J = 2.5 Hz, 2H), 3.81 (s, 6H). 13C NMR (75 MHz, CDCl3): 170.8, 160.4, 152.7, 133.8, 
130.3, 130.0, 129.5, 129.3, 129.1, 128.6, 128.5, 128.1, 128.1, 127.8, 127.8, 127.3, 126.7, 125.8, 
123.2, 111.8, 110.3, 102.0, 55.6, 45.5. 
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N-Benzoyl-N-cyclohexyl-2,8-dimethyl-6H,12H-5,11-methanodibenzo[b,f][1,5] 
diazocine-6-carboxamide 
According to the general procedure, using Tröger’s base 1p 
(48.5 mg, 0.2 mmol, 1 equiv.) dry Cu(OTf)2 (7.2 mg, 0.02 mmol, 10 
mol %), 2,2’-bipyridyne (9.4 mg, 0.06 mmol, 30 mol%), MeCN (2 
mL), cyclohexyl isocyanide 2a (49.7 µL, 0.40 mmol, 2.0 equiv.), 
benzoyl peroxide (58.1 mg, 0.24 mmol, 1.2 equiv.) the title 
compound was obtained after 18 h by flash column chromatography 
(hexane/EtOAc, 4:1) as a white solid (27.8 mg, 0.058 mmol, 29%). 1H NMR (400 MHz, CDCl3): 
7.84 – 7.78 (m, 2H), 7.50 – 7.41 (m, 3H), 7.05 (d, J = 8.2 Hz, 1H), 7.00 – 6.96 (m, 1H), 6.93 – 6.88 
(m, 2H), 6.65 (s, 1H), 6.51 (s, 1H), 4.86 (d, J = 17.3 Hz, 1H), 4.30 – 4.16 (m, 2H), 3.94 (d, J = 17.3 
Hz, 1H), 3.80 (d, J = 16.6 Hz, 1H), 3.62 (d, J = 16.5 Hz, 1H), 2.21 (s, 3H), 2.14 (s, 3H), 1.75 – 1.64 
(m, 3H), 1.56 – 1.49 (m, 2H), 1.38 – 1.31 (m, 1H), 1.23 – 1.11 (m, 3H), 1.09 – 1.00 (m, 1H). 13C 
NMR (101 MHz, CDCl3): 171.2, 170.4, 146.7, 140.7, 137.2, 134.8, 134.0, 132.3, 128.9, 128.8, 
128.5, 128.3, 127.8, 127.4, 126.9, 126.8, 125.5, 125.0, 74.5, 58.2, 58.0, 53.7, 31.1, 28.8, 26.4, 25.4, 
21.1. HRMS (ESI-MS): Mass calc. for [C31H33N3O2]+: m/z = 480.2646, found: m/z = 480.2651. 
 
Reactivity and Mechanistic studies. 
Ugi-type reaction with the acridinium salt intermediate (1a’)1c: synthesis of N-p-
toluyl-N-cyclohexyl-10-methyl-acridane-9-carboxamide (6aa) 
In an oven-dried screw cap schlenk dry 1a’ (58.6 mg, 0.2 mmol, 1 equiv.) 
was dissolved in dry MeCN (2 mL). Then cyclohexyl isocyanide 2 (49.7 
µL, 0.4 mmol, 2 equiv.) and sodium p- toluate (34.5, 0.48 mmol, 2.4 
equiv.) were added and the obtained mixture was stirred at room 
temperature for 4 h. After evaporating the solvent, the crude product 
was purified by by flash column chromatography (hexane/EtOAc, 9:1) 
obtain 6aa as a white solid (27.8 mg, 0.058 mmol, 29%). 1H NMR (300 
MHz, CDCl3): (300 MHz, CDCl3):  7.73 – 7.60 (m, 2H), 7.40 – 7.29 (m, 
2H), 7.25 – 7.19 (m, 2H), 6.97 – 6.90 (m, 2H), 6.90 – 6.82 (m, 2H), 6.81 
– 6.73 (m, 2H), 4.97 (s, 1H), 4.03 (tt, J = 12.0, 3.6 Hz, 1H), 3.41 (s, 3H), 2.51 (s, 3H), 1.76 – 1.57 
(m, 4H), 1.52 – 1.44 (m, 1H), 1.30 – 1.25 (m, 2H), 1.14 – 0.99 (m, 3H). 13C NMR (75 MHz, CDCl3): 
 176.0, 174.7, 144.0, 142.7, 135.0, 130.1, 129.5, 128.6, 128.4, 120.9, 120.5, 112.8, 59.3, 53.19, 
33.3, 29.8, 26.3, 25.3, 21.9. HRMS (ESI-MS): Mass calc. for [C29H30N2O2]+: m/z = 439.2380, 
found: m/z = 439.2381. 
Competition experiment 
In an oven-dried screw cap schlenk dry Cu(OTf)2 (5.4 mg, 0.015 mmol, 10 mol %), 2,2’-bipyridyne 
(7 mg, 0.045 mmol, 30 mol%), acridane 1a (29.3 mg, 0.15 mmol, 1 equiv.) and p-toluic acid (24.5 
mg, 0.18 mmol, 1.2 equiv.) were added following this order. The solid mixture was dissolved in 
acetonitrile (1.5 mL), then the cyclohexyl isocyanide 2a (37.2 µL, 0.30, 2 equiv.) and benzoyl 
peroxide (43.1 mg, 0.18 mmol, 1.2 equiv.) were added following this order. The obtained mixture 
was stirred at room temperature for 4 h. After evaporating the solvent, the crude product was 
purified by by flash column chromatography (hexane/EtOAc, 9:1) obtain a mixture of 3aa and 
6aa as a white solid (3aa + 6aa 66:33, 29.1 mg, 29%) 
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 Selected NMR examples 
N-benzoyl-N-cyclohexyl-10-methyl-acridane-9-carboxamide (3aa)  
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N-benzoyl-N-cyclohexyl-3,6-dimethoxy-xanthene-9-carboxamide (3pa) 
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Summary / Zusammenfassung 
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Csp3-H bonds are ubiquitous in natural and synthetic molecules, but chemists are still 
struggling to develop general and convenient methodologies for a gentle and direct activation of 
such bonds. Indeed, new mild and regioselective processes involving the oxidative 
functionalization of high energetic Csp3-H bonds are highly desirable, especially when valuable 
heterocyclic scaffolds are involved. Following this perspective, in this thesis are presented my 
results on the mild Csp3-H bond oxidative activation involved in the synthesis, ring expansion 
and functionalization of heterocycles. 
 
In Chapter 2, two different approaches in which the oxidative C-H functionalization is applied 
on the formation of reactive dipolar species trapped in-situ by dipolar cycloaddition are shown. 
In this context, the TEMPO mediated formal “dehydrogenation” of N-carbamoyl protected 
hydroxylamines, and the consequent trapping of the generated unstable nitrones were proposed. 
This methodology resulted as a very efficient approach for the synthesis of several N-acyl and 
N-carbomoyl isoxazolines, allowing also the reaction with more challenging substrate, such as 
alkyl and allyl hydroxylamine. Furthermore, a two-step one-pot azide formation/click-reaction 
preliminary study was displayed. The reaction consisted in a copper/hydroxylperoxide mediated 
Csp3-H activation, addition of trimethylsilyl-azide and the consecutive click-reaction step.  This 
strategy, in its simplicity, resulted very versatile, and it allowed the formation of poly-
heterocycles from unstable azide substituted systems. 
 
In Chapter 3, applications of diazocompounds in expansion ring reaction of heterocycles via 
Csp3-H oxidative functionalization were further explored. Following the experience grown in 
the García’s group, a novel methodology for the synthesis of demanding benzoazepine scaffold 
via TEMPO salt mediated Csp3-H oxidative functionalization/ring expansion of common 
tetrahydroisoquinoline was developed. Furthermore, a new synthetic pathway for a high value 
anti-obesity drug, so called Lorcaserin was porposed. Finally, a preliminary study for the 
achievement of a one-step Csp3-H bond functionalization/N-based expansion ring were 
displayed. 
 
In Chapter 4, a novel oxidative activation/Ugi-type reaction was proposed. This strategy 
allowed for the first time the functionalization of benzylic Csp3-H bonds following a Ugi-type 
approach. In this way, several 9-imide acridanes and xanthenes were prepared, and the 
acridane scaffolds resulted a precursor of a novel and potent class of organo-photocatalyst. In 
addition, the proposed approach was also efficiently enrolled in the functionalization of other 
classes of substrate. 
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Csp3-H Bindungen sind sowohl in der Natur, als auch in synthetischen Molekülen 
allgegenwärtig. Chemikern ist es bis jetzt allerdings nicht gelungen, eine allgemein geeignete 
Methode zu entwickeln, um diese Art von Bindung mild und direkt zu aktivieren. Tatsächlich 
ist die Funktionalisierung von hoch energetischen Csp3-H Bindungen von sehr großen Interesse, 
besonders wenn heterozyklische Strukturen involviert sind. In diesem Zusammenhang, befasst 
sich meine Arbeit mit der milden oxidativen Csp3-H Bindungsaktivierung in der Synthese, 
Ringerweiterung und der Funktionalisierung von Heterozyklen.  
In Kapitel 2 werden zwei verschiedene Konzepte der oxidativen C-H Funktionalisierung 
gezeigt, bei der die Bildung reaktiver bipolarer Spezies, die dann in situ durch eine bipolare 
Zykloaddition abgefangen werden, präsentiert. Vor diesem Hintergrund, wurde die durch 
TEMPO vermittelte formale „Dehydrogenierung“ von N-Carbamoyl geschützten 
Hydroxylaminen und das Abfangen der so gebildeten unstabilen Nitrone entwickelt. Diese 
Methode zeigte sich sehr effizient in der Synthese verschiedener N-Acyl und N-Carbamoyl 
Isoxazoline, als auch bei der Umsetzung anspruchsvoller Substrate, wie Alkyl- und Allyl-
substituierte Hydroxylamine. Des Weiteren, wurde eine vorläufige Studie einer zweistufigen 
Eintopf Azid-Bildungs- und Klick-Reaktion gezeigt. Die Reaktion basiert auf einer 
Kupfer/Hydroxlperoxid unterstützten Csp3-H Aktivierung, der Addition von Trimethylsilylazid 
und der konsekutiven Klick-Reaktion. Diese Strategie, in ihrer Einfachheit, ist ein vielseitiges 
Konzept für die Bildung von Polyheterozyklen ausgehend von labilen Azid-substituierten 
Systemen.   
In Kapitel 3 wurden die Anwendungen von Diazoverbindungen, an 
Ringerweiterungsreaktionen von Heterozyklen, via einer Csp3-H oxidative Funktionalisierung 
erforscht. Eine neue Methode für die Synthese anspruchsvoller Benzazepinderivate durch die 
TEMPO-Salz vermittelte Csp3-H oxidative Funktionalisierung/Ringerweiterung üblicher 
Tetrahydroisoquinoline wurde entwickelt. Des Weiteren, wurde ein neuer Syntheseweg für das 
Arzneimittel Lorcaserin vorgeschlagen. Schließlich wurde eine vorläufige Studie über das 
Erlangen einer einstufigen Csp3-H Bindungsfunktionalisierung/N-basierte Ringerweiterung 
vorgestellt. 
In Kapitel 4 wurde eine neue oxidative Aktivierung/Ugi-artige Reaktion vorgestellt. Durch 
diese Strategie war zum ersten Mal eine Funktionalisierung benzylischer Csp3-H Bindungen 
über eine Ugi-artige Reaktion möglich. Verschiedene 9-Imide, Acridane und Xanthene wurden 
hergestellt, wovon die Acridanverbindungen eine neue und vielversprechende Klasse von 
Organo-Photokatalysatoren darstellt. Außerdem konnte das vorgeschlagene Konzept auch in 
der Funktionalisierung anderer Substanzklassen verwendet warden. 
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1,3-DC 1,3-dipolar cycloaddition 
4-NHAc-T+ 4-Acetoamido-2,2,6,6-tetramethyl-1-
oxopiperidin-1-ium 
4-NHAc-TEMPO (4-Acetoamido-2,2,6,6-tetramethylpiperidin-
1-yl)oxyl 
4-OH-TEMPO (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-
yl)oxyl 
AcOEt Ethyl Acetate 
Ad Adamantyl 
BDE Bond-dissociation energy 
Bn Benzyl 
BOC tert-Butyloxycarbonyl 
BPO Benzoyil Peroxide 
bpy 2,2-Bipyridine 
BTF Trilfluorotoluene 
Bu n-Butane 
Cy Cyclohexyl 
DABCO 1,4-diazabicyclo[2.2.2]octane 
DCE Dichloroethane 
DCM Dichloromethane 
DCP Dicumyl Peroxide 
DFT Density functional theory 
DMAD Dimethyl acetylenedicarboxylate 
DME Dimethoxyethane 
DMF N,N-Dimethylformamide 
DDQ 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone 
DTBP Di-tert-butyl peroxide 
EDG Electron-donating group 
Et Ethyl 
EWG Electron-withdrawing group 
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GC-MS Gas chromatography – mass spectrometry 
HAT Hydrogen atom transfer 
HPLC High performance liquir chromatography 
IBX 2-iodobenzoic acid 
MeCN Acetonitrile 
Me Methyl 
MsOH Methanesulfonic acid 
MTBE Methyl tert-butyl ether 
N3 Azide 
NMR Nuclear magnetic resonance 
OMe Methoxy 
Ph Phenyl 
PIDA (Diacetoxyiodo)benzene 
PIFA (Bis(trifluoroacetoxy)iodo)benzene 
Piv Pivaoyl 
SET Single electron transfer 
T+ 2,2,6,6-tetramethyl-1-oxopiperidin-1-ium 
tBu tert-Butyl 
TEMPO (2,2,6,6-Tetramethylpiperidin-1-yl)oxyl 
TFA Trifluoroacetic acid 
TFE Tetrafluoroethylene 
TfO Triflate 
TfOH Triflic Acid 
THBP tert-Butyl hydroxy peroxide 
THIQ tetrahydroisoquinoline 
TIPS triisopropylsilyl 
TMS Trimethylsilyl 
 145 
 
TMSCHN2 Trimethylsilyl diazomethane 
TMSN3 Trimethylsilyl azide 
TPTA tris(4-bromophenyl)aminium 
hexachloroantimonate 
Troc 2,2,2-Trichlorethoxycarbonyl 
Tol p-Tolyl 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
